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Body of Abstract
Background: Post-stroke dysphagia and post-stroke depression (PSD) can have
devastating effects on stroke survivors and substantial financial impacts on the
healthcare system; however, there is a dearth of research examining this patient
population. Thus, we studied the incidence, risk, and cost of PSD in patients with poststroke dysphagia.
Methods: We conducted a retrospective, cross-sectional study of individuals with a
primary diagnosis of acute ischemic stroke and secondary diagnoses of dysphagia and/or
depression using administrative claims data from the 2017 Medicare 5% Limited Data
Set. Additionally, we developed a novel dysphagia severity index for use with
administrative data and applied it to our data sets.
Results: Persons with post-stroke dysphagia were as, or slightly more, likely to have PSD
compared to the general stroke population. Those with dysphagia (irrespective of
severity) had greater odds and hazard of diagnosis of PSD in the 90 days after discharge,
and those with dysphagia and PSD incurred higher healthcare costs.
Conclusion: Our results supported an association between post-stroke dysphagia and PSD
and that the presence of PSD in patients with post-stroke dysphagia increased postdischarge cost. Thus, future research is warranted to further explore the effects of PSD
on post-stroke dysphagia.
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CHAPTER 1: INTRODUCTION

Background and Significance
Stroke

Stroke is one of the leading causes of morbidity, mortality, and long-term disability
worldwide, impacting more than 795,000 people per year in the United States, with
approximately 75% of strokes occurring in people over the age of 65 (Centers for Disease
Control, 2020). Many stroke survivors experience serious physical and psychological
consequences after stroke, such as dysphagia (difficulty swallowing) and depression
(Kumar et al., 2010; National Stroke Association, n.d.). These common stroke sequelae
often delay functional recovery and are associated with poor patient outcomes,
increased hospital length of stay (LOS), and increased healthcare costs (Kumar et al.,
2010).

Post-Stroke Dysphagia

Dysphagia is a significant impairment that can occur in up to 78% of stroke survivors
(Martino et al., 2005). This condition has many negative consequences, including
increased burden on caregivers and healthcare providers, increased healthcare costs due
to prolonged hospitalizations and readmissions, institutionalization after discharge,
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decreased quality of life (QOL), and increased mortality (Altman et al., 2010; National
Stroke Association, n.d.). Many dysphagic patients experience improvement in swallow
function within the first two to four weeks after stroke (Bahcecı et al., 2017); however,
some patients continue with persistent dysphagia resulting in long-lasting disability
(Kumar et al., 2010). Dysphagia is also associated with serious complications and
comorbidities, such as malnutrition, dehydration, aspiration pneumonia, compromised
overall health (American Speech-Language-Hearing Association [ASHA], n.d.) and
depressive symptoms (Dziewas, et al., 2017; Holland, 2011; Verdonschot et al., 2013,
2017). Furthermore, dysphagia has serious psychosocial impacts, with dysphagic patients
reporting disinterest in eating, embarrassment, reduced self-esteem, and social isolation
(ASHA, n.d.; Ekberg et al., 2002).

Post-Stroke Depression

Post-stroke depression (PSD) is the most common stroke-related neuropsychiatric
disorder, affecting approximately one-third of stroke survivors (Hackett & Pickles, 2014;
Towfighi et al., 2017). PSD is a major predictor of negative outcomes after stroke due to
its association with cognitive and social impairments, reduced treatment efficacy,
disability, poor functional and rehabilitative outcomes, poor QOL, and high mortality
(Bucur & Papagno, 2018; Bhogal et al., 2004; Cole et al., 2001; Das & Rajanikant, 2018;
Towfighi et al., 2017). Though a large number of risk factors for PSD have been
investigated, such as demographics (e.g., age, gender, race), social factors (e.g., marital
status, social support), and medical history (e.g., history of stroke, premorbid
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cardiovascular risk factors, biomarkers), results from the literature remain controversial
(Babkair, 2017). Despite the substantial prevalence and serious consequences of PSD, it
remains under-recognized and, therefore, underidentified by healthcare providers
(Ibrahimagic et al., 2019; Kumar et al., 2010).

Problem Statement

It is known that both post-stroke dysphagia and PSD can have devastating effects on
patients’ physical, psychological, and social well-being as well as substantial financial
impacts on patients, caregivers, and the healthcare system (Dziewas et al., 2017; Paolucci
et al., 2019); however, because of the dearth of research specifically examining PSD in
post-stroke dysphagic patients, the degree to which these condition are associated, how
they impact stroke survivors, and their combined effects of post-stroke recovery are not
known. Furthermore, there is a lack of clinical guidelines to direct clinical practice and
treatment in this patient population. For these reasons, there is a great need for research
to examine the role of PSD in patients with post-stroke dysphagia. Thus, this study will
provide essential information about the association between PSD and post-stroke
dysphagia and propose a novel methodology for classifying dysphagia severity for use in
administrative data research, which may lead to future studies to examine the influence
of PSD on post-stroke dysphagia recovery, establish protocols for early identification of
post-stoke dysphagic patients with PSD, and develop treatment strategies to address
PSD in post-stroke dysphagic patients to maximize recovery and improve outcomes.
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Research Questions

1. What is the rate of PSD in patients with post-stroke dysphagia?
2. How can dysphagia severity in a post-stroke population be categorized using
dysphagia-specific ICD-10 diagnosis and procedure codes to determine if dysphagia
severity impacts diagnosis of PSD?
3. What are the mean healthcare costs for post-stroke dysphagic patients with and
without PSD?

CHAPTER 2: REVIEW OF THE LITERATURE

Section 1: Normal Swallowing
Anatomy, Physiology and Neurologic Control

The act of swallowing is an integrated, dynamic, and complex mechanism, involving a
series of sequential, coordinated sensorimotor events, including a combination of
volitional and reflexive movements of more than 30 nerves and muscles (Malandraki &
Robbins, 2013; Matsuo & Palmer, 2008; Sasegbon & Hamdy, 2017). The neural control of
swallowing recruits from all levels of the nervous system, including the cerebral cortex
(e.g., primary sensorimotor cortex, prefrontal cortex, sensorimotor integration areas, and
parieto-occipital region), subcortical regions (e.g., insula and frontal operculum, anterior
cingulate cortex, basal ganglia, thalamus, hypothalamus, amygdala, cerebellum, and
supplementary motor areas), brainstem, and peripheral nervous system (PNS)
(Dehaghani et al., 2016; Malandraki & Robbins, 2013; Matsuo & Palmer, 2008; Mistry &
Hamdy, 2008; Sasegbon & Hamdy, 2017). The brainstem swallowing center, which is
considered the core of the swallowing system, contains the central pattern generators
(CPGs) that – along with the premotor circuitry and motor neurons – control and
coordinate the phases of swallowing (Lang, 2009; Mistry & Hamdy, 2008). With regard to
cortical control, the literature indicate that cortical representation involved in swallowing
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is bilateral, though asymmetric, with some studies suggesting greater activity in the right
hemisphere (Ertekin & Aydogdu, 2003; Mistry & Hamdy, 2008; Sasegbon & Hamdy,
2017). Mosier and Bereznaya (2001) describe cortical control of swallowing as five
clusters of independent brain regions, with the regions within each cluster working in
excitatory and inhibitory coordination (Cichero & Murdoch, 2006). The clusters are
organized as follows: A – primary motor, sensory, and supplementary cortices and
cingulate gyrus; B – inferior frontal gyrus, secondary sensory cortex, corpus callosum,
basal ganglia, and thalamus; C – premotor and posterior parietal cortices; D –
cerebellum, and E – insula (Cichero & Murdoch, 2006; Mosier and Bereznaya, 2001). The
authors also suggest that certain clusters influence others. For example, the cortical
regions of Cluster A are involved in volitional motor behavior, planning, and execution;
sensory, motor, and cognitive processing; and are thought to act as sensorimotor output
that affect Cluster B, which facilitate sensory information integration about the bolus
(Cichero & Murdoch, 2006; Mosier and Bereznaya, 2001). Furthermore, excitation of
Cluster B provides an inhibitory effect on Cluster D, while Cluster C has the opposite
(excitatory) effect on Cluster A, potentially involving motor planning and implementation
(Cichero & Murdoch, 2006; Mosier and Bereznaya, 2001). Cluster D (cerebellum) controls
motor coordination, timing, sequencing, and proprioception, which modulates the
internal representation for swallowing versus the actual execution of swallowing,
impacting both Clusters A and B (Cichero & Murdoch, 2006; Mosier and Bereznaya,
2001). Finally, Cluster E (insula) affects Clusters A and C, potentially for the purpose of
movement synchronization (Cichero & Murdoch, 2006; Mosier and Bereznaya, 2001).
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The swallowing process is divided into three phases: oral, pharyngeal, and esophageal,
with the oral stage containing two phases: oral preparatory and oral transport (ASHA,
n.d). The volitional actions during the oral phase, such as the stereotypic motor pattern
of mastication, are controlled by discrete areas of the cerebral cortex and CPGs in the
reticular formation and trigeminal nucleus of the brainstem (Jean, 2001; Lang, 2009). The
events of the semi-reflexive pharyngeal phase are triggered and controlled by the
activation of cortical and subcortical brain regions, primarily the CPG in the nucleus
tractus solitarius located in the medulla oblongata of the brainstem (Jean, 2001; Lang,
2009; Mistry & Hamdy, 2008). The involuntary or reflexive esophageal phase is also
coordinated by the swallowing CPG located in the nucleus tractus solitarius of the
medulla oblongata (Jean, 2001; Lang, 2009; Mistry & Hamdy, 2008).

In the oral stage of swallowing, saliva, teeth, and three main muscle groups are
responsible for the execution of oral acceptance, containment, mastication,
manipulation, and bolus formation (Malandraki & Robbins, 2013; Sasegbon & Hamdy,
2017). The first muscle group needed for the oral preparatory and oral transport phases
includes the lips and cheeks, which are comprised of the orbicularis oris, buccinator,
risorius, lip elevators, and lip depressors, and are innervated by the Facial Nerve (CN VII)
(Sasegbon & Hamdy, 2017). The second muscle group is the tongue, which includes the
transverse, vertical, superior, and inferior longitudinal muscles; genioglossus; hyoglossus;
styloglossus; and palatoglossus and are innervated by the Facial (CN VII) (taste),
Glossopharyngeal (CN IX) (taste), Vagus (CN X) (innervates palatoglossus, taste and
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sensation for base of tongue), and Hypoglossal (CN XII) (muscle contractions) nerves
(Sasegbon & Hamdy, 2017). The third muscle group is the mandibular muscles,
comprised of the temporalis, masseter, lateral pterigoids, and medial pterigoids, and
innervated by the Facial nerve (CN VII) and the mandibular branch of the Trigeminal
nerve (CN V3) (Sasegbon & Hamdy, 2017).

The oral phase of swallowing begins with the sensory recognition of food or liquid, as the
olfactory and taste systems work in concert, which causes salivation triggered by
olfaction and taste via sensory fibers in the oropharynx that respond to temperature
and/or touch-pressure and chemoreceptors that respond to smell and taste (Malandraki
& Robbins, 2013). Saliva is produced in anticipation of and throughout eating. Saliva is an
important component of the swallowing process because it aids in mastication (by
softening and breaking down food), formation of a bolus, and lubrication (for bolus
passage into the pharynx) (Sasegbon & Hamdy, 2017). From the oropharyngeal sensory
fibers, the Trigeminal (CN V), Facial (CN VII), Glossopharyngeal (CN IX), and fibers shared
by the Vagus (CN X) and Accessory (CN XI) nerves receive sensory and taste information,
which is transmitted to groups of nuclei in the brainstem (e.g., regions of the nucleus
tractus solitarius, nucleus ambiguus, and reticular formation of both these groups of
nuclei) (Malandraki & Robbins, 2013). These nuclei receive supramedullary input and
transmit motor commands via the Trigeminal (CN V), Facial (CN VII), Glossopharyngeal
(CN IX), fibers shared by the Vagus (CN X) and Accessory (CN XI), and the Hypoglossal (CN
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XII) nerves to the terminal organs (i.e., nearly 40 pairs of oropharyngeal muscles)
(Malandraki & Robbins, 2013).

Teeth, which are innervated by the maxillary and mandibular branches of the Trigeminal
nerve (CN V), are also important structures in the swallowing process because they
physically crush and grind food during mastication, allowing for bolus formation
(Sasegbon & Hamdy, 2017). After food is introduced into the oral cavity and the lips,
teeth, and tongue take the bolus from the utensil, oral containment via labial seal
prevents anterior spillage out of the oral cavity and mastication, using rotary lateral
mandibular movement, occurs while lingual manipulation positions food on the molars
for crushing and grinding. Mastication is a volitional motor task controlled by the
brainstem CPG and supplemented by the motor cortex; however, once initiated, it
becomes largely automatic relying on preprogrammed movement patterns (Mistry &
Hamdy, 2008). During this time, sensory feedback prevents tongue injury during
mastication and indicates when the bolus has been adequately masticated. These oral
preparatory actions are performed through labial, buccal, lingual, mandibular, and velar
movements, which form the bolus (Malandraki & Robbins, 2013). Regarding liquids, the
oral phase is much simpler and faster than with solid foods as mastication is not required.
In normal swallowing, the liquid bolus is introduced through the lips where it is contained
behind closed lips (i.e., labial closure), held in the anterior floor of the mouth or between
the dorsal lingual surface and hard palate, and then is pulled together into a bolus prior
to the initiation of the pharyngeal swallow (Matsuo & Palmer, 2008).
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During the oral transport phase, the tongue initiates the anterior to posterior propulsion
of the bolus from the oral cavity to the pharynx. At the beginning of this phase, the bolus
is on the anterior tongue. The tip of the tongue either tips up or down (e.g., “tipper”
versus “dipper”) positioning the bolus on the superior lingual surface while the posterior
tongue lowers, which occurs via intrinsic lingual muscles (i.e., attached to other muscles
in the tongue, including the superior and inferior longitudinal, vertical and transverse
muscles) and extrinsic lingual muscles (i.e., attached to structures [like the hyoid bone],
including the hyoglossus, styloglossus, genioglossus, and palatoglossus) (Malandraki &
Robbins, 2013; Sasegbon & Hamdy, 2017). The tongue sequentially squeezes against the
hard palate causing anterior to posterior flexion that forces the bolus posteriorly toward
the pharynx (Sasegbon & Hamdy, 2017). As the bolus progresses posteriorly, the sensory
fibers in the oropharynx and tongue that respond to temperature and/or touch-pressure
are stimulated and trigger the initiation of the pharyngeal swallow (Malandraki &
Robbins, 2013; Sasegbon & Hamdy, 2017). While this process is occurring, the velum
elevates, contacts the nasopharynx, and seals the nasopharynx preventing food/liquid
from entering (Sasegbon & Hamdy, 2017).

The pharyngeal phase of swallowing involves numerous sensorimotor and physiologic
behaviors that occur simultaneously between the hypopharynx and the larynx to
transport the bolus from the oropharynx to the esophagus (Logemann, 1998). At the
initiation of the pharyngeal phase, the velum is elevated and in contact with the lateral
and posterior pharyngeal walls, providing complete closure of the velopharyngeal port
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(Matsuo & Palmer, 2008). Lingual-palatal contact propels the bolus against the posterior
pharyngeal wall, which contributes to the positive pressure that pushes the bolus
downward (Malandraki & Robbins, 2013). Laryngeal elevation and anterior hyoid
movement, via the extrinsic laryngeal muscles and thyrohyoid muscles, contribute to
airway protection and opening of the upper esophageal sphincter (UES) - comprised of
the inferior pharyngeal constrictor muscles, cricopharyngeus muscle, and the most
proximal part of the esophagus - for passage of the bolus from the pharynx to the
esophagus (Malandraki & Robbins, 2013). Adequate laryngeal closure is critical for airway
protection; therefore, it occurs at three anatomical levels: the true vocal folds, the false
vocal folds, and the epiglottis (Malandraki & Robbins, 2013). While all of this is occurring,
the pharyngeal constrictors begin contracting in a descending arrangement, the laryngeal
framework is pulled upward, the epiglottis inverts to seal the laryngeal vestibule,
pharyngeal stripping waves and pharyngeal contraction propel the bolus, and finally the
UES (closed at rest by tonic muscle contraction) opens, via relaxation of the
cricopharygeus muscle, to allow the bolus to pass from pharynx to the esophagus
(Malandraki & Robbins, 2013; Sasegbon & Hamdy, 2017).

The esophageal phase begins upon entry of the bolus through the UES. Afferent neurons
transmit the sensation of the arrival of the bolus in the esophagus to the
neurophysiological swallowing centers, which activate vagal efferent fibers producing a
proximal to distal sequence of contractions or peristaltic wave (i.e., “primary peristalsis”)
that propels the bolus toward the stomach (Malandraki & Robbins, 2013). When
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peristalsis is initiated, the lower esophageal sphincter (LES) relaxes and the bolus moves
into the stomach via peristalsis and gravity (Malandraki & Robbins, 2013).
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Section 2: Abnormal Swallowing (Dysphagia)
Stroke-Related Changes in Anatomy, Physiology, and Neurologic Control

Because swallowing is an extremely complex neuromechanism, involving the integration
of many coordinated sensorimotor events, including that of several brain regions (such as
the cortex, subcortical regions, and brainstem), more than 30 nerves and muscles, and
neural control from the peripheral nervous system (PNS) (Malandraki & Robbins, 2013;
Matsuo & Palmer, 2008; Sasegbon & Hamdy, 2017; Wilmskoetter et al., 2019b), it is clear
that a disruption in this process caused by stroke could result in serious impairments in
swallow (Wilmskoetter et al., 2020), thus, impacting a patient’s ability to safely and
efficiently eat and drink, potentially affecting nutrition and hydration. Neurologic insults
can disrupt neuronal transmission of information to and from the central nervous
system, resulting in impaired muscle and sensory function in the oropharyngeal system
(Malandraki & Robbins, 2013). In addition, patients with neurogenic (or post-stroke)
dysphagia frequently present with concomitant language and/or cognitive deficits, which
may further exacerbate symptoms and outcomes (Malandraki & Robbins, 2013).
Understanding not only the symptomatology but also the neurophysiological
underpinnings of post-stroke dysphagia is important because the trajectory of recovery
and clinical outcomes vary depending on brain lesion sites, severity, and complexity
(Logemann, 1998).

The literature posits that swallowing is modulated by a complex bilateral neural network
(Wilmskoetter et al., 2019b). In addition, studies have shown that pharyngeal
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musculature is represented bilaterally (yet asymmetrically) in the cerebral cortex;
therefore, a lesion the ‘‘dominant swallowing hemisphere’’ may result in dysphagia
following a unilateral hemispheric stroke (Cohen et al., 2016). Furthermore, several
scientific studies have revealed that right hemisphere stroke lesions are associated with
greater pharyngeal involvement, including longer pharyngeal transit times, greater risk
for penetration or aspiration, and/or more severe dysphagia (Malandraki & Robbins,
2013; Robbins et al., 1993; Suntrup-Krueger et al., 2017; Wilmskoetter et al., 2019b),
while left hemisphere lesions are associated with oral phase impairments, particularly
decreased lingual coordination and oral apraxia (Malandraki & Robbins, 2013). It is
reported that several different lesion locations can potentially cause dysphagia in stroke
patients, including the somatosensory and motor cortices, anterior cingulate, thalamus,
insula, internal capsule, brainstem, cerebral cortex (including insula, posterior central
gyrus, precentral gyrus, cingulate gyrus, supramarginal gyrus, angular gyrus), and
subcortical structures (including basal ganglia; Liu et al., 2017; Wilmskoetter et al.,
2019b).

The knowledge that stroke lesion location can influence the type and severity of
dysphagia is beneficial for clinicians diagnostically, to facilitate more accurate predictions
of physiological swallow impairments after stroke, and for treatment planning as well. For
example, strokes in the cerebral cortex have been shown to result in both oral and
pharyngeal dysphagia; however, their impact on the oral phase, such as reduced labial
closure, reduced oral containment, and lingual incoordination, is theorized to be due to
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the loss of cortical modulation of the oral swallow neurons (Sasegbon & Hamdy, 2017).
Understanding information about lesion location and how it relates to swallowing
impairment is important for clinicians initiating intervention because although symptom
onset is acute in patients with post-stroke dysphagia, and some recovery is expected due
to the cortical reorganization that generally occurs after stroke (Cohen et al., 2016;
Malandraki & Robbins, 2013), patients still benefit from intervention and management
for transient dysphagia symptoms. Furthermore, even though many stroke patients
recover swallowing function spontaneously during the acute phase (up to 90% of patients
after two weeks) and a number of patients continue to recover at four weeks, 11–50% of
patients present with persistent dysphagia at six months with a small proportion of
patients remaining with dysphagia longer than six months (Bahcecı et al., 2017; Cohen et
al., 2016). The reason is not frequently obvious why some patients experience persistent
dysphagia and others do not, though there may be other contributing factors, including
comorbidities, that may prolong a patient’s swallow recovery.
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Section 3: Post-Stroke Depression
Stroke-Related Changes in Anatomy, Physiology, and Neurologic Control

PSD is defined as a “prominent and persistent period of either depressed mood or
markedly diminished interest or pleasure in most or all activities that (1) is believed to be
the direct physiologic consequence of stroke, (2) is not better explained by another
psychiatric illness or as a feature of delirium, and (3) causes clinically significant distress
or impairment (Nemani & Gurin, 2021, p. 87). The etiology of PSD is not well-understood;
therefore, there is currently no consensus among experts regarding its cause or exactly
what areas of the brain are associated with PSD. However, researchers believe that PSD is
multi-factorial, involving biological and psycho-social factors, such as inflammation,
response to ischemia (as with stroke), genetic susceptibility, neurogenesis, and
involvement of the hypothalamo-pituitary-adrenal (HPA) axis (Das & Rajanikant, 2018;
Towfighi et al., 2018). Furthermore, it is suggested that the role of proinflammatory
cytokines in (stroke-induced) neuroinflammation and neurodegeneration is a major
factor in PSD (Das & Rajanikant, 2018; Towfighi et al., 2018). Multiple scientific studies
have identified brain regions, including the prefrontal cortex, dorsolateral prefrontal
cortex, amygdala, thalamus, hippocampus, anterior cingulate cortex, and basal ganglia,
that may be involved in the neuromechanism of PSD (Douven et al., 2017; Robinson &
Jorge, 2016; Shi et al., 2017b). Additionally, investigators have demonstrated that left
hemisphere lesions are linked with a higher incidence of depression, and location of
subcortical lesions have a greater influence on PSD (Das & Rajanikant, 2018). Recent
research has also shown that damage to the areas associated with PSD can decrease
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activity of the underlying neural networks, resulting in poorer patient prognosis (Shi et
al., 2017b). For example, a stroke lesion in the prefrontal cortex, which has dense axonal
connections to the limbic system, may result in disrupted transmission of information
pertaining to emotions, behavior, and motivation (associated with the limbic system; Shi
et al., 2017b). A study by Wilmskoetter et al. (2019a) performed neuroimaging mapping
of stroke lesions and revealed that brain lesions in cortical structures connected to the
limbic system are associated with reduced improvement in oral intake in dysphagic
patients after stroke. Since there is currently no known literature related to PSD in poststroke dysphagic patients, it may be possible that PSD in post-stroke dysphagic patients
with brain lesions in regions connected to the limbic system is an under-diagnosed
comorbidity that negatively affects stroke recovery, specifically swallow function
recovery, in this patient population.

Although the relationship between PSD and post-stroke swallow function recovery has
not yet been investigated, there have been a number of studies examining PSD and
general functional recovery after stroke. The literature suggest that PSD negatively
affects patients in many ways, including decreased neuroplasticity; physical, social, and
cognitive function; participation in rehabilitation therapies; and ability to perform
activities of daily living (ADLs; Bhogal et al., 2004; Parikh et al., 1990; Towfighi et al.,
2017; Žikić et al., 2014). The majority of studies suggest significantly greater functional
disability in patients with PSD versus non-depressed patients (Žikić et al., 2014).
Accordingly, PSD is associated with poorer functional outcomes and QOL and increased
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healthcare utilization and mortality rates (Bhogal et al., 2004; Parikh et al., 1990; Towfighi
et al., 2017).

There has been much research in the neurology literature examining PSD and functional
recovery, specifically motor recovery. For example, in a randomized controlled trial (RCT),
Chollet et al. (2011) compared fluoxetine (a selective serotonin reuptake inhibitor (SSRI)
antidepressant) to placebo in acute, ischemic stroke patients with PSD and moderate to
severe hemiplegia. The study findings revealed significantly improved motor function in
the fluoxetine group, suggesting that fluoxetine has (or SSRIs in general have) a positive
effect on motor recovery (Chollet et al., 2011). Similarly, a meta-analysis by Mead et al.
(2012) was conducted to determine if SSRIs improve recovery (i.e., reduce dependency
and disability) after stroke. The researchers found evidence that SSRI use after stroke
may improve dependence, disability, neurological impairment, anxiety, and depression
(Mead et al., 2012). Despite promising evidence in the literature, however, it is not yet
fully understood whether improvements in function from SSRIs are due to the role of
pharmacotherapy on neuroplasticity or if PSD impedes motor function recovery and
pharmacotherapy reverses those effects (Towfighi et al., 2017). Further research is
needed to examine the role of PSD in post-stroke recovery and to determine the factors
influencing whether PSD worsens functional outcomes (Chollet et al., 2011; Towfighi et
al., 2017). Likewise, additional research is warranted to explore the role of PSD in poststroke swallow recovery to determine what influence (if any) it has on patient outcomes.

CHAPTER 3: METHODOLOGY

Specific Aims
Aim 1: Determine the rate of PSD in patients with post-stroke dysphagia.

•

Hypothesis 1: The rate of PSD in patients with post-stroke dysphagia is at least as
high as the rate of PSD in the general stroke population.

Aim 2: To categorize dysphagia severity in an inpatient post-stroke population using

dysphagia-specific ICD-10 diagnosis and procedure codes and to determine if dysphagia
severity impacts diagnosis of PSD.
•

Hypothesis 1: A stable subset of dysphagia diagnosis and procedure codes will
identify groups of patients with distinct dysphagia severity characteristics.

•

Hypothesis 2: Patients who fall in different dysphagia severity groups will have
different risk of PSD diagnosis after discharge.
o Hypothesis 2a: Post-stroke patients with more severe dysphagia will have
a greater proportion of PSD diagnosis within the 90 days after discharge.
o Hypothesis 2b: Post-stroke patients with more severe dysphagia will have
greater odds of being diagnosed with PSD within the 90 days after
discharge.
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o Hypothesis 2c: Post-stroke patients with more severe dysphagia and a
diagnosis of PSD will have a shorter time to first depression diagnosis.

Aim 3: Compare the mean healthcare costs in post-stroke dysphagic patients with and

without PSD.
•

Hypothesis 1: Dysphagic patients with PSD will incur greater healthcare costs than
dysphagic patients without PSD.

21

Study Design
We conducted a retrospective, cross-sectional study of individuals with a primary
diagnosis of acute ischemic stroke (AIS) using administrative data from the 2017
Medicare 5% Limited Data Set (LDS), the most recent data set available at the start of this
study. Per the university Institutional Review Board, this study was not considered human
subject research.

Description of Administrative Database

The Centers for Medicare & Medicaid Services (CMS) provide LDS files for research. LDS
files include de-identified (i.e., no specific direct identifiers as defined in the Health
Insurance Portability and Accountability Act (HIPAA) Privacy Rule (CMS.gov, 2020),
patient-level claims data for a nationally representative random sample of all Medicare
beneficiaries.

Data Coding

For this study, we used several medical code sets, including International Classification of
Diseases, Tenth Revision, Clinical Modification (ICD-10-CM); International Classification of
Diseases, Tenth Revision, Procedure Coding System (ICD-10-PCS); Healthcare Common
Procedure Coding System (HCPCS); and Current Procedural Terminology (CPT). (See
Appendices 1-3 for tables containing all codes used in this study.) ICD-10-CM and ICD-10PCS codes are U.S. versions of the International Classification of Disease, Tenth Revision
(ICD-10), which was developed by the World Health Organization (WHO) to classify
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mortality and morbidity (Steindel, 2010). ICD-10-CM is used for diagnostic coding while
ICD-10-PCS is used for inpatient procedures (LaPointe, 2018). HCPCS is used to code
procedures, services, supplies, and materials and has three levels: Level I CPT codes,
Level II National codes, and Level III Local codes (not nationally accepted and rarely used)
(PMIC, 2019). HCPCS Level I CPT (simplified as “CPT”) codes are used to code physician
and allied healthcare professional procedures and services. HCPCS Level II codes are used
for supplies, equipment, materials, and services not represented in CPT codes.

Patient Population

We included Medicare beneficiaries 65 years of age and older who were discharged from
the hospital with a primary diagnosis of AIS. Within this population, we examined
patients with diagnosis of dysphagia and/or depression during inpatient hospitalization
and within 90 days after discharge. Individuals with a history of dysphagia or depression
within 90 days prior to stroke were excluded.

Outcome Measures

Our outcomes of interest included diagnosis of dysphagia and/or depression during the
inpatient hospitalization or within a 90-day follow-up window after discharge; dysphagia
severity (indicated by feeding status [e.g., feeding tube use], nutrition [e.g., diagnosis of
malnutrition], and respiratory compromise [e.g., aspiration pneumonia, intubation, etc.];
see Appendix 4); hospital length of stay (LOS); time from stroke to depression; and
healthcare costs.
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Aim 1: Data Set Construction

We constructed the data set for Aim 1 in four steps (Figure 1). First, we identified ICD-10CM diagnosis codes relevant to our diagnoses of interest (e.g., AIS, dysphagia,
depression). Second, we pulled claim-level diagnosis, procedure, Diagnosis Related
Groups (DRGs), dates of service, reimbursement amounts, and provider data from
Standard analytic files (SAFs) and patient demographic data from Denominator files for
relevant outcomes of interest. Third, we extracted outpatient claims data less than or
equal to 90 days prior to stroke, removed patients who had a diagnosis of dysphagia or
depression prior to stroke, and pulled data relevant to our outcomes of interest. Finally,
we reviewed discharge dates, extracted claims data within a 90-day follow-up window
after discharge, and identified patients with dysphagia and/or depression.

Figure 1. Flow chart of the construction of the Aim 1 data set.
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Aim 2: Data Set Construction

For Aim 2, we studied a population of patients diagnosed with post-stroke dysphagia
during two different time points: (1) during acute hospitalization and (2) within the 90day time period after discharge from the acute hospital. For inpatient data set
construction, first, we extracted all AIS survivors with a diagnosis of dysphagia and NIHSS
score (a measure of stroke severity) (N=445) from our original (Aim 1) data set. We
limited our analysis to this group of patients to ensure that we would have a valid
measure of stroke severity (the NIHSS score) for external construct validity of our
dysphagia groups. The selection of this patient subgroup for the development of a
severity grouping also helps assure that the population represents patients seen in
hospitals that have adopted the most recent recommendations for the ICD-10 coding for
AIS severity, which minimizes variations due to coding conventions. Second, we compiled
ICD-10-CM and ICD-10-PCS codes relevant to dysphagia (Appendix 4), based on the
literature (Cohen et al., 2020; Gonzalez-Fernandez et al., 2009; Pu, et al., 2017) and
clinical expertise. Third, we created dichotomous variables that represented common
dysphagia sequelae, subgroup diagnoses, and procedures using the compiled codes
(Appendix 4) to identify post-stroke patients in the acute hospital with specific dysphagiarelated outcomes. For example, the variable Respiratory Problems included ICD-10-CM
codes for respiratory conditions such as acute respiratory distress syndrome (ARDS),
respiratory failure, dyspnea, and acute respiratory distress. Fourth, we programmed
individual array coding schemes in SAS for each type of code set (ICD-10-CM and ICD-10PCS). For the post-discharge data set, we examined the same patient sample from the
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previous Aim 2 data set and pulled additional post-discharge data, including Healthcare
Common Procedure Coding System (HCPCS) and Current Procedural Terminology (CPT)
codes relevant to dysphagia (Appendix 4) and outpatient visits (e.g., first visit coded with
depression). We also removed patients who had died, were discharged to hospice,
and/or had missing follow-up data (final N=359).

Aim 3: Data Set Construction

The Aim 3 data set was constructed using the post-discharge Aim 2 data set of AIS
survivors who had received a diagnosis of post-stroke dysphagia while in the acute
hospital and had a documented NIHSS score (a measure of stroke severity) in their
electronic record (n=359). We extracted each patient’s Medicare administrative claims
data for the 90 days after discharge from the Index hospital admission to summarize
healthcare costs from the perspective of the medical care system (measured as claims
paid by Medicare plus the coinsurance and deductible amounts paid by patients, in
United States dollars [USD]). We used claims data from the Medicare service-specific
data tables to calculate total costs (defined as payments) for the 90-day post-discharge
period. Data sets used were (1) inpatient costs after discharge (e.g., inpatient
rehabilitation admission or admission to an acute hospital), (2) outpatient costs, (3) home
health costs, (4) skilled nursing facility (SNF) costs, and (5) Part B (carrier) costs. Data
from each service table were aggregated at the patient level by summing total payments
for the service type. Patients who did not use a service were then assigned $0 cost for
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that service. Total cost for 90 days post-discharge was the sum of cost across all service
types.
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Statistical Approaches and Data Analysis
All statistical analyses were conducted using SAS statistical software (version 9.4,
released 2016, SAS Institute, Inc., Cary, N.C., USA). Univariate analyses for demographics
and clinical characteristics were conducted. Frequency tables were used for categorical
variables to determine proportions (frequency and percentages) while mean, standard
deviation, and range were computed for continuous variables. P-values were considered
statistically significant for α<0.05.

Variable Definitions

Variables were defined as follows:
•

Dysphagia: Patient administrative data contained billing codes related to
dysphagia (Cohen et al., 2020; Gonzalez-Fernandez et al., 2009; Appendix 1);
dichotomous.

•

Depression: Patient administrative data contained billing codes related to
depression (Appendix 1); dichotomous.

•

Cognitive decline: Patient administrative data contained billing codes related to
cognitive decline (Appendix 1); dichotomous.

•

Days to depression: Number of days from admission date for AIS to first visit
coded for depression; continuous.

•

Charlson Comorbidity Index (CCI): A validated index for predicting the outcome
and risk of mortality from many comorbid diseases (Charlson et al., 1987; Quan et
al., 2005; Quan et al., 2011); continuous.
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•

Stroke Administrative Severity Index (SASI): A validated measure of stroke severity
at hospital discharge (Simpson et al., 2018); continuous.

•

National Institutes of Health Stroke Scale (NIHSS): A reliable 15-item scale used to
identify the severity of neurological symptoms after stroke, estimate prognosis,
and predict recovery in acute stroke patients (Brott et al., 1989); continuous.

•

Length of stay (LOS): Period of a single hospitalization; continuous. Longer
hospitalizations are considered a marker for poor outcomes.

•

Dual eligibility: Beneficiary of both Medicare and Medicaid, which indicates low
socioeconomic status (Moon & Shin, 2006); dichotomous.

•

Tissue plasminogen activator (tPA) administration: Treatment for ischemic stroke
that dissolves the clot and improves blood flow; dichotomous. Used as proxy for
better quality of care in research and a marker for better expected outcomes.

Aim 1 Data Analysis

For Aim 1, we calculated proportions using frequency tables to determine the rate of PSD
in patients with post-stroke dysphagia. We compared demographics and clinical
characteristics using t-tests for continuous variables and chi-square for categorical
variables. In addition, we estimated regression coefficients and adjusted odds ratios (OR)
using logistic regression to determine if PSD is associated with post-stroke dysphagia and
if patients diagnosed with post-stroke dysphagia are more likely to be diagnosed with
PSD. Finally, we performed time-to-event (survival) analyses (including the Cox
proportional hazards model) to assess the time to depression after stroke and estimate
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the hazard (hazard ratio, HR) for being diagnosed with PSD in dysphagic versus nondysphagic patients.

Student’s T-Test
The two-sample t-test is a widely used parametric test that compares the means of two
data sets to determine if they are equal, which indicates no difference (Winters et al.,
2010). We compared the means of the continuous variables age, CCI, SASI, and LOS in
dysphagic and non-dysphagic patients to determine if differences were significant
between groups.

Chi-Square Test for Independence
The chi-square test is a nonparametric test used to determine if there is a significant
association between categorical variables, testing the distributions of independent data
sets against a theoretical distribution (Winters et al., 2010). A larger chi-square statistic
indicates that distributions are more alike or related, with a value of 0 suggesting no
relationship (Winters et al., 2010). We tested relationships between the categorical
variables gender, race, depression, cognitive decline, tPA administration, and dual
eligibility in dysphagic and non-dysphagic patients to determine if associations were
significant between groups.
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Logistic Regression
Logistic regression is used to describe the relationship between a dichotomous outcome
variable and one or more predictor variables (covariates; Hosmer et al., 2013). In logistic
regression, multiple covariates can be included in a single model, which allows for
simultaneous adjustment of multiple potential confounders (Wiest et al., 2015).

In our first step to build a logistic regression model (Proc Logistic in SAS), we used
purposeful selection to include clinically relevant predictor variables (Hosmer et al., 2013;
Stoltzfus, 2011) in our initial model, such as age (in years); gender (male/female); race
(white, black, Hispanic, or other); CCI (score); SASI (score); tPA (yes/no); LOS (in days),
and dual eligibility (yes/no). Next, for model building, we used a direct approach,
simultaneously placing all predictor variables identified for inclusion with equal
importance into a multivariable model (Hosmer et al., 2013; Stoltzfus, 2011). Then we
checked for multicollinearity between predictor variables by examining several values,
including variables with high correlation (>0.8 indicating multicollinearity), a Variance
Inflation Factor (VIF) greater than 10, tolerance values greater than 0.1, and small
Eigenvalues (close to 0) with large corresponding condition values (indicating
multicollinearity; Schreiber-Gregory, 2017). Given that multicollinearity was not detected,
we continued with model building, using a less stringent variable inclusion criterion
(alpha of <0.25) so as not to exclude potentially important variables at this initial stage of
model development (Hosmer et al., 2013; Mickey & Greenland, 1989; Stoltzfus, 2011).
Variables that were not significant at p<0.25 were manually removed one at a time, and
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the model was refit using the traditional level of statistical significance (p<0.05) until a
parsimonious model was constructed.

To determine how well the final model fit the data, we took a random 10% sample of the
population and applied the Hosmer–Lemeshow (HL) goodness-of-fit (GOF) test, which is a
chi-square-based test that divides the population into subgroups based on estimated
probability of success and assesses if observed event rates match expected event rates
(Hosmer et al., 2013; Montgomery et al., 2012; Stoltzfus, 2011). If the model fit is good,
then the HL statistic will follow a chi-square distribution; however, a small p-value (<
0.05) indicates a poor fit (Hosmer et al., 2013; Montgomery et al., 2012). A criticism of
the HL GOF test is that it has low power (Stoltzfus, 2011); however, in our case, low
power is not a concern because of our large data set (N=9,163). The concern would be
that because power increases as sample size increases, small deviations from the model
in a large data set will appear significant (Paul et al., 2013). We have addressed this
limitation by conducting the HL GOF test with a smaller 10% random sample of our data
set (n=917).

Time-to-Event (Survival) Analysis
Time-to-event (survival) analysis refers to statistical procedures that analyze the time
until a well-defined endpoint (event) occurs (Schober & Vetter, 2018). These specific
analyses are required because of the unique features of time-to-event data. For example,
not all individuals will experience the event of interest during the study observation
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period, resulting in unknown/incomplete observations for some individuals (called
“censoring”), which must be resolved through the application of appropriate statistical
techniques (Schober & Vetter, 2018).

Cox Proportional Hazards Model
The Cox proportional hazards model (Cox, 1972) is a common semiparametric method
for analyzing time-to-event data that does not makes assumptions about the distribution
of survival times (Schober & Vetter, 2018). It is a regression model used to assess the
relationship among multiple predictors to a time-to-event outcome (Vittinghoff et al.,
2005). The Cox model provides the hazard ratios (HRs) (and 95% confidence intervals
(Cis)) of an individual experiencing an event given a set of covariates and assumes a
relationship between covariates and the hazard function (Fisher & Lin, 1999; Schober &
Vetter, 2018). In this study, the starting point was admission to the hospital with a
primary diagnosis of AIS, and the terminal event was the first post-stroke visit coded for
depression.

First, we used time-to-event analysis (Proc Lifetest in SAS) to estimate the unadjusted
time to diagnosis of depression (event) from the initial diagnosis of stroke (in days) by
dysphagic versus non-dysphagic groups without controlling for covariates. Second, we
constructed conventional Cox proportional hazards models (Proc Phreg in SAS) to
determine which covariates (age, gender, race, CCI, SASI, tPA, LOS, or dual eligibility)
significantly affect the time of PSD diagnosis using adjusted HRs. Third, we manually
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removed each covariate if it did not meet inclusion criteria defined as adequate model fit
statistic, likelihood ratio tests, and statistical significance (<0.05). Fourth, we tested for
interaction effects between covariates, and last, we included all significant covariates in
the final parsimonious model. After the final model was constructed, we performed
diagnostics to check for adequacy of the model.

A fundamental assumption of Cox regression is that hazards between groups are
constant (or proportional) over time (Bellera, et al., 2010; UCLA: Statistical Consulting,
n.d.-a; Schober & Vetter, 2018). If this assumption of proportionality is violated, biased
and/or incorrect estimates may be derived resulting in misleading interpretations
(Bellera, et al., 2010; UCLA: Statistical Consulting, n.d.-a). Thus, we assessed the
proportionality of the hazards using graphical checks for categorical covariates by which
Kaplan-Meier survival curves are plotted for each level of categorical covariate, and then
the survival function graphs were judged as to whether or not the survival curves appear
parallel (with a parallel graph indicative of proportionality) (Bellera, et al., 2010; Fisher &
Lin, 1999; UCLA: Statistical Consulting, n.d.-a). Typically, graphical checks alone are not
sufficient to assess proportionality due to their subjectivity (Bellera, et al., 2010);
however, it was evident that survival function graphs for all categorical covariates we
assessed (dysphagia, gender (female), race (white), dual eligibility) were not parallel
(displayed crossed curves). This was suggestive of non-proportionality, meaning there
was an interaction between these covariates and time (Bellera, et al., 2010; UCLA:
Statistical Consulting, n.d.-a). For the continuous covariate (age), we applied the
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empirical score process using a transform of the martingale residuals as a diagnostic for
proportionality (Lin et al., 1993). Then we inspected the simulation graph for an aberrant
observed pattern and checked the corresponding supremum test results for significance
(p<0.05), indicative of a violation of the proportional hazards assumption (Allison, 2010;
Introduction to Survival, n.d.; Lin et al., 1993). No violation was detected for the
continuous covariate (age).

To account for the non-proportionality of four of the covariates (dysphagia, female,
white, dual eligibility), we created time-dependent variables that explicitly introduced
covariate-by-time interactions into the Cox model, which generalizes the model to permit
the use of non-proportional hazards, thereby addressing the proportionality violation
(Allison, 2010; Bellera, et al., 2010; Cox, 1972; UCLA: Statistical Consulting, n.d.-a). After
running the Cox models again with each covariate-by-time interaction term, we found
that the interaction covariates for dysphagia and white remained significant, indicating
non-proportionality; however, our use of the method for extending the Cox model by
including covariate-by-time interactions as predictors allowed for the incorporation of
non-proportionality in the Cox model (Allison, 2010; UCLA: Statistical Consulting, n.d.-a).

Aim 2 Data Analysis

For Aim 2, we developed a novel dysphagia severity index for use with administrative
data to categorize patients with similar dysphagia severity during acute hospitalization
(hypothesis 1) and then used the severity index to examine the risk for receiving a
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diagnosis of depression after discharge in patients diagnosed with post-stroke dysphagia
(hypothesis 2). We described demographics and clinical characteristics using frequencies
and proportions, comparing results for categorical variables using chi-square or Fisher’s
exact test, and we calculated means and standard deviations for continuous variables,
comparing means using t-tests. Bivariate comparisons were performed using one-way
analysis of variance (ANOVA) for continuous, normally distributed variables; KruskalWallis for non-normally distributed variables; and chi-square test or Fisher’s exact for
dichotomous variables.

Billing data does not contain clinical details about disease severity or treatment response;
therefore, a proxy for severity is needed in order to adequately utilize and analyze claims
data (Gonzalez-Fernandez et al., 2009; VanDerwerker et al., 2020). There is currently no
universal standard for dysphagia severity classification in post-stroke patients for use
with administrative data in the literature; therefore, we developed a novel proxy index
for dysphagia severity in administrative data with key clinical variables using cluster
analysis.

Aim 2 Hypothesis 1
Cluster Analysis
Cluster analysis is a data exploration technique for organizing data into homogenous
groups (or clusters) such that objects or individuals grouped together in one cluster
resemble one another and are distinctly different from objects or individuals grouped in
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other clusters (Everitt et al., 2010). Cluster analysis facilitates improved understanding of
the underlying characteristics that define each cluster (Lu, 2018). Unsupervised K-means
cluster analysis is a method by which a partitioning algorithm divides observations into a
specified number (k) of clusters (chosen a priori) and then randomly selects k points as
initial cluster means (centroids), called “cluster seeds” (Frades & Matthiesen, 2010; King,
2015; MacQueen, 1967). Next, each observation is assigned iteratively to the cluster with
the closest centroid, based on the minimum Euclidean squared distance, and the
centroids of the newly formed clusters are recalculated (Abbas, 2008; Everitt et al., 2010;
Frades & Matthiesen, 2010; King, 2015; Lu, 2018). This process is repeated until the
centroids have stabilized – allocation of the same or similar observations to each cluster
occurs in successive rounds (Frades & Matthiesen, 2010) or the sum of the distances
between the observations and their respective centroids is minimized (Abbas, 2008; King,
2015).

We performed K-means cluster analysis to categorize patients with dysphagia based on
indicator dysphagia groups constructed from ICD-10 diagnosis and procedure codes for
patients during acute hospitalization for AIS. First, we ran a correlation analysis using
Pearson correlation coefficients (Proc Corr in SAS) to determine if any variables were
highly correlated. Codes with strong correlation were combined. Next, we performed a
cluster analysis (Proc Fastclus in SAS) to group billing codes into their respective disjoint
clusters (SAS Institute, 1999). Using an iterative process, we started with a large number
of clusters (k=7) and repeatedly estimated the k-means algorithm while reducing k
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clusters by one for each new iteration until an optimal number of clusters was identified.
Criteria for the optimal number of clusters was defined as estimated consensus among
graphical representations of the clusters (SAS Institute, 2015), cubic cluster criterion
(CCC) (Sarle, 1983), pseudo-F statistic (PSF) (Caliński & Harabasz, 1974), and maximal Rsquare value (King, 2015; Lu, 2018; SAS Institute, 2015). Once the final number of clusters
was agreed upon, the codes were appraised for clinical significance and relevance within
the clusters, and irrelevant codes (for which very few or no patients were diagnosed)
and/or codes that yielded poor statistical results (e.g., over-powering R-square value,
negative CCC, etc.) were removed.

We performed cluster validation to assess the quality of the clustering generated by our
algorithm (Frades & Matthiesen, 2010). For validation, we tested cluster stability by
running the algorithm on three random samples of 60% of the data set and compared
the cluster means of key outcomes to the means of those key outcomes from the initial
cluster analysis to determine if the algorithm produced similar results (structures) with
different data sources (Frades & Matthiesen, 2010). Once we concluded that our
algorithm was valid, we used the algorithm, now referred to as the “Administrative Data
Dysphagia Severity Scale” (ADDSS), to examine the risk for receiving a diagnosis of
depression after discharge from the acute hospital in patients with a post-stroke
dysphagia diagnosis.
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Aim 2 Hypothesis 2
We calculated frequencies and proportions to determine if patients with more severe
dysphagia have a greater proportion of PSD diagnosis within the 90 days after discharge
(hypothesis 2a). In addition, we used logistic regression to determine if post-stroke
patients with more severe dysphagia have greater risk of being diagnosed with PSD
within the 90 days after discharge (hypothesis 2b). Finally, we performed time-to-event
(survival) analyses to assess the time to depression after stroke to determine if poststroke patients with more severe dysphagia and a diagnosis of PSD have a shorter time to
first depression diagnosis after discharge from the acute hospital (hypothesis 2c).

Logistic Regression
Logistic regression is used to describe the relationship between a dichotomous outcome
variable and one or more predictor variables (covariates; Hosmer et al., 2013). In logistic
regression, multiple covariates can be included in a single model, which allows for
simultaneous adjustment of multiple potential confounders (Wiest et al., 2015).

In our first step to building our logistic regression models (Proc Logistic in SAS), we used
purposeful selection to include clinically relevant predictor variables (Hosmer et al., 2013;
Stoltzfus, 2011), in addition to our primary independent variable of interest, PSD, in our
initial models, such as age (in years); CCI (score); female (yes/no); race (white, black,
Hispanic, or other); tPA (yes/no); dual eligibility (yes/no); and dysphagia severity cluster
(mild, moderate, severe). We checked for multicollinearity between predictor variables
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(Proc Corr and Proc Reg in SAS) by examining several values, including variables with high
correlation (>0.8 indicating multicollinearity), a Variance Inflation Factor (VIF) greater
than 10, tolerance values greater than 0.1, and small Eigenvalues (close to 0) with large
corresponding condition values (indicating multicollinearity; Schreiber-Gregory, 2017).
Given that multicollinearity was not detected, we continued with model building. Next,
we fit logistic regression models with key covariates judged to have potentially strong
impacts on the data. Variables that were not significant at p<0.25 were manually
removed one at a time, and the models were refit using the traditional level of statistical
significance (p<0.05). Typically, we would refit the models until a parsimonious model
was constructed; however, we were unable to fit a parsimonious model because none of
the covariates reached statistical significance (p<0.05). (Details in the Aim 2 Results
section.)

Time-to-Event (Survival) Analysis
Time-to-event (survival) analysis refers to statistical procedures that analyze the time
until a well-defined endpoint (event) occurs (Schober & Vetter, 2018). These specific
analyses are required because of the unique features of time-to-event data. For example,
not all individuals will experience the event of interest during the study observation
period, resulting in unknown/incomplete observations for some individuals (called
“censoring”), which must be resolved through the application of appropriate statistical
techniques (Schober & Vetter, 2018). For our Aim 2 time-to-event analysis, we used Proc
Lifetest in SAS to model the underlying survival distribution function of our time-to-event
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data (Allison, 2010) and estimate the unadjusted time to diagnosis of depression (event)
from the initial diagnosis of stroke (in days) by dysphagia severity groups. Then we
compared Kaplan-Meier survival curves between dysphagia severity groups.

Aim 3 Data Analysis

For Aim 3, we calculated means and standard deviations for continuous variables and
frequencies and proportions for categorical variables. We compared demographics and
clinical characteristics for normally distributed data using t-tests for continuous variables
and chi-square or Fisher’s exact for categorical variables. We used nonparametric
Wilcoxon Rank Sum/Mann Whitney U and Kruskal-Wallis for non-normally distributed
variables. For the cost analysis, we performed gamma-distributed generalized linear
modeling with a log-transformed link function. To analyze cost by dysphagia severity
clusters/groups, we applied the ADDSS, created in Aim 2, to this data set.

Cost Analysis
First, we graphically assessed the normality of the distributions of the cost data using
histograms, and we also used the Shapiro-Wilk test (Shapiro & Wilk, 1965) to determine if
the data were normally distributed. Next, we assessed for homoscedasticity via the White
test (White, 1980), which tests for constant variance in a regression model. Once we
confirmed the data were non-normally distributed and that heteroscedasticity was
present, we applied generalized linear models (GLMs) to compare healthcare costs in
post-stroke dysphagic patients with and without a diagnosis of depression. We used
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gamma-distributed GLMs (Proc Genmod in SAS) with logarithmic transformation based
on the right-skewed distribution and presence of heteroscedasticity in our cost data.
GLMs with gamma distribution are known for being an appropriate statistical approach
for analysis of cost data, which typically have a right-skewed distribution (Manning et al.,
2005). We chose the natural log transformation (log link) because it is known to stabilize
variance (approximate homoscedasticity) and result in improve distribution symmetry in
cost data (Blough & Ramsey, 2000). Next, in addition to our primary independent variable
of interest (post-stroke depression [PSD]), we determined which clinically relevant
covariates would be included in our initial models to control for potential population
differences. We chose age, NIHSS score, CCI score, female gender, race (white, black,
Hispanic, other), tPA administration, dual eligibility, and dysphagia severity cluster (mild,
moderate, severe) as covariates to be included one at a time in each of our individual
GLMs. We did not include discharge location (home, inpatient rehabilitation [IPR] facility,
skilled nursing facility [SNF], transferred to another facility [from the acute hospital]) as a
covariate in the models because this is an in-hospital designation that is endogenous to
post-discharge cost values. Finally, covariates that were not significant at p<0.25 were
manually removed one at a time, and the models were refit using the traditional level of
statistical significance (p<0.05) until a parsimonious model was constructed.

We determined the goodness of fit (GOF) of our final models via the deviance to degrees
of freedom (DF) ratio, which posits that if the model is a good fit for the data, the
deviance to DF ratio value will be close to one (UCLA: Statistical Consulting, n.d.-b). Our
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gamma-distributed GLMs met this criterion; therefore, they were judged to have
adequate goodness of fit for our data.

CHAPTER 4: RESULTS

Aim 1 Results
To determine the rate of PSD in patients with post-stroke dysphagia, we analyzed a data
set of Medicare beneficiaries who had been diagnosed with AIS from the 2017 Medicare
5% LDS. We used descriptive statistics to show trends in the data set and hypothesis
testing to address our hypothesis: The rate of PSD in patients with post-stroke dysphagia
is at least as high as the rate of PSD in the general stroke population. Our results
supported our hypothesis. We found that the rate of PSD in post-stroke dysphagic
patients is slightly higher than the rate in non-dysphagic patients.

Patient Characteristics

Our data set of 9,163 patients had a mean age of 78.66 years (SD 8.56) with a range of
65-98 years. Fifty-three percent of patients were women and 82% were white, which is in
line with the demographic makeup of the overall Medicare beneficiary population in
which 54% are women and 75% are white (“Medicare Beneficiary,” 2017). (Patient
characteristics and descriptive data are summarized in Table 1.) Of the patients in the
general stroke population, 1,440 (15.72%) were diagnosed with dysphagia during their
inpatient hospitalization. Compared to patients not diagnosed with dysphagia, those with
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a dysphagia diagnosis had higher CCI and SASI scores, though they were not significantly
higher. Furthermore, there were no significant differences in age, gender, or race
between patients diagnosed with dysphagia and patients not diagnosed with dysphagia.
In contrast, those diagnosed with dysphagia demonstrated significantly higher rates of
depression diagnosis than those not diagnosed with dysphagia during acute
hospitalization, 12.01% versus 9.52%, respectively (p=0.003). Patients diagnosed with
dysphagia also demonstrated greater incidence of cognitive decline (p <.0001) at 29.24%
compared to 18.93% for patients not diagnosed with dysphagia. The mean LOS for
patients with a dysphagia diagnosis was 7.99 days (SD 5.76, p<.0001), which on average
was approximately three days longer than patients without a dysphagia diagnosis. Fewer
patients diagnosed with dysphagia received tPA (3.47%) as compared to patients not
diagnosed with dysphagia (5.31%, p=0.003). Those with a dysphagia diagnosis were also
more likely to have dual eligibility (p =0.0042).
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Table 1. Baseline characteristics and descriptive data for Aim 1
General Stroke
Population

Stroke with
Dysphagia

Stroke without
Dysphagia

N=9,163 (100%)

N=1,440 (15.72%)

N=7,723 (84.28%)

Mean (SD)

Mean (SD)

Mean (SD)

Range

Range

Range

Age, years

78.66 (8.56)
65-98

80.46 (8.76)
65-98

78.33 (8.48)
65-98

0.099

CCI
max possible 24

3.82 (2.18)
1-17

4.35 (2.19)
1-15

3.72 (2.16)
1-17

0.589

SASI
max possible 56

6.04 (6.84)
0-48

9.31 (6.60)
0-45

5.44 (6.71)
0-48

0.423

LOS, days

5.33 (4.24)
1-93

7.99 (5.76)
1-56

4.83 (3.69)
1-93

<.0001

Time to depression,
days

35.88 (30.46)
3-246

40.16 (30.69)
3-182

33.96 (30.18)
3-246

0.729

N (%)

N (%)

N (%)

4901 (53.49)

780 (54.17)

4121 (53.36)

Characteristics

Female
Race

p-value

0.573
0.115

White

7532 (82.20)

1157 (80.35)

6375 (82.55)

--

Black

1042 (11.37)

171 (11.88)

871 (11.28)

--

Hispanic

132 (1.44)

25 (1.74)

107 (1.39)

--

Other

457 (4.99)

87 (6.04)

370 (4.79)

--

Depression

908 (9.91)

173 (12.01)

735 (9.52)

0.003

Cognitive decline

1883 (20.55)

421 (29.24)

1462 (18.93)

<.0001

tPA

460 (5.02)

50 (3.47)

410 (5.31)

0.003

Dual eligibility

1616 (17.64)

292 (20.28)

1324 (17.14)

0.004

Footnote: N=population size, SD=standard deviation, CCI=Charlson Comorbidity Index,
SASI=Stroke Administrative Severity Index, tPA=tissue plasminogen activator, LOS=length
of stay
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Odds of PSD

We used multivariable logistic regression to examine the relationship between PSD and
post-stroke dysphagia. All predictor variables were included in the initial model (Table 2).
After insignificant variables were manually removed and collinearity was verified, we ran
the final parsimonious model (Table 3). The HL GOF test of a random 10% sample of the
population (n=917) demonstrated that the model was a good fit with an insignificant pvalue >0.05 (p=0.7984).

Table 2. Initial multivariable logistic regression model to determine association between
PSD and post-stroke dysphagia with all potential covariates included.
Variable

Coefficient

SE

OR

95% CI

p-value

Post-stroke dysphagia

0.9904

0.0828

2.692

2.289-3.167

<.0001

Age

-0.2714

0.0441

0.762

0.699-0.831

<.0001

Female

0.5438

0.0759

1.722

1.484-1.999

<.0001

White

0.5722

0.1421

1.850

1.435-2.384

<.0001

Hispanic

-0.7632

0.3858

0.487

0.174-1.358

0.048

Other

0.2339

0.1815

1.319

0.884-1.967

0.198

CCI

-0.00407

0.0172

0.996

0.963-1.030

0.813

SASI

-0.00876

0.00573

0.991

0.980-1.002

0.126

tPA

0.2426

0.1546

1.275

0.941-1.726

0.117

LOS

0.0145

0.00783

1.015

0.999-1.030

0.065

Dual eligibility

0.3497

0.0917

1.419

1.185-1.698

0.0001

Intercept

-1.2083

0.3661

--

--

0.001

Racea

Footnote: SE=standard error, OR=odds ratio, CI=confidence interval, CCI=Charlson
Comorbidity Index, SASI=Stroke Administrative Severity Index, tPA=Tissue plasminogen
activator, LOS=length of stay in acute hospital. aReference group was black patients.
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Table 3. Final multivariable logistic regression model with significant covariates included
and Hosmer-Lemeshow Goodness-of-Fit test.
Variable

Coefficient

SE

OR

95% CI

p-value

Post-stroke dysphagia

0.9972

0.0804

2.711

2.315-3.174

<.0001

Age

-0.2714

0.0441

0.762

0.699-0.831

<.0001

Female

0.5383

0.0757

1.713

1.477-1.987

<.0001

White

0.5684

0.1419

1.818

1.413-2.340

<.0001

Hispanic

-0.7677

0.3857

0.478

0.171-1.333

0.047

Other

0.2289

0.1814

1.295

0.868-1.931

0.207

Dual eligibility

0.3553

0.0912

1.427

1.193-1.706

<.0001

Intercept

-1.1812

0.3587

--

--

0.001

n

Percent of X2
population

DF

p-value

917

10

8

0.7984

Racea

HLb

4.6094

Footnote: n=sample size, SE=standard error, OR=odds ratio, CI=confidence interval,
X2=chi-square statistic, DF=degrees of freedom. aReference group was black patients.
b
Hosmer-Lemeshow Goodness-of-Fit test applied to a 10% random sample of the
population.
We conducted multivariable logistic regression analysis on the entire population
(N=9,163), which revealed that patients who were diagnosed with post-stroke dysphagia
were 2.7 times more likely to be diagnosed with PSD within 90 days after discharge
(adjusted OR, 2.711; 95% CI, 2.315-3.174; p<.0001) compared to patients who were not
diagnosed with post-stroke dysphagia. White patients were 81.8% more likely to be
diagnosed with PSD than black patients (adjusted OR, 1.818; 95% CI, 1.413-2.340;
p<.0001). Furthermore, white patients were shown to be the only race significantly more
likely to be diagnosed with depression after stroke. The odds of being diagnosed with
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PSD increased in women by 71.3% (adjusted OR, 1.713; 95% CI, 1.477-1.987; p<.0001)
and in individuals who qualified for dual eligibility by 42.7% (adjusted OR, 1.427; 95% CI,
1.193-1.706; p<.0001). The odds of depression diagnosis decreased by 23.8% with age
(adjusted OR, 0.762; 95% CI, 0.699-0.831; p<.0001).

Unadjusted Time to Depression

Without covariate adjustment, the unadjusted estimation of mean time from diagnosis of
AIS to diagnosis of depression was 40 days (SD ± 30.69) for patients diagnosed with
dysphagia and 34 days (SD ± 30.18) for patients not diagnosed with dysphagia (Table 1).
Although patients who had a diagnosis of post-stroke dysphagia demonstrated greater
mean days to depression diagnosis than patients who did not have a diagnosis of poststroke dysphagia, these results were not significant (p=0.729). The unadjusted survival
plot (Figure 2) illustrated the differences in time to depression diagnosis between those
who were diagnosed with dysphagia and those who were not diagnosed with dysphagia.
It showed that both groups had an equally high probability of survival (not being
diagnosed with PSD) soon after discharge, and as the 90-day post-discharge time period
progressed, patients without a dysphagia diagnosis demonstrated better survivability
(less likelihood of being diagnosed with depression) than patients with a dysphagia
diagnosis. Furthermore, patients who were diagnosed with dysphagia appeared to
experience a steady increase in diagnosis of PSD compared to those not diagnosed with
dysphagia over the 90-day post-discharge time period, with the dysphagic group
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demonstrating an approximately 1.5-fold higher probability of being diagnosed with PSD
during the last 15 days of follow-up.

Figure 2. Survival curve for PSD during 90-day post-discharge follow-up period by
presence of dysphagia diagnosis, Kaplan-Meier method.

Unadjusted initial Cox proportional hazards models were run on each covariate
separately to determine potential influence on time to depression. We found a significant
effect for dysphagia, age, gender (female), race (white), LOS, and dual eligibility.
Unadjusted Cox models showed that the hazard for depression diagnosis in patients who
have been diagnosed with post-stroke dysphagia was 2.4-fold greater (HR, 2.420; 95% CI,
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2.099-2.790; p<.0001) than the hazard of depression diagnosis in those without a
dysphagia diagnosis. Conversely, with each increase in year of age after discharge from
the hospital, the hazard for diagnosis of PSD decreased by 1.5% (HR, 0.985; 95% CI,
0.978- 0.993; p=0.0002). The hazard for women was approximately 54% (HR, 1.541; 95%
CI, 1.345- 1.766; p<.0001) great than the hazard for men, while the hazard of depression
diagnosis for white patients was 37% (HR, 1.37; 95% CI, 1.087- 1.727; p=0.0077) greater
than the hazard for depression diagnosis for non-white patients. For each one-day
increase in LOS, the hazard of PSD diagnosis increased by 2.2% (HR, 1.022; 95% CI, 1.0101.034; p=0.0002). The hazard of PSD diagnosis for those who qualified for dual eligibility
was about 41% (HR, 1.414; 95% CI, 1.210- 1.652; p<.0001) greater than the hazard for
those who did not qualify for dual eligibility. No significant effects were observed for
Hispanic or “other” race, CCI, SASI, or tPA.

Adjusted Time to Depression

Results from the extended Cox model with covariate adjustment (Table 4) were
comparable to unadjusted results. Based on the model, having a diagnosis of dysphagia,
being female, being white, and having dual eligibility significantly increased the risk of
being diagnosed with depression after stroke, while every year of age significantly
decreased the risk of depression diagnosis. The dysphagia-by-time interaction covariate
that we incorporated into the extended Cox model allowed the effect of dysphagia (our
covariate of greatest interest) to change with time (Allison, 2010), and its significance
suggested that the dysphagia effect did, in fact, vary over time since discharge from the
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hospital. This is illustrated by the adjusted cumulative hazard plot (Figure 3), which
showed that when controlling for significant covariates, the hazard for diagnosis of PSD
was initially low (<0.01) until about the tenth day after discharge and then consistently
increased throughout the duration of the 90-day follow-up period for both patients with
and without a diagnosis of post-stroke dysphagia. On average and on any given day in the
90 days after discharge, the hazard for diagnosis of depression for patients who had a
dysphagia diagnosis was approximately 76% greater (HR, 1.755; 95% CI, 1.368-2.251;
p<.0001) than the hazard for patients who did not have a dysphagia diagnosis. In
addition, the hazard of PSD diagnosis for women was about 67% higher than (HR, 1.666;
95% CI, 1.449-1.915; p<.0001) the hazard for men, while the hazard of depression
diagnosis for individuals with dual eligibility was approximately 40% higher than (HR,
1.404; 95% CI, 1.193-1.654; p<.0001) the hazard for those who did not have dual
eligibility. In contrast, hazard decreased significantly by 2.5% (HR, 0.975; 95% CI, 0.9670.982; p<.0001) with each year of age, suggesting that older stroke survivors are less
likely to be diagnosed with depression. When controlling for significant covariates, we
found that the hazard of PSD diagnosis for white patients was 71% higher than (HR,
1.708; 95% CI, 1.401-2.082; p<.0001) the hazard for non-white patients, placing white
patients at greater risk for diagnosis of depression than any other race. We ran additional
Cox models to determine if there were any significant interaction effects between
dysphagia and other significant covariates (age, gender (female), race (white), LOS, dual
eligibility) for time to depression and found none.
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The adjusted cumulative hazard plot (Figure 3) showed that when controlling for
significant covariates, there was a low immediate hazard for depression diagnosis
followed by a steady increase in hazard for both groups, people with and without a
diagnosis of dysphagia, over time, continuing until the end of the follow-up period. The
group with a diagnosis of dysphagia demonstrated a higher hazard for depression
diagnosis almost immediately after discharge and for the duration of the 90-day followup period compared to the group without a diagnosis of dysphagia. Furthermore, those
diagnosed with post-stroke dysphagia demonstrated an approximately 1.75-fold higher
hazard for PSD diagnosis than those not diagnosed with post-stroke dysphagia,
suggesting that at any given time in the 90 days after discharge, the hazard for
depression diagnosis is higher for patients diagnosed with dysphagia compared to
patients not diagnosed with dysphagia.

Table 4. Final parsimonious Cox proportional hazards model with significant covariates.
Variable

Coefficient

SE

HR

95% CI

p-value

Post-stroke dysphagia

0.56246

0.56246

1.755

1.368-2.251

<.0001

Female

0.51049

0.07109

1.666

1.449-1.915

<.0001

Race, white

0.53525

0.10101

1.708

1.401-2.082

<.0001

Dual eligibility

0.33958

0.08341

1.404

1.193-1.654

<.0001

Age (years)

-0.02581

0.00412

0.975

0.967-0.982

<.0001

Footnote: SE=standard error, HR=hazard ratio, CI=confidence interval
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Figure 3. Hazard curve for PSD during 90-day post-discharge follow-up period by
presence of dysphagia diagnosis with covariates.
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Aim 2 Results
For Aim 2, we developed a novel proxy index of dysphagia severity for use with
administrative data – ADDSS – to identify patients with similar dysphagia and stroke
severity during acute hospitalization (hypothesis 1). Then we used the ADDSS to examine
the proportion of, risk of, and time to depression diagnosis by dysphagia severity group
after discharge (hypothesis 2). Our results supported hypothesis 1 in that we created the
ADDSS using a stable subset of ICD-10 dysphagia diagnosis and procedure codes to
identify groups of patients with distinct dysphagia severity characteristics. Our results
were not supportive of hypothesis 2, given that we did not find a statistically significant
difference in risk of PSD diagnosis after discharge by dysphagia severity, nor did the
evidence support our hypothesis 2 sub-hypotheses (2a, 2b, or 2c).

Patient Characteristics

In our NIHSS data set of 445 post-stroke patients with a diagnosis of dysphagia in the
acute hospital, the mean age of the sample was 80 years (8.96) with a range of 65 to 98
years (Table 5 for baseline characteristics and descriptive data of the population). Fiftyfive percent of patients were female and 83% were white, which is similar to the
demographic makeup of the overall Medicare population in which 54% are female and
75% are white (“Medicare Beneficiary,” 2017). On average, patients in this sample
presented with moderate stroke severity, indicated by a mean NIHSS score of 11.46
(8.25). The mean SASI score was 10.44 (6.92), or severe (Simpson et al., 2018), and the
mean CCI score was 4.45 (2.29), suggestive of high comorbidity (Goldstein et al., 2004).
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The mean LOS in this population was 7.88 days (5.17), which is slightly higher than the
average six-day LOS among ischemic stroke patients (Koton et al., 2010) and lower than
the average LOS of post-stroke dysphagic patients, considering that a diagnosis of
dysphagia may result in almost five additional days in the acute hospital (Atrill et al.,
2018). In addition, the mean cost of the inpatient stay was $84,620 ($89,510).
Approximately 5% of patients received tPA, 27% presented with cognitive decline, and
13% were diagnosed with depression during inpatient hospitalization. The majority of
patients were discharged from the acute hospital to a SNF (33%) or an IPR facility (30%),
and about 7% died in the hospital.
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Table 5. Baseline characteristics and descriptive data for Aim 2

Stroke with Dysphagia, N=445 (100%)
Characteristics
Mean (SD)
Age, years
80.06 (8.96)
65-98
Female
Race
White
Black
Hispanic
Other
NIHSS
11.46 (8.25)
max possible 42
0-38
SASI
10.44 (6.92)
max possible 56
0-45
CCI
4.45 (2.29)
max possible 24
1-15

LOS, days
Cost incurred

N (%)

243 (54.61)
371 (83.37)
45 (10.11)
6 (1.35)
23 (5.17)

7.88 (5.17)
1-36
$84,620 ($89,510)
$7,196-$911,378

tPA

22 (4.94)

Cognitive decline

120 (26.97)

Depression

59 (13.26)

Dual eligibility

91 (20.45)

Discharge location
Home

31 (6.97)

IPR

135 (30.34)

SNF

147 (33.03)

HH

36 (8.09)

Trans

13 (2.92)

Other

53 (11.91)

Died in hospital

30 (6.74)

Footnote: N=population size, SD=standard deviation, NIHSS=National Institutes of Health
Stroke Scale, SASI=Stroke Administrative Severity Index, CCI=Charlson Comorbidity Index,
LOS=length of stay, tPA=tissue plasminogen activator, IPR=inpatient rehabilitation,
SNF=skilled nursing facility, HH=home health, Trans=transferred to another facility
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Hypothesis 1: Development of ADDSS

Cluster Analysis
Through the previously described procedure, we used K-means cluster analysis to group
dysphagia-related variables into clusters to infer dysphagia severity. All variables
(Appendix 4) were included in the initial algorithm (Table 6). Through a trial-and-error
process during each iteration, we manually removed any variables that were judged to
overwhelm the explanatory power of the other variables (high R-square value) and/or
were not clinically meaningful and then re-ran the algorithm until the resulting statistics
were considered optimal (Table 6). Based on the estimated criteria for the ideal number
of clusters, we considered three clusters to be optimal for this data set. The three distinct
clusters each characterized a disparate level of dysphagia severity (i.e., mild, moderate,
or severe). The cluster means and distributions of variables across the three clusters are
shown in Table 7.

Table 6. K-means cluster analysis iterations and statistics
Iteration

Cluster (k)

Overall
R-Square

Pseudo F
Statistic

Approx. Expected
Overall R-Squared

Cubic Clustering
Criterion

1st
2nd
3rd
4th
5th

7
6
5
4
3

0.65
0.59
0.58
0.57
0.38

138.29
124.49
152.05
199.11
135.17

0.49
0.47
0.44
0.40
0.32

28.04
18.07
22.72
27.65
7.38
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Table 7. Cluster means by variable
Variable
Aspiration pneumonia
Cognitive impairment
Dehydration
Feeding device placement
Intubation
Malnutrition
Respiratory problems
Tracheotomy/Tracheostomy

Cluster 1
0.33
0.29
0.06
1.00
0.02
0.16
0
0

Cluster 2
0.04
0.29
0.04
0
0.01
0.03
0
0

Cluster 3
0.38
0.15
0.05
0.38
0.34
0.08
0.98
0.09

Description of Clusters
Clinical classifications of the clusters were assessed via the means of each of the eight
variables (attributes) (Table 7) across clusters and graded into three qualitative
categories. Cluster 1 showed evidence of dysphagia severity in the setting of alternative
nutrition with the highest means for feeding device placement, malnutrition, and
dehydration. Using feeding device placement as the primary marker of dysphagia severity
and given that the mean for feeding device placement in Cluster 1 was 1.0 versus 0 and
0.38 for Clusters 2 and 3, respectively, patients in Cluster 1 were judged to have severe
dysphagia severity. Patients in this cluster also showed evidence of aspiration pneumonia
and cognitive impairment and contained six out of eight (75%) of the total attributes
(dysphagia indicator variables constructed from dysphagia-related ICD-10 diagnosis and
procedure codes in the cluster analysis), suggesting that patients in this group had
substantial stroke-related illness; therefore, patients in Cluster 1 were also judged to
have moderate overall stroke severity. Thus, Cluster 1 represented moderate stroke with
severe dysphagia severity with an emphasis on alternative nutrition.
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Cluster 2 had the lowest means of all attributes, except cognitive impairment, which was
the only notable attribute in this cluster. Cases in this group had little evidence of active
feeding, nutrition, or respiratory problems; hence, patients in Cluster 2 had mild
dysphagia severity (with more cases of cognitive impairment compared to feeding,
nutrition, or respiratory problems). Cluster 2 also contained 63% of the total attributes,
suggesting that (like patients in Cluster 1) patients in Cluster 2 had substantial strokerelated illness and, as such, were determined to have had moderate overall stroke
severity. Thus, Cluster 2 represented moderate stroke with mild dysphagia.

Cluster 3 demonstrated evidence of dysphagia severity with more cases of respiratory
compromise than any other clusters and the highest means for respiratory problems,
aspiration pneumonia, intubation, and tracheotomy/tracheostomy. Because it is known
that aspiration pneumonia is difficult to differentiate from other pneumonia types and,
consequently, is often misdiagnosed (Son et al., 2017), feeding device placement, not
aspiration pneumonia, was used as the most important (and reliable) marker for
dysphagia severity. Additionally, intubation in this cluster was likely driven by diagnoses
of respiratory conditions, not dysphagia severity; therefore, given that the mean for
feeding device placement (0.38) was the second highest out of all of the clusters, we
determined that patients in Cluster 3 had moderate dysphagia severity. Cluster 3 also
contained 100% of the total attributes, indicating that patients in this cluster were very ill
compared to those in the other clusters; therefore, these patients were judged to have
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moderate/severe overall stroke severity. Thus, Cluster 3 represented moderate/severe
stroke with moderate dysphagia severity with respiratory complications.

Cluster Validation
We conducted a subgroup sensitivity analysis by applying the three-cluster solution
(algorithm) to three 60% random samples of the data set to assess cluster stability (Table
8). We compared the cluster means of key outcomes that are indicators of stroke severity
(NIHSS, LOS, and CCI) to their means from the initial cluster analysis and determined that,
overall, they were stable and demonstrated a good fit. In the Mild dysphagia severity
with moderate stroke cluster (Cluster 2), mean NIHSS scores were 10.08 in the initial
100% sample and 10.67, 11.60, and 10.32, respectively, across 60% random samples, and
in the Moderate dysphagia severity with moderate/severe stroke cluster (Cluster 3),
NIHSS scores were 16.23 in the initial 100% sample and 15.52, 16.53, and 16.64,
respectively, across the three 60% random samples. In the Severe dysphagia severity with
moderate stroke cluster (Cluster 1), mean NIHSS scores were 13.51 in the initial 100%
sample and 13.97, 12.69, and 11.12, respectively, across all three 60% random samples.
The validation of cluster distribution for mean NIHSS score by severity showed very small
differences in patient characteristics, indicating consistency and stability.

In the Mild dysphagia severity with moderate stroke cluster (Cluster 2), mean CCI scores
were 4.27 in the initial 100% sample and 4.21, 4.36, and 4.12, respectively, across 60%
random samples. The mean CCI score in the initial 100% sample for the Moderate
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dysphagia severity with moderate/severe stroke cluster (Cluster 3) was 5.11, and across
the first, second, and third 60% random samples, mean CCI scores were 4.96, 4.76, and
5.05, respectively. Mean CCI scores in the Severe dysphagia severity with moderate
stroke cluster (Cluster 1) were 4.65 in the initial 100% sample, and in the first, second,
and third 60% random samples, they were 5.08, 4.76, and 5.00, respectively. Mean CCI
scores were very similar (close) across clusters and samples, demonstrating excellent
consistency and stability.

In the initial 100% sample for the Mild dysphagia severity with moderate stroke cluster
(Cluster 2), mean LOS was 6.22 days, and across the 60% random samples, it was 6.32,
6.58, and 7.42 days, respectively. For the Moderate dysphagia severity with
moderate/severe stroke cluster (Cluster 3), in the initial 100% sample, mean LOS was
10.51 days and 10.72, 12.41, and 10.43 days, respectively, across the 60% random
samples. Mean LOS in the initial 100% sample for the Severe dysphagia severity with
moderate stroke cluster (Cluster 1) was 13.52 days, and across the first, second, and third
60% random samples, mean LOS was 12.74, 13.06, and 7.75 days, respectively. The
cluster distribution for mean LOS demonstrated the greatest stability across all samples
in the Mild dysphagia severity with moderate stroke cluster (Cluster 2), which comprised
the largest proportions of the 100% and three 60% samples, respectively. The most
notable disparities in mean LOS were observed in the third 60% random sample of the
Severe dysphagia severity with moderate stroke cluster (Cluster 1) and the second 60%
random sample of the Moderate dysphagia severity with moderate/severe stroke cluster
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(Cluster 3), which could be explained by the small sample sizes in those clusters (n=74
and n=16, respectively), yielding more unstable results (which is typical of means in small
samples). In addition, mean LOS is known for being sensitive to outliers and, thus, could
have been affected by unknown outliers not included in the original cluster analysis.
Despite this, mean NIHSS scores demonstrated overall adequate stability.

Table 8. Subgroup sensitivity analysis for cluster validation
Clustera Variable

Initial 100%
sample (mean)

1st 60% sample
(mean)

2nd 60% sample
(mean)

3rd 60% sample
(mean)

1

13.51
4.65
13.52
14%
10.08
4.27
6.22
71%
16.23
5.11
10.51
15%

13.97
5.08
12.74
15%
10.67
4.21
6.32
76%
15.52
4.96
10.72
9%

12.69
4.76
13.06
18%
11.60
4.36
6.58
75%
16.53
4.76
12.41
6%

11.12
5.00
7.75
28%
10.32
4.12
7.42
56%
16.64
5.05
10.43
16%

2

3

NIHSS
CCI
LOS
% in cluster
NIHSS
CCI
LOS
% in cluster
NIHSS
CCI
LOS
% in cluster

Footnote: NIHSS=National Institutes of Health Stroke Scale, LOS=length of stay,
CCI=Charlson Comorbidity Index. Three-cluster algorithm applied to three separate 60%
random samples of the data set.
a
Cluster 1=severe dysphagia severity with moderate stroke; Cluster 2=mild dysphagia
severity with mild stroke; Cluster 3=moderate dysphagia severity with severe stroke.

Composition of Clusters
The demographics and characteristics of patients in each cluster are shown in Table 9.
The distributions of gender and race proportions in each cluster were similar to the
distributions in the overall sample, with the Mild dysphagia severity cluster containing
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the oldest group (mean, 80.66; SD, 9.06) and the Moderate dysphagia severity cluster
containing the youngest group (mean, 77.62; SD, 8.37). We found statistically significant
differences in age, NIHSS score, SASI score, LOS, acute hospital costs, dual eligibility, and
discharge disposition among the three clusters.

Mild Severity
The Mild dysphagia severity cluster, which also represented patients with moderate
stroke severity, comprised the largest proportion of patients (71%) out of all of the
clusters and had patients with the lowest severity. This cluster consisted of 54% women.
Although patients in the Mild cluster were the oldest, they had the lowest mean NIHSS
score (10.08 ±7.93), SASI score (9.26 ±6.19), CCI score (4.27 ±2.26), and LOS (6.22 ±3.34)
compared to patients in the other clusters. Furthermore, the Mild cluster had the second
highest proportion of tPA administration (5%), highest proportion of patients who were
discharged home (9%) and to IPR (32%), and lowest proportion of patients who died in
the acute hospital (3%) compared to patients in the other clusters. They also incurred the
lowest costs (mean, $59,571; SD, $53,326) compared to patients in the other clusters.

Moderate Severity
The Moderate dysphagia severity cluster, which represented patients with
moderate/severe stroke severity, contained 15% of the sample and, overall, had patients
with the greatest severity, indicated by stroke-related outcomes, such as the highest
mean NIHSS, SASI, and CCI scores (16.23 ±8.18, 16 ±8.87, 5.11 ±2.24, respectively) and
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highest costs (mean, $155,309; SD, $145,766) among all clusters. Similar to the other two
clusters, about 55% of patients in this cluster were women. Patients in the Moderate
dysphagia severity with moderate/severe stroke cluster had the lowest proportion of tPA
administration (0%), highest proportion of patient mortality in the acute hospital (20%),
and lowest proportion of patients to discharge home (0%). Patients in the Moderate
dysphagia severity with moderate/severe stroke cluster stayed in the acute hospital
(mean, 10.51; SD, 5.75) longer than patients in the Mild cluster on average but had a
shorter mean LOS than those in the Severe dysphagia severity cluster. The majority of the
patients in the Moderate dysphagia severity cluster discharged to IPR (30%) versus all
other discharge locations.

Severe Severity
The Severe dysphagia severity cluster, which represented patients with moderate stroke
severity, was comprised of 14% of the sample. Fifty-six percent of patients in this cluster
were women, which is a similar proportion to the Mild and Moderate dysphagia severity
clusters. Out of the three clusters, patients in the Severe dysphagia severity with
moderate stroke cluster demonstrated mean NIHSS (13.51 ±7.78), SASI (10.63 ±5.12),
and CCI scores (4.65 ±2.38) that were higher than patients in the Mild dysphagia severity
with moderate stroke cluster but lower than patients in the Moderate dysphagia severity
with moderate/severe stroke cluster. Similarly, the proportion of patients who died in the
acute hospital (10%) in the Severe dysphagia severity with moderate stroke cluster was
higher than that of patients in the Mild dysphagia severity cluster but lower than those in
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the Moderate dysphagia severity cluster. Patients in the Severe dysphagia severity cluster
also had the longest mean LOS (13.52 ±6.82) and greatest proportion of patients who
were discharged to SNF (56%). Their hospital costs (mean, $137,728; SD, $98,165) were
higher than costs incurred by patients in the Mild dysphagia severity with moderate
stroke cluster but lower than those in the Moderate dysphagia severity with
moderate/severe stroke cluster. Surprisingly, they had the highest proportion of tPA
administration (8%).
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Table 9. Demographic and characteristic composition of clusters
Clustera

Demographics /
Characteristics
N=445 (100%)

Age, years
NIHSS
max possible 42
SASI
max possible 56
CCI
max possible 24
LOS, days
Cost incurred

Mild
Dysphagia

Moderate
Dysphagia

Severe
Dysphagia

Emphasis on
cognitive
impairment

Emphasis on
respiratory
compromise

Emphasis on
alternative
nutrition

n=317 (71%)

n=65 (15%)

n=63 (14%)

Mean (SD)
Range
80.66 (9.06)
65-98
10.08 (7.93)
0-38
9.26 (6.19)
0-36
4.27 (2.26)
1-15

Mean (SD)
Range
77.62 (8.37)
65-94
16.23 (8.18)
1-38
16 (8.87)
0-45
5.11 (2.24)
1-13

Mean (SD)
Range
79.59 (8.69)
66-98
13.51 (7.78)
1-33
10.63 (5.12)
0-31
4.65 (2.38)
1-12

6.22 (3.34)
1-24
$59,571
($53,326)
$7,196-$474,099

10.51 (5.75)
3-27
$155,309
($145,766)
$18,853-$911,378

13.52 (6.82)
5-36
$137,728
($98,165)
$16,697-$628,341

n (%)
Female
Race
White

n (%)

p-value

0.0280
<.0001
<.0001
0.1395
<.0001
<.0001

n (%)

172 (54.26)

36 (55.38)

35 (55.56)

270 (85.17)

53 (81.54)

48 (76.19)

0.7548
0.7082
--

Black

30 (9.46)

7 (10.77)

8 (12.70)

--

Hispanic

4 (1.26)

0 (0)

2 (3.17)

--

Other

13 (4.10)

5 (7.69)

5 (7.94)

--

tPA

17 (5.36)

0 (0)

5 (7.94)

0.1246

Depression

45 (14.20)

10 (15.38)

4 (6.35)

0.2847

Dual eligibility

56 (17.67)

20 (30.77)

15 (23.81)

0.0144

Discharge
disposition
Home

<.0001
30 (9.46)

0 (0)

1 (1.59)

--

IPR

102 (32.18)

19 (29.23)

14 (22.22)

--

SNF

98 (30.91)

14 (21.54)

35 (55.56)

--
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HH

34 (10.73)

1 (1.54)

1 (1.59)

--

Trans

5 (1.58)

8 (12.31)

0 (0)

--

Other

37 (11.67)

10 (15.38)

6 (9.52)

--

Died in hospital

11 (3.47)

13 (20.00)

6 (9.52)

--

Footnote: N=population size, n=sample size, SD=standard deviation, NIHSS=National
Institutes of Health Stroke Scale, SASI=Stroke Administrative Severity Index, CCI=Charlson
Comorbidity Index, LOS=length of stay, tPA=tissue plasminogen activator, IPR=inpatient
rehabilitation, SNF=skilled nursing facility, HH=home health, Trans=transferred to
another facility
a
Mild dysphagia severity with moderate stroke; Moderate dysphagia severity with
moderate/severe stroke; Severe dysphagia severity with moderate stroke.

Hypothesis 2: Application of ADDSS

Proportion of PSD Diagnosis After Discharge by Dysphagia Severity
We applied the ADDSS to our post-discharge sample. Then we calculated frequencies and
proportions of dysphagic patients with a diagnosis of PSD, stratified by dysphagia severity
cluster, and used the chi-square test to determine statistical significance. We found that
the proportions of PSD diagnosis across all three dysphagia severity groups were very
similar (17%, 14%, and 16%, p=0.9016, respectively), revealing no statistically significant
difference in proportions of PSD diagnosis in the 90 days after discharge by dysphagia
severity (Table 10). Thus, we concluded that the evidence was not supportive of
hypothesis 2a.
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Table 10. Proportion of and time to PSD diagnosis by dysphagia severity
Clustera
Mild

Moderate

Dysphagia

Dysphagia

Severe
Dysphagia

Variable

Emphasis on
cognitive
impairment

Emphasis on
respiratory
compromise

Emphasis on
alternative
nutrition

N=359 (100%)

n=266 (74%)

n=42 (12%)

n=51 (14%)

n (%)

n (%)

n (%)

45 (16.92)

6 (14.29)

8 (15.69)

Mean (SD)
Range

Mean (SD)
Range

Mean (SD)
Range

39.31 (39.00)
5-91

63 (71.50)
9-96

70.88 (73.50)
12-124

Depression

Time to depression,
days

p-value

0.9016

0.0218

Footnote: N=population size, n=sample size, SD=standard deviation
a
Mild dysphagia severity with moderate stroke; Moderate dysphagia severity with
moderate/severe stroke; Severe dysphagia severity with moderate stroke.

Risk of PSD Diagnosis After Discharge by Dysphagia Severity
We performed multivariable logistic regression to (1) examine the relationship between
PSD and post-stroke dysphagia by dysphagia severity levels and (2) test hypothesis 2b to
determine if post-stroke patients with more severe dysphagia had greater risk of being
diagnosed with PSD within the 90 days after discharge. In addition to our primary
independent variable of interest, PSD, we included key predictor covariates, including
dysphagia severity (by ADDSS clusters), age, CCI score, and dual eligibility, in our initial
individual logistic regression models; however, we found none of the covariates to be
statistically significant. Thus, no significant effect was found between dysphagia severity
and risk of PSD diagnosis in the 90 days after discharge. Nonetheless, we observed that
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compared to patients in the mild dysphagia cluster, those in the moderate and severe
dysphagia severity groups were less likely to be diagnosed with PSD after discharge, but
these results did not reach statistical significance. Thus, the evidence was not supportive
of hypothesis 2b.

Time to PSD Diagnosis After Discharge by Dysphagia Severity
The unadjusted estimated mean time from diagnosis of AIS to diagnosis of depression
was 39 days (SD ±39.00) for patients with mild dysphagia, 63 days (SD ±71.50) for
patients with moderate dysphagia, and 70 days (SD ±73.50) for patients with severe
dysphagia (Table 10). These results were statistically significant (p=0.0218) and
demonstrated that those with mild dysphagia had the shortest mean time to PSD
diagnosis within the 90-day period after discharge compared to patients in the other
severity groups. Patients who had moderate dysphagia were diagnosed with depression,
on average, sometime in between those in the mild and severe dysphagia severity
groups, and those with severe dysphagia demonstrated the longest mean time to PSD
diagnosis.

We created a dichotomous variable for dysphagia severity: “mild” (patients classified as
having mild dysphagia severity) and “not mild” (patients classified as having moderate or
severe dysphagia severity) and performed a time-to-event (survival) analysis to generate
an unadjusted survival plot (Figure 4). The survival plot illustrates the differences in time
to depression diagnosis between patients with mild dysphagia and patients with
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moderate and severe dysphagia. Patients in both groups had an equally high probability
of not being diagnosed with PSD soon after discharge, with the likelihood of being
diagnosed with depression steadily increasing in both groups as the 90-day postdischarge period progressed (shown as descending survival curves in Figure 4). The
median time to depression was 39 days (IQR, 44) for patients in the mild dysphagia
severity group and 72.5 days (IQR, 48) for patients in the moderate or severe dysphagia
severity group (p=0.0124). This means that 50% of patients with mild dysphagia had a
diagnosis of depression a little more than one month after discharge, while 50% of
patients with moderate or severe dysphagia had a diagnosis of depression almost at the
end of the 90-day post-discharge follow-up period. Overall, patients with mild dysphagia
demonstrated a greater likelihood of being diagnosed with depression in the 90 days
after discharge compared to patients with moderate or severe dysphagia severity. These
findings were not supportive of hypothesis 2c in which we hypothesized that patients
with more severe dysphagia would have a shorter time to first depression diagnosis after
discharge from the acute hospital.
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Figure 4. Survival curves for PSD during 90-day post-discharge follow-up period by
dysphagia severity (mild vs. moderate/severe), Kaplan-Meier method.

72

Aim 3 Results
To determine if dysphagic patients with a PSD diagnosis incurred greater healthcare costs
than dysphagic patients without a PSD diagnosis, we performed a cost analysis on a data
set of post-discharge Medicare beneficiaries with a primary diagnosis of AIS who had
been diagnosed with dysphagia during their inpatient acute hospitalization. We found
that our results supported our hypothesis that patients who were diagnosed with
dysphagia and PSD did, in fact, incur higher healthcare costs in the 90 days after
discharge than those diagnosed with dysphagia alone.

Patient Characteristics

Our data set of 359 post-stroke patients diagnosed with dysphagia was stratified by
dysphagia severity cluster according to the ADDSS (Table 11). There were no significant
differences in gender or race among patients in all three dysphagia severity groups. The
group with Mild dysphagia severity (and moderate stroke) contained 74% of the sample
and had a mean age of 80.15 years (SD 8.94) with a range of 65-98 years. Patients in the
Mild dysphagia cluster also had the lowest statistically significant mean NIHSS (8.53
±6.87, p<.0001), SASI (9.16 ±6.34, p<.0001), and CCI (4.18 ±2.12, p=0.0276) scores; mean
LOS (6.20 ±3.16, p<.0001); and proportion of dual eligibility (16%, p=0.0144) compared to
those in the Moderate and Severe dysphagia clusters. Patients in the Mild group had the
second highest proportion of tPA administration (6%, p=0.1306), lowest proportion of
feeding tube placement (0%, p<.0001), and while they also had the highest proportion of
depression diagnosis after discharge (17%), this result was not statistically significant
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(p=0.3894). Those in the Mild cluster were discharged home (23%, p<.0001) more than
patients in the higher severity clusters, and the proportions discharged to IPR and SNF
(37% and 38%, p<.0001, respectively) were in-between those in the Moderate and
Severe dysphagia clusters.

The Moderate dysphagia severity (with moderate/severe stroke) group contained 12% of
the sample and had the youngest patients, with a mean age of 76.43 years (SD 8.09) and
a range of 65-98 years. Patients in the Moderate dysphagia cluster had the highest mean
NIHSS (16.02 ±7.47, p<.0001), SASI (14.67 ±7.45, p<.0001), and CCI (4.86 ±1.83,
p=0.0276) scores of all the clusters. The mean LOS (11.52 ±5.84, p<.0001) was higher in
the Moderate dysphagia group than in the Mild group and lower than the Severe group.
Patients in the Moderate dysphagia group received the lowest proportion of tPA
administration (0%, p=0.1306), though not statistically significant, and they also had the
lowest proportion of discharge home (2%, p<.0001) and the highest discharge to IPR
(45%, p<.0001). Twelve percent of patients in this group received a depression diagnosis
after discharge, which was in-between those in the Mild and Severe dysphagia clusters;
however, this finding was not statistically significant. Half of all patients in the Moderate
dysphagia group had feeding tube placement (p<.0001), which was in-between the
proportions for the Mild and Severe groups.

The Severe dysphagia (with moderate stroke) group contained 14% of the sample and
had a mean age of 78.57 years (SD 8.22) with a range of 65-95 years. Patients in the
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Severe dysphagia cluster had mean NIHSS (12.53 ±7.99, p<.0001), SASI (10.69 ±5.57,
p<.0001), and CCI (4.41 ±2.20, p=0.0276) scores that were in-between those of patients
in the Mild and Moderate dysphagia clusters. Patients in the Severe dysphagia cluster
also had the longest mean LOS (13.57 ±3.16, p<.0001) and the greatest proportion of
patients who discharged to SNF (69%, p<.0001) compared to those in the Mild and
Moderate clusters. They also had the lowest proportion of depression diagnosis after
discharge (10%); however, this finding was not statistically significant. Patients in the
Severe group also had the highest proportion of feeding tube use at 100% (p<.0001).
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Table 11. Baseline characteristics and descriptive data for Aim 3
Clustera

Demographics /
Characteristics
N=359 (100%)

Age, years
NIHSS
max possible 42
SASI
max possible 56
CCI
max possible 24
LOS, days

Mild
Dysphagia
Emphasis on
cognitive impairment
n=266 (74%)
Mean (SD)
Range
80.15 (8.94)
65-98
8.53 (6.87)
0-29
9.16 (6.34)
0-36
4.18 (2.12)
1-15

Moderate
Dysphagia
Emphasis on
respiratory compromise
n=42 (12%)
Mean (SD)
Range
76.43 (8.09)
65-98
16.02 (7.47)
3-31
14.67 (7.45)
0-41
4.86 (1.83)
1-11

Severe
Dysphagia
Emphasis on
alternative nutrition
n=51 (14%)
Mean (SD)
Range
78.57 (8.22)
65-95
12.53 (7.99)
1-33
10.69 (5.57)
0-31
4.41 (2.20)
1-12

6.20 (3.16)
2-21

11.52 (5.84)
3-27

13.57 (6.22)
5-34

n (%)

n (%)

p-value

0.0280
<.0001
<.0001
0.0276
<.0001

n (%)

Female

142 (53.38)

22 (52.38)

30 (58.82)

0.7548

Race
White

223 (83.83)

35 (83.33)

39 (76.47)

0.3361
--

Black

29 (10.90)

5 (11.90)

7 (13.73)

--

Hispanic

2 (0.75)

0 (0)

1 (1.96)

--

Other

12 (4.51)

2 (4.76)

4 (7.84)

--

Depression

44 (16.54)

5 (11.90)

5 (9.80)

0.3894

Feeding tube

0 (0)

21 (50)

51 (100)

<.0001

tPA

16 (6.02)

0 (0)

5 (9.80)

0.1306

Dual eligibility

43 (16.17)

13 (30.95)

15 (29.41)

0.0144

Discharge location

<.0001

Home

61 (22.93)

1 (2.38)

2 (3.92)

--

IPR

99 (37.22)

19 (45.24)

14 (27.45)

--

SNF

100 (37.59)

14 (33.33)

35 (68.63)

--

Trans

6 (2.26)

8 (19.05)

0 (0)

--

Footnote: N=population size; n=sample size, SD=standard deviation, NIHSS=National
Institutes of Health Stroke Scale, SASI=Stroke Administrative Severity Index, CCI=Charlson
Comorbidity Index, LOS=length of stay, tPA=tissue plasminogen activator, IPR=inpatient
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rehabilitation, SNF=skilled nursing facility, HH=home health, Trans=transferred to
another facility
a
Mild dysphagia severity with moderate stroke; Moderate dysphagia severity with
moderate/severe stroke; Severe dysphagia severity with moderate stroke.

Cost of Care

Unadjusted Cost
Using univariate analysis to examine total 90-day post-discharge cost, we found that, on
average, dysphagic patients (irrespective of severity) with a depression diagnosis had
$12,667 higher mean total costs after discharge than those without depression, these
results are statistically significant, p<.0001 (Table 12). When comparing the fully adjusted
cost estimate from the multivariable model, there is some overlap in the 95% confidence
intervals (CIs) which is not surprising given the small sample size used for this estimate.
The mean unadjusted total 90-day post-discharge costs by dysphagia severity clusters
show that patients with Mild and Severe dysphagia with a depression diagnosis had
higher mean total costs ($15,914 and $11,680, respectively) than those without a
depression diagnosis in the same dysphagia severity groups, while patients with
Moderate dysphagia with a depression diagnosis had $316 lower mean total costs
compared to those with Moderate dysphagia without a depression diagnosis (Table 12).

We also found that patients in the Moderate dysphagia group (with moderate/severe
stroke severity) had statistically significant unadjusted higher mean inpatient costs after
discharge than those with Mild or Severe dysphagia severity (Figure 5 and Appendix 5).
Patients with Moderate dysphagia had more inpatient rehabilitation admissions and/or
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readmissions to the acute hospital after discharge than those with more or less severe
dysphagia (and less severe stroke severity). These results are consistent with the medical
characteristics of the patients in the Moderate dysphagia group, in that they
demonstrated the highest stroke severity, likely resulting in greater impairment and
disability and requiring more intensive rehabilitation, which is why they also had the
largest proportion of discharge to IPR facilities. Furthermore, patients in the Moderate
dysphagia group were the most ill and had the most serious respiratory comorbidities,
such as aspiration pneumonia, intubation, and tracheotomy/tracheostomy, out of all
groups; thus, readmissions to the acute hospital are expected in this group. In contrast,
we found that those with the least dysphagia severity (Mild) were overwhelmingly
discharged home (23%) compared to patients with Moderate (2%) and Severe (4%)
dysphagia severity, respectively (Table 11), and, as expected, patients discharged home
had the lowest unadjusted mean total 90-day post-discharge costs, inpatient costs, and
carrier costs after discharge (p<.0001, respectively) (Appendix 6).
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Table 12. Estimated mean total 90-day post-discharge costs and 95% confidence intervals
for patients with and without depression diagnosis by overall dysphagia and dysphagia
severity clusters
Clustera

Costb

Depression
Yes

No

Overall
Dysphagiac
N=359 (100%)
Mean (SD),
95% CI
p-value

Mild
Dysphagiad
Emphasis on
cognitive
impairment
n=266 (74%)
Mean (SD),
95% CI
p-value

Moderate
Dysphagiad
Emphasis on
respiratory
compromise
n=42 (12%)
Mean (SD),
95% CI
p-value

Severe
Dysphagiad
Emphasis on
alternative
nutrition
n=51 (14%)
Mean (SD),
95% CI
p-value

44,613 (21,820)
34,417-57,829
<.0001
31,946 (26,559)
28,642-35,631
<.0001

43,074 (22,458)
32,526-57,042
<.0001
27,160 (21,688)
23,968-30,778
<.0001

54,177 (17,388)
23,549-124,644
<.0001
54,493 (39,186)
40,116-74,021
<.0001

48,588 (20,597)
21,119-111,785
<.0001
36,908 (25,895)
28,043-48,576
<.0001

Footnote: N=population size, n=sample size, SD=standard deviation, CI=confidence
interval
a
Mild dysphagia severity with moderate stroke; Moderate dysphagia severity with
moderate/severe stroke; Severe dysphagia severity with moderate stroke.
b
Cost in United States dollars (USD).
c
Column values are unadjusted
d
Column values are adjusted
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Figure 5. Mean total cost for types of care by dysphagia severity for 90 days postdischarge.

Adjusted Cost
We used multivariable analysis via gamma-distributed GLMs with logarithmic
transformation to compare healthcare costs across dysphagia severity groups, with our
main independent variable being PSD diagnosis. We included clinically relevant predictor
variables in each of our initial individual models to determine if they were statistically
significant as potential confounding factors (Table 13).
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Table 13. Regression parameters for 90-day post-discharge cost for each univariable
model to identify significant covariates for inclusion in the multivariable model
Variable

Depression

Parameter Estimate

p-value

0.3340

0.0201

Dysphagia severity
Mild

0.0002
Reference

--

Moderate

0.6031

--

Severe

0.2447

--

Age

-0.0124

0.0442

NIHSS

0.0278

<.0001

Female

0.0102

0.9214

CCI

0.0252

0.3399

tPA

-0.0920

0.6761

Dual eligibility

0.1921

0.1377

Race

0.6490

White

-0.2014

0.2160

Black

Reference

--

Hispanic

-0.1716

0.7690

Other

-0.1287

0.6413

Footnote: NIHSS=National Institutes of Health Stroke Scale, CCI=Charlson Comorbidity
Index, tPA=tissue plasminogen activator, Reference=reference group in the model
Controlling for the statistically significant covariates from our initial models, we fit our
final parsimonious cost model measuring the effect of PSD on total 90-day post-discharge
cost (Table 14). The results showed that a diagnosis of PSD was associated with increased
mean total healthcare costs in the 90 days following discharge from the acute hospital. It
also showed that stroke severity (NIHSS score) and dysphagia severity (moderate)
significantly contributed to the variations in cost. This is illustrated in the increase in
marginal cost difference between dysphagic patients with and without a diagnosis of

81

depression, for which the unadjusted difference was $12,667 and now, controlling for
dysphagia severity and stroke severity, the cost difference has increased to $15,556.

Table 14. Estimated mean 90-day post discharge cost for patients with and without
depression, controlling for effects of differences in dysphagia severity and stroke severity
Parameter
Estimate

SE

95% CI

p-value

Yes

0.3599

0.1419

0.0819 – 0.6379

0.0112

No

Reference

--

--

--

Reference

--

--

--

Moderate

0.5108

0.1687

0.1801 – 0.8414

0.0025

Severe

0.2243

0.1475

-0.0647 – 0.5134

0.1282

0.0167

0.0074

0.0021 – 0.0312

0.0246

Variable

Depression

Dysphagia severity
Mild

NIHSS

Footnote: SE=standard error, CI=confidence interval, NIHSS=National Institutes of Health
Stroke Scale, Reference=reference group in the model

In order to estimate the adjusted mean costs for the dysphagia severity groups with and
without PSD, we created a variable that represented dysphagia severity by cluster (mild,
moderate, or severe) in the presence or absence of PSD (“Mild/No PSD,” “Mild/PSD,”
“Mod/No PSD,” “Mod/PSD,” “Sev/No PSD,” “Sev/PSD”). The “combination” independent
variable was then used in a multivariable cost estimation model to measure the effect of
PSD and dysphagia severity on total 90-day post-discharge cost. The results showed that
having a PSD diagnosis and being in the mild dysphagia severity cluster were associated
with higher 90-day costs (p=0.0089) (Table 15). We also found that stroke severity had a
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significant effect on cost (p=0.0259). The marginal cost difference was $15,914 higher for
patients with Mild dysphagia severity with a diagnosis of depression compared to
patients with Mild dysphagia severity without a diagnosis of depression, controlling for
stroke severity. This finding supports our hypothesis that dysphagic patients with PSD will
incur greater healthcare costs than dysphagic patients without PSD.

Table 15. Estimated mean 90-day post discharge cost for patients in three different
dysphagia severity groups with and without depression, controlling for effects of
differences in stroke severity
Parameter
Estimate

SE

95% CI

p-value

Reference

--

--

--

Mild/PSD

0.4119

0.1575

0.1032 – 0.7206

0.0089

Moderate/No PSD

0.5604

0.1786

0.2105 – 0.9104

0.0017

Moderate/PSD

0.5228

0.4342

-0.3282 – 1.3737

0.2286

Severe/No PSD

0.2427

0.1556

-0.0623 – 0.5478

0.1189

Severe/PSD

0.5049

0.4289

-0.3356 – 1.3455

0.2390

0.0165

0.0074

0.0020 – 0.0311

0.0259

Variable

Dysphagia severity & PSD
Mild/No PSD

NIHSS

Footnote: SE=standard error, CI=confidence interval, NIHSS=National Institutes of Health
Stroke Scale, PSD=post-stroke depression, Reference=reference group in the model

To contrast cost differences between patients with mild dysphagia and those with
moderate or severe dysphagia, we constructed a dichotomous variable for dysphagia
severity – “mild” (patients classified as having mild dysphagia severity) or “not mild”
(patients classified as having moderate or severe dysphagia severity). This approach
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helped create more proportionate sample sizes per cluster (n=266 and n=93,
respectively), which is helpful to understand the effect of small cluster samples on the
variation in the adjusted cost estimates. Multivariable analysis results from this model
(Table 16) were very similar to results from our other models (Tables 14 and 15) in that
depression had a significant effect on cost, as did dysphagia severity (in this case,
moderate or severe) and stroke severity (Figure 6), with a marginal cost difference
between dysphagic patients with and without a diagnosis of depression of $10,745,
controlling for dysphagia severity and stroke severity.

Table 16. Estimated mean 90-day post discharge cost for patients with and without
depression, controlling for effects of differences in dysphagia severity (by dichotomous
dysphagia severity variable) and stroke severity
Parameter
Estimate

SE

95% CI

p-value

Yes

0.3541

0.1421

0.0755 – 0.6327

0.0127

No

Reference

--

--

--

Reference

--

--

--

0.3530

0.1229

0.1122 – 0.5938

0.0041

0.0165

0.0074

0.0020 – 0.0311

0.0259

Variable

Depression

Dysphagia severity
Mild
Not mild
NIHSS

Footnote: SE=standard error, CI=confidence interval, NIHSS=National Institutes of Health
Stroke Scale, Not mild= patients classified as having moderate or severe dysphagia
severity, Reference=reference group in the model
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Figure 6. Effect of depression on 90-day post-discharge cost by mild dysphagia severity
vs. moderate or severe dysphagia severity.

Overall, results from this cost analysis consistently showed that not only does depression
diagnosis significantly increase healthcare costs in the 90 days after discharge, so do
stroke severity and dysphagia severity. We found that patients with dysphagia and
depression (regardless of dysphagia severity) incur higher healthcare costs in the 90 days
after discharge than dysphagic patients without depression, an unadjusted effect size of
$12,667. Furthermore, we found that the presence of depression resulted in a 36%
increase (β, 0.3599; 95% CI, 0.0819-0.6379; p=0.0112) in cost after controlling for
dysphagia severity and stroke severity (adjusted effect size). We also found that
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dysphagia severity cluster is an important covariate in explaining variations in postdischarge cost for patients diagnosed with both post-stroke dysphagia and PSD, which is
supportive of our Aim 2 Hypothesis 1 (i.e., development of the ADDSS) – that these
dysphagia severity clusters are useful and clinically meaningful predictors in
administrative data analyses.

CHAPTER 5: DISCUSSION

Aim 1 Discussion
Section 1: Brief Summary of Results

Objectives
The objectives for Aim 1 were to not only examine the rate of diagnosis of PSD in patients
with a diagnosis of post-stroke dysphagia but also to determine if it is at least as high as
the rate of diagnosis of PSD in the general stroke population. Furthermore, we studied
the relationship between PSD and post-stroke dysphagia, evaluated the odds and hazard
of being diagnosed with depression after stroke, and estimated the time to depression
from the initial stroke diagnosis in patients with and without a diagnosis of dysphagia.

Hypothesis and Results
Consistent with our hypothesis, the results from Aim 1 demonstrated that the rate of
diagnosis of PSD in patients with a diagnosis of post-stroke dysphagia is at least as high as
the rate of diagnosis of PSD in the general stroke population. In fact, patients diagnosed
with dysphagia demonstrated slightly higher proportions of depression diagnosis during
acute hospitalization (12%) compared to patients not diagnosed with dysphagia
(approximately 10%). We also found that PSD diagnosis was significantly affected by
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dysphagia diagnosis during the 90-day post-discharge follow-up period as well, with
those who had been diagnosed with dysphagia being almost three times more likely to be
diagnosed with depression than patients who had not been diagnosed with dysphagia
and the patients diagnosed with dysphagia demonstrating an approximately 1.75-fold
higher hazard for PSD diagnosis than the patients not diagnosed with dysphagia. The
mean time from stroke to depression diagnosis was higher for patients diagnosed with
dysphagia compared to those not diagnosed with dysphagia (40 days versus 34 days,
respectively), signifying that patients with a dysphagia diagnosis were diagnosed with
depression later than patients without a dysphagia diagnosis; however, these results
were not significant. Additional results are discussed in detail in the following sections.

Section 2: PSD in Patients with Post-Stroke Dysphagia

Related Research
Dysphagia is a common consequence of stroke (Dziewas, et al., 2017; GonzalezFernandez et al., 2013; Labeit et al., 2018; Martino et al., 2005; Rofes et al., 2011, 2013),
as is depression (Broomfield et al., 2014; Gillen et al., 1999; Saxena et al., 2007; Stein et
al., 2020; Towfighi et al., 2017; Williams, 2005). It is believed that dysphagia has a
substantial effect on mental health and is linked to depression (Dziewas, et al., 2017;
Holland, 2011; Verdonschot et al., 2013, 2017); however, the incidence of PSD in poststroke dysphagic patients is not known. To our knowledge, there is no literature that
specifically examines PSD in post-stroke dysphagic patients as a primary outcome. There
are some incidental reports of dysphagia in stroke survivors with depression (Ayerbe et
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al., 2011; Kang et al., 2012; Harris et al., 2017; Saxena et al., 2008); however, establishing
rates of PSD in dysphagic patients and elucidating the relationship between PSD and
post-stroke dysphagia were not the main objectives in these studies. For example, Kang
et al. (2012) examined the effects of a dysphagia exercise program on swallow function
and its indirect effect on depressive symptoms in subacute stroke patients with
dysphagia (onset of stroke within six months) in a rehabilitation hospital. Although PSD
was not their primary outcome of interest, the researchers reported that post-stroke
dysphagic patients in both the control and experimental groups had severe (score of >29)
mean Beck Depression Inventory (BDI) (Beck & Steer, 1993) scores before dysphagia
treatment (Kang et al., 2012; Smarr & Keefer, 2011). After two months of treatment, the
control group’s mean BDI scores remained severe (score of >29), and the mean BDI
scores of the experimental group, who demonstrated significant improvement in (oral
phase) swallow function, significantly decreased to scores in the moderate range (score
of 20-28) (Kang et al., 2012; Smarr & Keefer, 2011). While improvement in mean BDI
scores was observed in the experimental group, patients continued to experience
moderate depressive symptoms, which could be due to the fact that their swallow
function improvement (in oral phase only), though statistically significant, was not
clinically meaningful (Kang et al., 2012). The researchers noted that there was no
meaningful difference in proportions of patients with aspiration pneumonia or
transitioning from tube feeding to oral feeding between groups (Kang et al., 2012);
therefore, it is feasible that patients who continued to have pharyngeal phase dysphagia,
particularly severe enough to result in aspiration pneumonia and/or the need for non-
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oral nutrition (tube feeding), would also continue to experience depressive symptoms.
Harris et al. (2017) examined the prevalence of PSD and its association with functional
status among African American stroke survivors in an inpatient rehabilitation setting.
Although the researchers did not primarily study dysphagia in this patient population,
they reported that individuals with depression had a significantly higher proportion of
dysphagia compared to those without depression (60% versus 44.1%, p=0.014),
suggesting that dysphagia is more common in those with depression during the subacute
stroke period (Harris et al., 2017).

Incidence of PSD Diagnosis
One of the main findings in the present study was that patients diagnosed with poststroke dysphagia are at least as likely as those not diagnosed with post-stroke dysphagia
to be diagnosed with PSD. There is a slightly higher proportion of PSD diagnosis in
patients who had been diagnosed with post-stroke dysphagia compared to those who
had not, 12% versus about 10%, respectively; however, the difference in proportions as
well as the actual proportions of post-stroke dysphagia and PSD were much lower than
expected, considering the substantially higher incidence of both diagnoses reported in
the literature. Notwithstanding, our findings coincide with Harris et al.’s (2017) results
(but with our proportions much lower than theirs). There are no other studies for direct
comparison; however, our findings are still lower than expected if compared to studies
that have reported incidence of PSD and post-stroke dysphagia separately. For example,
our results showed that 10% of the general stroke population were diagnosed with
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depression during acute hospitalization, which is substantially lower than the
approximately 33% of stroke survivors who are reportedly diagnosed with depression at
any one time after stroke (Hackett & Pickles, 2014; Kutlubaev & Hackett, 2014; Towfighi
et al., 2017; Zhang et al., 2020). Similarly, our results demonstrated that 16% of the
general stroke population had a diagnosis of dysphagia, which is remarkably low
compared to Martino et al.’s (2005) systematic review report of 37-80% of stroke
survivors experiencing dysphagia (depending on type of dysphagia screen and/or
assessment used, timing of assessment after stroke, and lesion location).

Section 3: The Problem of Underdiagnosis and Undercoding

Underdiagnosis and Undercoding of Dysphagia
We found that 16% of post-stroke patients have dysphagia in the acute hospital setting.
The difference in our findings compared to those in the literature can be primarily
explained by underdiagnosis and undercoding (Cohen et al., 2020; Dziewas, et al., 2017;
Gonzalez-Fernandez et al., 2008; Labeit et al., 2018; Rofes et al., 2011; Takizawa et al.,
2016). Despite its high prevalence, post-stroke dysphagia is frequently underdiagnosed
because of a number of factors, including restricted availability of dysphagia experts
(speech-language pathologists [SLPs]) in hospitals, limited access to costly instrumental
diagnostic equipment or other material resources in certain medical settings, and lack of
consensus for which patients require dysphagia screening (Dziewas, et al., 2017; Labeit et
al., 2018; Rofes et al., 2011). Furthermore, various methods for dysphagia evaluation are
reported in studies examining post-stroke dysphagia, including patient report, screening

91

tools, bedside swallow assessment, and modified barium swallow study – all with varying
levels of sensitivity for detecting dysphagia (Takizawa et al., 2016); therefore, depending
on the evaluation method used, dysphagia may be missed in some stroke patients. For
example, silent aspiration can occur in up to 67% of post-stroke patients with dysphagia
(Daniels et al., 1998; Martino et al., 2012), and if the diagnostic tool to evaluate
dysphagia does not have adequate sensitivity to detect silent aspiration (like patient
report, screening tools, or bedside swallow assessments), then a potentially large
proportion of individuals with dysphagia will go undiagnosed. In addition, underdiagnosis
and undercoding of dysphagia are known limitations in administrative data analysis
(Cohen et al., 2020; Gonzalez-Fernandez et al., 2008; Takizawa et al., 2016).
Nevertheless, there is high specificity in dysphagia diagnosis within medical billing data;
therefore, we can confidently assume that the patients who are diagnosed with
dysphagia do, in fact, have dysphagia (Cohen et al., 2020). Conversely, we cannot assume
that just because a patient does not have a diagnosis of dysphagia that dysphagia is not
present; therefore, interpretations of the findings from this study should be made with
caution.

Underdiagnosis and Undercoding of PSD
Correspondingly, PSD is an often underestimated and underdiagnosed sequela of stroke
(Dar et al., 2017). It is underdiagnosed for a variety of reasons, including difficulties
evaluating depression in patients with cognitive and/or language disorders (which are
common after stroke), misattributing common symptoms of stroke and depression (such
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as fatigue, poor sleep, and emotional lability) resulting in misclassification by healthcare
providers, and use of screening tools with inadequate sensitivity for detecting depression
(Conroy et al., 2020; Starkstein & Robinson, 1989; Williams, 2005). In addition, patients
may not report depressive symptoms because of the social stigma associated with
mental health disorders (Alaghehbandan & MacDonald, 2013). Due to the risk of
mortality and number of serious co-occurring conditions that may present after stroke, it
is feasible that healthcare providers in the acute hospital are more focused on basic lifesustaining functions as opposed to assessing for neuropsychiatric manifestations in acute
stroke patients, resulting in overlooked diagnoses of PSD. Dar et al. (2017) and VanItallie
(2005) recommended that healthcare professionals be adequately trained to recognize
depressive symptoms, use appropriate diagnostic rating scales, and be able to
discriminate signs of depression from other disorders (e.g., dementias and normal grief
reactions). Furthermore, like post-stroke dysphagia, PSD is also known to be undercoded
in administrative billing data, resulting in questionable accuracy of diagnostic information
and underreporting of diagnostic procedures (Alaghehbandan & MacDonald, 2013),
which may misrepresent the true proportion of medical conditions and level of care
received by patients. To address the issue of undercoding, researchers have developed
promising case-finding algorithms with adequate sensitivity and specificity for the
detection of PSD in administrative databases; thus, the utilization of administrative data
for PSD research remains useful (Alaghehbandan & MacDonald, 2013; Damush et al.,
2008; West et al., 2000). Nevertheless, as with dysphagia, we should not assume that
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depression is not present just because there is no diagnosis of PSD in the medical record.
For this reason, the results from this study should be interpreted cautiously.

Addressing Underdiagnosis and Undercoding
Underdiagnosis and undercoding are alarming problems in healthcare because they not
only demonstrate that patients who have serious medical conditions may not be
identified or may be identified but their diagnosis not adequately coded, but it also
means that these patients may not receive treatment for potentially critical conditions.
For example, we know that post-stroke dysphagia can lead to serious complications if not
managed, such as malnutrition, dehydration, aspiration pneumonia, and death (Labeit et
al., 2018), and we also know that PSD is a predictor of negative outcomes after stroke,
including disability; poor physical, social, and cognitive function; lower quality of life; and
high mortality (Towfighi et al., 2017). Because of the prevalence and seriousness of these
medical conditions, medical providers need to be alert to the issues of underdiagnosis
and undercoding and be trained in not only identifying these patients but also properly
coding for their respective medical diagnoses. As another example, increased surveillance
for recognizing symptoms of dysphagia and depression in post-stroke patients and
targeted and repeated (respective) dysphagia and depression screenings early in the
acute post-stroke phase using appropriate diagnostic instruments are necessary to
adequately detect high risk patients. Then providers can assign timely interventions
and/or referrals as needed, potentially mitigating the risks of morbidity and mortality in
this patient population.
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As a result of the probable undercoding of post-stroke dysphagia and PSD in this study,
our findings are likely grossly underestimated and more conservative than the true
population incidences. Nonetheless, because of our large, representative sample size
(N=9,163), our results may be more generalizable than other studies with smaller, less
representative samples, and, to our knowledge, they establish the first reported
incidence of PSD in Medicare patients with dysphagia who are 65 years of age and older
after AIS.

Section 4: Likelihood of PSD Diagnosis

In the present study, fewer patients who received tPA administration were diagnosed
with post-stroke dysphagia, which is expected given that tPA is known to reduce the
severity of stroke. Those with a dysphagia diagnosis demonstrated significantly higher
proportions of cognitive decline and had increased LOS (by about three days longer) than
patients without a dysphagia diagnosis. We found that having a diagnosis of dysphagia,
being female, being white, and having dual eligibility were positively associated with
depression diagnosis after stroke, while age was negatively associated with PSD
diagnosis. Compared to patients without a diagnosis of post-stroke dysphagia, those with
a diagnosis of dysphagia were 2.7 times more likely to be diagnosed with depression after
discharge from the acute hospital. In addition, white patients were 82% more likely to
have a PSD diagnosis after discharge than black patients and were overall more likely to
have a PSD diagnosis than any other race; however, due to the disproportionate number
of white patients in this study (>80%), these results should be interpreted with caution.
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The odds of being diagnosed with depression increased in women by 71%, and for those
with dual eligibility, which is indicative of low socioeconomic status (SES), the odds
increased by 43%. Age was the only factor for which the odds of PSD diagnosis were
reduced (by 24%).

Although there were very few studies by which to compare our findings, we found that
our results were similar to Ayerbe et al.’s (2011) findings that at three months poststroke, dysphagic patients were almost twice as likely to have depression than nondysphagic patients; however, Saxena et al. (2008) found no significant association
between PSD and dysphagia at six months after stroke (in multivariate analyses). The
reason for the disparity may be due to variations in study methodology, sample sizes,
diagnostic assessments and time frames, etc., which are discussed in detail below.
Despite the discordance with Saxena et al.’s (2008) results, our findings are supported by
other non-stroke dysphagia literature, which posit that dysphagia is associated with
affective complaints (Verdonschot et al., 2013, 2017). In a systematic review by
Verdonschot et al. (2017), the researchers found that all 24 articles they appraised
suggested that depressive symptoms were significantly and positively associated with
dysphagia. Furthermore, dysphagia is known to have severe social and psychological
impacts that reduce quality of life, such as embarrassment, isolation, and loss of selfesteem due to swallowing difficulties and anxiety, panic, and avoidance of meals due to
fear of food sticking in the throat and choking (Ekberg et al., 2002). For these reasons, it
is plausible that dysphagia is not only associated with PSD but also increases the odds of
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PSD in post-stroke patients, as we found in the present study. Furthermore, these
dysphagia-related psychological impacts may exacerbate or be exacerbated by similar
psychosocial impacts of PSD, such as social withdrawal, social deterioration, and social
discontentment (Dar et al., 2017). Given that the nature of association between poststroke dysphagia and PSD is not understood, it is feasible to consider that both could
potentially contribute to, cause, or affect each other.

Sienkiewicz-Jarosz et al.’s (2010) results revealed that stroke patients with more
depressive symptoms had lower income, which was comparable to our findings with
patients who had dual eligibility (an indicator of low SES), as were Khedr et al.’s (2020)
results that PSD is significantly associated with lower SES. It is known that low SES is a
determinant of poor health status, and the combination of low SES and high levels of
psychological distress has been shown to have a multiplicative effect in which low SES
magnifies the negative effects of psychological distress (Lazzarino et al., 2013a, 2013b).
Furthermore, it is believed that those with lower SES possess fewer financial, social, and
psychological resources to manage adverse events (Lazzarino et al., 2013a, 2013b;
Matthew & Gallo, 2011); therefore, our findings that individuals with dual eligibility (an
indicator of low SES) have increased odds of PSD compared to those who do not have
dual eligibility are in line with the literature.

With regard to gender differences, we found that women were more likely to be
diagnosed with PSD than men, which was similar to Goldmann et al.’s (2016) findings that
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the odds of PSD were higher in women. Conversely, our results contradicted Ayasrah et
al.’s (2018) findings in which gender was not found to predict PSD. In the 15 studies
examining prevalence of depression that Appelros et al. (2010) reviewed, most reported
that PSD was more common in women than men, while others found no difference
between women and men, and one study found a higher prevalence of PSD in men. The
authors concluded that whether or not being a woman is a risk factor for PSD remains illdefined (Appelros et al., 2010). Even so, we know that there are gender-related
differences in depression outside of the setting of stroke, with women almost twice as
likely than men to become depressed during their lifetime (Kuehner, 2017; Salk et al.,
2017). The reasons for this “gender gap” in depression remain unclear; however, there is
evidence to support several possible factors, including genetic susceptibility, hormonal
influences, psychological stress responsiveness, coping styles, and social roles (Kuehner,
2017). For example, studies have shown that women may be more likely to develop
depression after a stressful life event (Cohen et al., 2019) and, due to gender socialization
and cultural ideals about women, feel more comfortable seeking help when experiencing
symptoms of depression. Additional reasons for the “gender gap” may be clinician bias
and stereotypes about gender, in which clinicians’ diagnostic priorities tend to skew more
toward assessing women for depressive symptoms versus men. Furthermore, clinician
assessment methods (e.g., informal patient interview) may be biased toward depressive
symptoms that are more characteristic in women (Sigmon et al., 2005), such as sadness
or crying, and may not capture depressive symptoms more characteristic in men, such as
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anger or substance abuse. For these reasons, it is plausible that after stroke, women are
more likely to be diagnosed with depression than men, as we found in the present study.

We found the odds of PSD diagnosis decreased with age, which is in agreement with
Goldmann et al.’s (2016) findings that older patients demonstrated lower odds of PSD;
however, our findings differed from Ayasrah et al.’s (2018) results in which age was not
found to predict PSD. McCarthy et al. (2016) reported that at three months post-stroke,
patients between 25-64 years of age had significantly greater depressive symptoms than
those 65 years and older, with the 25-54 age group demonstrating the highest risk for
depression out of all age groups examined, which is in line with our findings that older
patients have lower odds of PSD diagnosis. The authors noted, however, that their results
were in accordance with some similar studies but contradicted the results of others and
suggested that these disparities were due to variability in study methods, such as using
age as a dichotomous, instead of continuous, variable and restricting age groups in study
samples (McCarthy et al., 2016). Furthermore, McCarthy et al. (2016) proposed that the
association between age and PSD may be curvilinear as opposed to linear, meaning that
risk of PSD is greatest between the ages of 25 and 54, attenuating through midlife and
early old age, and then increasing again in late old age. Another potential reason for the
inconsistent findings in studies examining age and PSD could be the underdiagnosis of
depression in older individuals as a result of age-related clinician bias in which depression
is assumed to be a normal response to a serious medical event, disease diagnosis, or
even advancing age (Stewart, 2004). Clinicians may observe symptoms of depression but
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not diagnose or refer an older patient for intervention if these symptoms are assumed an
expected reaction in this particular patient age group.

We found that white patients were more likely to be diagnosed with PSD than any other
race within the three-month time period after discharge from the acute hospital;
however, it should be noted that we had a disproportionately large number of white
patients in our population (>80%), which can bias results. Accordingly, our findings should
be interpreted with caution. Nevertheless, our results were similar to Goldmann et al.’s
(2016) findings from their prospective study that comprised an adequate representation
of Hispanic patients (50.8% Hispanic, 25.7% non-Hispanic white, and 17.5% non-Hispanic
black) that non-Hispanic white post-stroke patients had greater odds of depression one
month after stroke compared to other races; however, no significant differences were
found in diagnosis of PSD between non-Hispanic white and Hispanic patients after a year.
In Jia et al.’s (2010) retrospective study of Veterans Affairs patients utilizing
administrative data, researchers found that post-stroke non-Hispanic white patients had
higher odds of PSD than Hispanic and non-Hispanic black patients one year after stroke,
which is in agreement with our findings; however, Jia et al.’s (2010) study population was
also comprised of disproportionately greater number of white patients versus patients of
other races/ethnicities (65.54% white, 21.9% black, 7% Hispanic, and 5.55% other), which
could potentially bias results. In contrast to these and our findings, Sienkiewicz-Jarosz et
al. (2010), Ayerbe et al. (2011), and Saxena et al. (2008) did not find any significant
associations between PSD and race/ethnicity. Furthermore, they found no significant
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associations between PSD and other demographic variables, such as age and gender,
either. We found that our results were both consistent with and in contradiction to
results from other studies examining variables associated with PSD, which is common in
this area of research, especially for demographic variables (De Ryck et al., 2014;
Kutlubaev & Hackett, 2014; Towfighi et al., 2017; Zhang et al., 2020). For example, in Shi
et al.’s (2017a) meta-analysis, the investigators found that demographic factors, such as
female gender and age (<70 years) were risk factors for PSD during the acute and
subacute (≤ three months) phases, while in Babkair’s (2017) integrative systematic
review, the investigator found that significant associations for demographic variables,
such as gender and age, were inconsistent across studies. Several researchers who have
conducted systematic reviews and meta-analyses have reported that because of varying
and conflicting results in the numerous studies evaluating predictors of PSD, there are no
consistent associations between PSD and demographic variables, such as age and gender
(Babkair, 2017; De Ryck et al., 2014; Kutlubaev & Hackett, 2014; Towfighi et al., 2017).
Moreover, they reported limited comparison and generalizability in most studies due to
differences in inclusion/exclusion criteria, settings, assessment timing, and depression
diagnostic criteria and tools; disparate variables that may be poorly quantified;
methodological variations; and inadequate sample sizes with underpowered analyses as
the reasons for disparities across study results (Babkair, 2017; Kutlubaev & Hackett,
2014; Towfighi et al., 2017). As such, our ability to make direct comparisons to analogous
studies is limited; however, we believe that we have addressed many of the authors’
criticisms of previous studies and, therefore, are confident that this study makes a
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meaningful contribution to the literature by elucidating the association between the
diagnosis of PSD and patients diagnosed with post-stroke dysphagia.

Section 5: Hazard of PSD Diagnosis

The results of our survival analyses revealed that, when controlling for significant
covariates, the hazard for PSD diagnosis in patients with and without a diagnosis of
dysphagia was initially low after discharge and consistently increased for the duration of
the 90-day follow-up period; however, the group with a dysphagia diagnosis
demonstrated an approximately 1.75-fold higher hazard for PSD diagnosis than the group
without a dysphagia diagnosis during the 90 days after discharge, suggesting that
patients diagnosed with dysphagia were more likely to be diagnosed with depression
than patients not diagnosed with dysphagia. We found that on average and on any given
day in the 90 days after discharge, the hazard for diagnosis of depression for patients
diagnosed with dysphagia was approximately 76% greater than that for patients not
diagnosed with dysphagia. The hazard of PSD diagnosis for women was about 67% higher
than for men, while the hazard of diagnosis of depression for individuals with dual
eligibility was approximately 40% higher than for those who did not have dual eligibility.
Conversely, hazard decreased significantly by 2.5% with each year of age, suggesting that
older stroke survivors are less likely to be diagnosed with depression. Finally, we found
that the hazard of PSD diagnosis for white patients was 71% higher than for non-white
patients, suggesting that white patients are at greater risk for diagnosis of depression
than any other race; however, because of the imbalance in racial demographics in our
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study population (white patients make up >80%), these findings should be interpreted
cautiously.

We are unable to directly compare these results to analogous studies because, to our
knowledge, there are no studies that have examined the hazard of PSD diagnosis in
patients diagnosed with post-stroke dysphagia; therefore, our findings may be the first to
establish that diagnosis of dysphagia has a highly significant effect on the hazard of
diagnosis of depression after AIS during the first 90 days after discharge from the
hospital. Nevertheless, we can compare our findings to the few published studies that
have assessed hazard. For example, Aben et al. (2003) included female gender and age in
their Cox regression analyses to assess the effect of cohort (stroke versus myocardial
infarction) on the cumulative incidence of depression, and though they did not discuss
the hazard of these variables explicitly, their results showed that, similar to our findings,
the hazard of depression in the stroke cohort was significantly higher (about 60%) in
women versus men. Contrary to our findings that with every year of age, the hazard of
PSD diagnosis significantly decreased, age was not found to be a significant covariate in
Aben et al.’s (2003) study. Likewise, Leentjens et al.’s (2006) findings that female gender
was not significant contradicted our results that being female significantly increased the
hazard of being diagnosed with depression after stroke. As with studies reporting the
odds of PSD diagnosis, our findings are consistent with some results from studies
examining hazard, yet contrary to others. As previously discussed in detail, the reasons
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for these disparities may be variations in methodology, sample size, inclusion/exclusion
criteria, diagnostic timing and tools, etc.

Section 6: Time to Depression Diagnosis

With regard to time to depression diagnosis, to our knowledge, there have been no
previous studies that have examined time from initial stroke diagnosis to depression
diagnosis in patients diagnosed with post-stroke dysphagia; thus, the present study
appears to be the first on this specific topic. We found the mean time to depression
diagnosis after stroke was 40 days for patients diagnosed with dysphagia and 34 days for
patients not diagnosed with dysphagia. Although patients with a dysphagia diagnosis
were diagnosed with depression later than patients without a dysphagia diagnosis on
average, these findings were not significant. Nonetheless, we also found that patients
with a post-stroke dysphagia diagnosis had a 1.5-fold higher likelihood of being diagnosed
with depression in the last 15 days of the 90-day post-discharge follow-up period
compared to those without a post-stroke dysphagia diagnosis.

Later Onset of PSD versus Later Diagnosis of PSD
The reason for our findings that patients with a diagnosis of dysphagia were diagnosed
with depression later than those without a diagnosis of dysphagia could be that
depression actually developed during the subacute, as opposed to the acute, phase after
stroke, which is feasible given that the literature suggests the timing of PSD is variable
among individuals and initial onset can occur between several days to years after stroke
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(Conroy et al., 2020). Most studies report the highest rates of PSD within the first month
to a year after stroke, with a decline in the subsequent 12 to 24 months thereafter
(Conroy et al., 2020; Ostir et al., 2011; Towfighi et al., 2017). Additionally, patients with a
diagnosis of post-stroke dysphagia often have higher stroke severity (Arnold et al., 2016)
and greater functional limitations (Castagna et al., 2019) than those not diagnosed with
post-stroke dysphagia, requiring continuation of care at an IPR facility or SNF after
discharge. As a result, these patients could potentially develop later-onset PSD when
transitioning from a medical facility where they received 24-hour care, to home, where
they experience an abrupt discontinuation of constant care and reduced socialization.

Conversely, it is possible that PSD was present in patients diagnosed with dysphagia
earlier than detected, but the diagnosis was delayed due to the previously stated reasons
for underdiagnosis of PSD, such as barriers diagnosing patients with concurrent cognitive
and/or language disorders and misclassification of depressive symptoms as stroke
symptoms. Because PSD is associated with worse functional outcomes, increased
disability, and higher mortality after stroke (Towfighi et al., 2018; Zhang et al., 2020), the
timing of depression diagnosis is important for early identification and prompt
intervention; however, optimal screening time after stroke is not known (Towfighi et al.,
2018). Nevertheless, it is plausible that early and recurrent depression screenings starting
during acute hospitalization would benefit those at risk for PSD.
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Section 7: Aim 1 Limitations

Although retrospective, “big data” studies have many advantages, the use of large data
sets with medical administrative data also have disadvantages and carry potential bias
(Kaplan et al., 2014), which are the main reasons for the limitations of this study. First,
because administrative data consists of medical and billing code sets and were not
collected specifically for research purposes, crucial information and details about
patients may be omitted, such as premorbid level of function (e.g., disability,
dependence); diagnostic methods and severity (of dysphagia and depression); and
behavioral, environmental, and social factors (Kaplan et al., 2014). For example, although
we removed patients with a diagnosis of dysphagia or depression within 90 days prior to
stroke from the data set, we cannot be sure that those patients did not have a prior
history of or undiagnosed dysphagia or depression before our 90-day pre-stroke cutoff.
Second, sampling bias limits the generalizability of the study results to the population
actually represented in the data set (Kaplan et al., 2014), which in our case, limits
generalizability to those 65 year of age and older who receive Medicare benefits and
excludes stroke survivors younger than 65 and those who do not have Medicare. Third,
coding errors and misclassification bias are recognized limitations in the use
administrative data (Cohen et al., 2020), and since undercoding of dysphagia and
depression is well-known (Cohen et al., 2020; Gonzalez-Fernandez et al., 2009), our
findings may be conservative and the true population values are likely underestimated.
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Aim 2 Discussion
Section 1: Brief Summary of Results

Objectives
Because claims data lack clinical details about disease severity, a proxy for severity is
needed to adequately utilize and analyze administrative data (Gonzalez-Fernandez et al.,
2009). To our knowledge, there is currently no method for post-stroke dysphagia severity
classification for use with administrative data. Thus, we saw an opportunity to address
this gap in the literature. Accordingly, our first objective for Aim 2 was to create a novel
proxy index for dysphagia severity for use with administrative data (called the ADDSS).
The second objective was to use this novel proxy index to stratify our sample based on
inferred dysphagia severity and determine if post-stroke dysphagic patients with varying
degrees of dysphagia severity had different PSD-related outcomes. Therefore, we
examined if dysphagia severity, via the ADDSS, was related to differences in PSD diagnosis
as well as time to PSD diagnosis within a 90-day post-discharge follow-up period in poststroke dysphagic patients.

Hypotheses and Results
For hypothesis 1, we used a stable subset of ICD-10 dysphagia diagnosis and procedure
codes to develop a clinically relevant, novel dysphagia severity index for use with
administrative data – the ADDSS. Cluster validation subsequent to the development of
the ADDSS revealed an interesting and unanticipated finding that dysphagia severity
categories were not the same as stroke severity (NIHSS score) categories. (Additional
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details in Section 3.) Then we applied the ADDSS to our data set to test hypothesis 2 and
its sub-hypotheses, which we found were not supported by our data. We did not find
that patients in different dysphagia severity groups had significantly different risk of PSD
diagnosis after discharge (hypothesis 2), nor did we find a statistically significant
difference in proportions of PSD diagnosis across dysphagia severity groups within the 90
days after discharge (hypothesis 2a). Furthermore, no significant effect was found
between dysphagia severity and the odds of receiving a PSD diagnosis in the 90 days after
discharge (hypothesis 2b). Lastly, the data did not support that post-stroke patients with
a diagnosis of PSD and more severe dysphagia had a shorter time to first depression
diagnosis compared to those with a diagnosis of PSD and less dysphagia severity
(hypothesis 2c). These results are discussed in detail in Sections 4 and 5.

Section 2: Construct Validity of the ADDSS

Utility of the ADDSS
Large administrative databases are being used more often in dysphagia research,
especially in studies of stroke (Bartlett & Thibeault, 2018). In a recent review by Bartlett
and Thibeault (2018), the authors examined research articles that used administrative
datasets or clinical registries to study dysphagia, and almost half of the articles focused
on stroke. Thus, there is great value and importance in developing instruments
specifically for use in administrative-level post-stroke dysphagia research (such as the
ADDSS).
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Because the ADDSS algorithm was shown to be valid and produced stable dysphagia
severity clusters, it can be used in post-stroke dysphagia research when stratification by
dysphagia severity is desired. It could also potentially be helpful in other aspects of poststroke dysphagia research, such as epidemiologic post-stroke dysphagia incidence and
prevalence reporting, identifying dysphagic subgroups (e.g., patients with dysphagiarelated sequelae), and capturing the burden of post-stroke dysphagia (e.g., healthcare
utilization and cost). Additionally, we developed the ADDSS and performed a subsequent
subgroup sensitivity analysis with an inpatient population and then applied the ADDSS to
an outpatient population – all of which revealed similar results. Therefore, we believe
that the ADDSS may have utility in grouping post-stroke patients into disparate dysphagia
severity groups in both inpatient and outpatient stroke populations as well; however, this
should be further explored in future studies.

Other Administrative-Level Instruments
There are no other administrative-level post-stroke dysphagia severity classification
instruments available to compare to the ADDSS; however, there other stroke severity
instruments designed to be used with U.S. administrative data for which we may conduct
indirect comparisons. For example, the Stroke Administrative Severity Index (SASI;
Simpson et al., 2017) is a valid measure of stroke severity at hospital discharge for use
with administrative claims data. Like the ADDSS, the SASI was developed using similar
source data (the Medicare 5% LDS) and methods. That is, exploratory cluster analysis was
used to group together patients who had similar International Classification of Diseases
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[ICD] diagnosis and procedure codes (ICD-9 for the SASI and ICD-10 for the ADDSS) into
distinct clusters – three stroke severity clusters for the SASI (mild, moderate, and severe)
and three dysphagia severity clusters for the ADDSS (mild, moderate, and severe).
Additionally, both the SASI and the ADDSS were based on the NIH Stroke Scale (NIHSS),
which was used as the theoretical framework and for internal and external validation for
the SASI and for construct validation of the dysphagia severity groups for the ADDSS.

Additional examples of stroke severity instruments for use with administrative data in
stroke research are the Administrative Data Stroke Scale (ADSS) and the Administrative
Stroke Outcome Variable (ASOV; Patel et al., 2021). The ADSS and ASOV were designed
for use in population-wide studies – the ADSS measuring stroke severity at admission and
the ASOV as an estimate for 90-day modified Rankin Scale (mRS). The ADSS was
developed using the National Inpatient Sample (NIH), an all-payer U.S. national and
regional inpatient database. Similar to our instrument (ADDSS) design, Patel et al. (2021)
also used the NIHSS as a template for their ADSS and selected variables based on ICD-9
diagnostic and procedural codes as indicators of stroke severity. Instead of cluster
analysis, the researchers used forward selection stepwise multivariable logistic regression
to develop the ADSS. Then they used the ADSS model to predict poor functional
outcome, which was defined using the ASOV as “good outcome” versus “bad outcome”
to differentiate patients with minimal-to-moderate post-stroke disability from those with
severe disability (Patel et al., 2021). To validate their instruments, the researchers used
two separate cohorts for external validation.
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These stroke severity instruments have similarities to our ADDSS in their implementation
with administrative data, some comparable development methods, and their (potential)
utility. The SASI, ADSS, and ASOV were designed to categorize stroke severity and can
also be used to predict and answer questions about comorbidities. They have great utility
in addressing the challenges of studying administrative claims data for stroke patients
from which valuable information may be absent, such as admission and discharge NIHSS
scores and 90-day mRS outcomes. They adjust for stroke severity differences in
population-wide stroke studies to not only allow for comparisons with studies that do not
use administrative data (e.g., clinical trials) but also to limit confounding of stroke
severity in administrative-level studies. The ADDSS is a dysphagia-specific instrument for
use with AIS patients with the purpose of categorizing patients into disparate dysphagia
severity clusters. It also has potential for being used as a prediction tool and for
answering questions about comorbidities. In future research, we not only plan to conduct
reliability and validation studies with the ADDSS, but we also plan to further explore the
utility of the ADDSS for predicting depression diagnosis in post-stroke dysphagic patients,
such as how the ADDSS severity groups could be used to predict swallow function
recovery in the acute hospital setting. For example, perhaps individuals with mild poststroke dysphagia (per the ADDSS classification) may spontaneously recover swallow
function without intervention, while those with moderate dysphagia may recover
swallow function with minimal therapy, and individuals with severe dysphagia will
recover swallow function with maximum therapeutic intervention (or recover only some
swallow function or none at all). Although future studies are promising, currently, the
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ADDSS is not yet a validated instrument. Thus, an important question is: Since there are
already validated administrative-level stroke severity instruments available, could we use
those to estimate dysphagia severity, instead of developing a dysphagia-specific index?

Section 3: Why is a Dysphagia-Specific Index Needed?

Association Between Stroke Severity and Dysphagia Severity
There is evidence in the literature that stroke severity is not only associated with
dysphagia, but it is also predictive of dysphagia severity (De Stefano et al., 2021;
Jeyaseelan et al., 2015; Khedr et al., 2021; Otto et al., 2016; Takizawa et al., 2016).
Jeyaseelan et al. (2015) conducted a retrospective study of stroke patients in an inpatient
acute rehabilitation unit to determine the utility of the NIHSS as a predictor for poststroke dysphagia (via modified barium swallow study [MBSS] and/or radiographic
evidence of aspiration pneumonia). The researchers found that the presence of
dysphagia was significantly correlated with stroke severity, with the proportion of
dysphagic patients generally increasing as NIHSS score increased (Jeyaseelan et al., 2015).
An NIHSS score with a cut-off of >9 demonstrated sensitivity of 75%, specificity of 62%,
positive predictive value (PPV) of 46%, and negative predictive value (NPV) of 85% and,
therefore, was determined to be moderately predictive of dysphagia (Jeyaseelan et al.,
2015). In a retrospective study at a tertiary hospital, De Stefano et al. (2021) examined
factors that contributed to the severity and persistence of dysphagia in subacute stroke
patients. The researchers found that an admission NIHSS score of >12 was significantly
predictive of moderate or severe dysphagia (measured by the American Speech-
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Language-Hearing Association (ASHA) National Outcome Measurement System (NOMS)
score) after 60 days (De Stefano et al., 2021). Otto et al.’s (2016) cross-sectional,
prospective study of acute stroke patients demonstrated a statistically significant
correlation between stroke severity (NIHSS score) and dysphagia severity (via the
Protocol for Investigation of Oropharyngeal Dysphagia in Adults), with an NIHSS score of
0-6 (minor stroke, per the researchers’ definition) correlated with normal swallowing and
mild dysphagia and an NIHSS score of ³16 (severe stroke, per the researchers’ definition)
correlated with severe dysphagia. Although there is some evidence to support the NIHSS
being potentially predictive of post-stroke dysphagia severity, adequate sensitivity,
validity, and reliability have not yet been demonstrated for its use as a prediction tool for
dysphagia severity. For these reasons, there is not sufficient evidence to support the use
of a stroke severity instrument to estimate dysphagia severity in research with
administrative data at this time.

Discordance Between Stroke Severity and Dysphagia Severity
In discordance with the aforementioned literature, our study results showed that
dysphagia severity (ADDSS) did not coincide with stroke severity (NIHSS score). That is,
our dysphagia severity cluster classification did not extend to stroke severity
classification. For example, we found that patients in the mild ADDSS group primarily had
cases of cognitive impairment but showed little evidence of feeding or nutrition problems
(important indicators of dysphagia) and demonstrated almost no indication of respiratory
compromise. Accordingly, we presumed that patients in the mild ADDSS group would
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also present with mild stroke; however, that was not supported by the data. Conversely,
the mild ADDSS group contained 63% of the total attributes (dysphagia indicator
variables constructed from dysphagia-related ICD-10 diagnosis and procedure codes in
the cluster analysis), which are suggestive of stroke-related illness. Additionally, patients
in this group had NIHSS scores indicative of moderate stroke (mean, 10.08; SD, 7.93).
Thus, we determined that patients in the mild ADDSS group actually had moderate
stroke.

Patients in the moderate ADDSS group had the most cases of respiratory compromise
compared to the other clusters, including such attributes as respiratory problems,
aspiration pneumonia, intubation, and tracheotomy/tracheostomy; however, dysphagia
severity was judged not by aspiration pneumonia, which is known to be difficult to
differentiate from other pneumonia types and is often misdiagnosed (Son et al., 2017),
but by feeding device placement, which is a (reliable) key marker for dysphagia severity.
Because the feeding device placement mean (the metric by which we graded the clusters
into qualitative categories) was the second highest out of all three clusters, we
determined that patients in this group had moderate dysphagia severity. Again, we
presumed that patients in the moderate ADDSS group would also present with moderate
stroke; however, that was not supported by the data. This group contained 100% of the
total attributes, suggesting that patients were very ill, and patients had NIHSS scores
indicative of moderate/severe stroke (mean, 16.23; SD, 8.18). Thus, we determined that
patients in the moderate ADDSS group actually had moderate/severe stroke. It seemed
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that stroke severity indicators captured respiratory issues associated with respiratory
compromise and aspiration pneumonia in these patients but not dysphagia. This is
further supported by intubation in this cluster being likely driven by diagnoses of
respiratory conditions, not dysphagia severity, given the overwhelming presence (and
higher means) of respiratory compromise attributes versus feeding/nutrition attributes.

Patients in the severe ADDSS group demonstrated dysphagia severity in the setting of
alternative nutrition with the highest means for feeding device placement (primary
marker for dysphagia), malnutrition, and dehydration compared to the other clusters.
Accordingly, we presumed that patients in the severe ADDSS group would also present
with severe stroke; however, that was not supported by the data. This group also showed
evidence of aspiration pneumonia and cognitive impairment and contained 75% of the
total attributes, suggesting that patients in this group had substantial stroke-related
illness; however, patients in the severe ADDSS group had NIHSS scores indicative of
moderate stroke (mean, 13.51; SD, 7.78). Thus, we determined that patients in the
severe ADDSS group actually had moderate, not severe, stroke.

Because of the incongruity between NIHSS scores and ADDSS clusters found in this study,
it is important to recognize that stroke severity and dysphagia severity are not
synonymous. For this reason, when conducting (administrative-level) dysphagia severity
research, general stroke severity instrument instruments should not be used when the
outcome of interest is dysphagia-specific.
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General Versus Disease-Specific Instruments
There are advantages and disadvantages to both general (generic) and disease/condition-specific instruments that measure health-related outcomes. For example, in
QOL scales used to measure health related QOL (HRQOL), which may include outcome
measures like patient perception, presence/absence of symptoms, and/or functional
limitations (e.g., physical, psychosocial, etc.; Timmerman et al., 2014), general
instruments are advantageous because of their broader content and applicability across
diverse clinical populations. This allows for comparisons across diseases/conditions;
however, because general instruments were designed to allow for generalizability, they
lack specificity. Conversely, disease-specific instruments, which are designed for use with
specific patient populations, have the benefit of measuring more specific symptoms,
resulting in increased responsiveness and clinical utility compared to general QOL
instruments (Hobart et al., 2002; Ware et al., 2016). The main disadvantage of diseasespecific instruments is that they cannot be used or compared across diseases/conditions.

An example of a general (generic) instrument is the Centers of Disease Control and
Prevention HRQOL 14-Item Measure (CDC HRQOL–14 Measure), which is a population
measure for HRQOL that consists of broad questions, such as perceived health status,
activity limitations, pain, depression, anxiety, sleeplessness, etc. (Hennessy et al., 1994;
Moriarty et al., 2003), and can be used with a variety of populations. Although it has
many beneficial applications for general use, its utility is not adequate when assessing
diagnostic specific HRQOL. An example of a disease-/condition-specific instrument is the
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Stroke Specific Quality of Life scale (SS-QOL), which is a well-known assessment of HRQOL
for patients with stroke (Williams et al., 1999). The SS-QOL can be used across patients
with various types of stroke; however, it was not designed for use to measure outcomes
about specific stroke-related diagnoses. It measures post-stroke HRQOL using 12
domains, including energy, upper extremity function, work/productivity, mood, self-care,
social roles, family roles, vision, language, thinking, and personality. Although this
instrument was specifically designed for use with stroke survivors, there is no domain for
dysphagia, which is a common sequela of stroke. The only items that are remotely
related to dysphagia are under the Self-Care domain; however, those items involve
assistance preparing or cutting food, not the act of eating, drink, or swallowing. Thus,
even though SS-QOL is a disease-/condition-specific instrument designed for use in stroke
patients, its use would not be appropriate for post-stroke dysphagic patients if the
outcomes of interest are dysphagia-specific. Another QOL instrument that was developed
based on the SS-QOL is the Stroke and Aphasia Quality of Life Scale (SAQOL-39), which
was designed for stroke survivors with long-term aphasia (Hilari et al., 2003). The disease/condition-specific SAQOL-39 has four domains, including physical, psychosocial,
communication, and energy, with items adapted from the original SS-QOL specifically for
individuals with aphasia. To improve content validity, the SAQOL-39 also has four
additional items (not part of the SS-QOL) related to speech, language, and cognitive
difficulties. Similar to the SAQOL-39, there is a dysphagia-specific QOL scale called the
Swallowing Quality of Life (SWAL-QOL), which is a measure of QOL in individuals with
swallowing disorders (McHorney et al., 2000a, 2000b, 2002). The SWAL-QOL has 10
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domains, including burden, eating duration, eating desire, food selection,
communication, fear, mental health, social, sleep, and fatigue, that are specific to
swallowing/dysphagia.

We know that it is vital to use appropriate clinical assessments in patient populations for
which they were designed to maintain the validity and interpretability of the instrument.
For instance, in clinical research, investigators would not use a general QOL assessment
to examine QOL in dysphagic patients, given that there is a swallowing-specific scale
available, such as the SWAL-QOL. Likewise, in research involving administrative data,
disease-specific instruments should be utilized (when available) over general instruments
to ensure the most rigorous results.

Need for Dysphagia-Specific Instruments for Administrative Data
Administrative claims data reflect clinical practice; however, crucial information required
to discern dysphagia severity in post-stroke patients, such as dysphagia diagnostic
instrument results, oral health status, and diet texture and liquid consistency levels, is not
captured. For this reason, it is compulsory that an appropriate administrative-level,
dysphagia-specific instrument be developed for use with post-stroke patients. To this
end, we have proposed the ADDSS in lieu of the few other general stroke severity
administrative-level instruments available.
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The ADDSS also has potential for utility in research that combines administrative data
with clinical data. For example, the ADDSS severity levels could be used adjunctively with
data collected clinically from the Functional Oral Intake Scale (FOIS), which measures
change in functional eating abilities over time in post-stroke patients (Crary et al., 2005).
The categorization of the seven levels of the FOIS lend themselves to the ADDSS severity
levels, such that FOIS levels 1-2 (nothing by mouth to feeding tube dependent with
minimal attempts with food/liquid) correspond to ADDSS severe dysphagia severity, FOIS
levels 3-4 (feeding tube dependent with consistent oral intake to total oral diet of single
consistency) correspond to ADDSS moderate dysphagia severity, and FOIS levels 5-7
(total oral diet with multiple consistencies, requiring special preparation or
compensations to total oral diet with no restrictions) correspond to ADDSS mild
dysphagia severity. The ADDSS severity levels may also be suitable in conjunction with
clinical data from the International Dysphagia Diet Standardisation Initiative (IDDSI) levels
(Cichero et al., 2017), such that IDDSI 7 (regular/easy to chew), 6 (soft and bite size), 0
(thin), and 1 (slightly thick) correspond to ADDSS mild severity; IDDSI 5 (minced & moist)
and IDDSI 2 (mildly thick) correspond to ADDSS moderate severity; and IDDSI 3
(liquidised/moderately thick) and IDDSI 4 (pureed) correspond to ADDSS severe severity.
The ADDSS could also potentially have applicability for use with clinical data from the
Eating Assessment Tool (EAT-10), which estimates initial dysphagia severity and monitors
treatment response (Belafsky et al. 2008). The next steps in this line of research are to
conduct validity and reliability testing of the ADDSS for its use in administrative data
research to classify post-stroke dysphagia severity.
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Section 4: Diagnosis of PSD by Dysphagia Severity

To our knowledge, there have been no previous studies that have examined the
association between dysphagia severity and depression diagnosis in patients diagnosed
with post-stroke dysphagia; thus, the present study appears to be the first on this specific
topic. We hypothesized that patients in different dysphagia severity groups would have
different risk of PSD diagnosis after discharge (hypothesis 2); however, our results were
not supportive of this hypothesis. We found no statistically significant difference in risk of
PSD diagnosis after discharge by dysphagia severity. Thus, our hypothesis that poststroke patients with more severe dysphagia would have greater odds of PSD diagnosis
within the 90 days after discharge (2b) was also not supported. Additionally, we
hypothesized that post-stroke patients with more severe dysphagia would have a greater
proportion of PSD diagnosis within the 90 days after discharge (2a); however, we found
that the proportions of patients diagnosed with PSD across all three dysphagia severity
groups were very similar (17%, 14%, and 16%, p=0.9016, respectively), revealing no
statistically significant difference. Thus, the evidence was not supportive of this
hypothesis either.

Although we were unable to directly compare our results to analogous studies because,
to our knowledge, there are no other administrative-level studies of post-stroke
dysphagia and PSD in the literature, we were able to make general comparisons to the
few non-stroke clinical studies that have examined dysphagia severity and depression.
For example, Nguyen et al. (2005) conducted a retrospective study of patients treated for
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head-and-neck cancer (HNC) with dysphagia at a Veterans Affairs (VA) hospital and found
that dysphagia severity (measured by MBSS) was significantly and positively correlated
with depression (measured by the Hospital Anxiety-Depression Scale-Depression [HADSD]), with patients with moderate to severe dysphagia demonstrating greater depression
scores than those with mild dysphagia. Our results that post-stroke dysphagia severity
was not significantly associated with depression diagnosis were dissimilar to Nguyen et
al.’s (2005) findings. The discordance in findings is primarily a result of the limitations in
comparing prospective versus retrospective studies (e.g., study methodology, sample
sizes, diagnostic assessments used, timing of assessments, etc.) and comparing disparate
patient populations (stroke versus HNC). In a prospective study of patients with HNC and
dysphagia at an outpatient clinic, Krebbers et al. (2020) found that the presence of
aspiration during fiberoptic endoscopic evaluation of swallowing (FEES), signifying
increased dysphagia severity, was significantly associated with lower depression scores
(measured by the HADS-D). That is, patients who presented with more severe dysphagia
reported fewer symptoms of depression than those who presented with less severe
dysphagia. Our findings were contradictory to Krebbers et al.’s (2020) results in that we
found no significant association between dysphagia severity and depression. The reasons
for discordance between Krebbers et al.’s (2020) and our findings are likely the same as
with Nguyen et al.’s (2005) study findings. Additionally, the discrepancy in our respective
results could also be heavily influenced by our disparate patient populations and time
intervals. Krebbers and colleagues (2020) examined patients at least six months after
their HNC treatments who were in total remission. It is feasible that, in time, patients
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who are medically stable and disease-free may adjust to their dysphagia symptoms or
limitations (Krebbers et al., 2020), such as the patients who had HNC, and
experience/report fewer symptoms of depression. In another prospective study,
Verdonschot et al. (2016) studied patients with dysphagia at an otorhinolaryngology
outpatient clinic to determine the relationship between dysphagia severity and affective
symptoms. The patient sample included individuals with HNC at least six months posttreatment, patients with a neurologic diagnosis (e.g., Parkinson’s disease, stroke)
considered stable and/or who had received stable medication management for at least
three months, and patients with other medical diagnoses (e.g., Zenker’s diverticulum,
cervical spine degeneration; Verdonschot et al., 2016). The researchers did not find any
significant associations between dysphagia severity via FEES and clinically relevant
symptoms of depression (measured by HADS-D; Verdonschot et al., 2016), which was
consistent with our findings. Nevertheless, there were limitations to Verdonschot et al.’s
(2016) study that could have affected their results. For example, the researchers used
FEES to measure dysphagia severity; however, they proposed that if another diagnostic
instrument had been used, such as MBSS, manometry, or electromyography, dysphagia
severity results may have been different (Verdonschot et al., 2016). Furthermore, some
literature suggests that the use of the HADS-D to measure depressive symptoms has
disadvantages, such as low sensitivity and specificity for detecting depressive symptoms
in certain populations of older adults (Edelstein et al., 2010). Other study limitations
reported by Verdonschot et al. (2016) included methodologic issues, such as
heterogeneity of the study sample and a small sample size, resulting in small subgroup
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sizes, which limited the types of subgroup analyses that could be conducted. Finally,
because of the underlying association between HNC and neurologic diseases with
affective symptoms, researchers could not definitively attribute depressive symptoms to
dysphagia alone (Verdonschot et al., 2016). For these reasons, the results of Verdonschot
et al.’s (2016) study should be interpreted with caution.

There is evidence in the literature, and from Aim 1 of this study, to support that
dysphagia is associated with depression (Dziewas, et al., 2017; Holland, 2011;
Verdonschot et al., 2013, 2017); however, there is a paucity of studies examining the
relationship between dysphagia severity and depression. For this reason, we cannot yet
draw definitive conclusions from the results of this study. We can, however, consider the
reasons why we may have found no association between post-stroke dysphagia severity
and diagnosis of PSD in the 90 days after discharge from the hospital. The first possibility
is that there may not be a relationship between dysphagia severity and depression, which
is consistent with Verdonschot et al.’s (2016) findings, and that the association between
dysphagia and depression is irrespective of dysphagia severity. That is, having dysphagia
is what matters most in relation to depression, despite severity. The second potential
explanation of our findings is timing. Our study time period was limited to the 90 days
after discharge, and we know from the literature that timing of PSD is variable among
individuals, with initial onset occurring between several days to years after stroke
(Conroy et al., 2020). Therefore, it is feasible that patients without a depression diagnosis
presented with depression at a later time that occurred outside of this study, which we
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were not able to capture. The third possible reason for our results is that there is, in fact,
an effect of dysphagia severity on PSD diagnosis, which would be consistent with Nguyen
et al.’s (2005) and Krebbers et al.’s (2020) findings; however, underdiagnosis and
undercoding of dysphagia and PSD, which are well-documented phenomena, could have
been barriers in detecting the true proportions of patients with diagnoses of post-stroke
dysphagia and PSD (Cohen et al., 2020; Dar et al., 2017; Gonzalez-Fernandez et al., 2008).

Section 5: Diagnosis of PSD by Dysphagia Severity and Time

With regard to time to depression diagnosis, to our knowledge, there have been no
previous studies that have examined time from initial stroke diagnosis to depression
diagnosis stratified by dysphagia severity in patients diagnosed with post-stroke
dysphagia; thus, the present study appears to be the first on this topic. We hypothesized
that post-stroke patients with more severe dysphagia and a diagnosis of PSD would have
a shorter time to first depression diagnosis (2c); however, found the (statistically
significant) mean time to depression diagnosis after stroke was 39 days for patients with
mild dysphagia, 63 days for patients with moderate dysphagia, and 70 days for patients
with severe dysphagia. Patients with mild dysphagia were diagnosed with PSD sooner on
average than the patients with more severe dysphagia; thus, the evidence was not
supportive of our hypothesis (2c). Additionally, we found that 50% of patients with mild
dysphagia had a diagnosis of depression a little more than one month after discharge,
while 50% of patients with moderate or severe dysphagia had a diagnosis of depression
almost at the end of the 90-day post-discharge follow-up period.
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A reason for our findings that patients with mild dysphagia were diagnosed with PSD
sooner than those with more severe dysphagia after discharge could be due to
healthcare providers’ focus on medical, not psychological, conditions in patients with
greater dysphagia severity, given the risks of serious complications, such as malnutrition,
dehydration, aspiration pneumonia, compromised overall health, and mortality (ASHA,
n.d.). Thus, providers could potentially overlook the symptoms of depression in these
more severely dysphagic patients, while depressive symptoms in patients with less
dysphagia severity, who may be considered at lower risk for complications, more easily
attract the attention of healthcare providers. Another explanation of our findings could
be a result of clinician training and experience compounded by discharge disposition.
Depressive symptoms can be challenging to recognize by untrained and/or inexperienced
healthcare providers because they typically present as somatic (e.g., fatigue) and/or
other affective symptoms (e.g., guilt, worthlessness, lack of interest) in older adults, not
depressed mood, which may be mistakenly attributed to stroke or cognitive impairment,
instead of PSD (Dar et al., 2017; Lökk & Delbari, 2010; VanItallie, 2005). Furthermore,
discharge disposition may also play a role in our results in that patients with mild
dysphagia may be discharged to a location (e.g., IPR facility, home with home health)
where they may receive attention from healthcare providers who have adequate training
to recognize the symptoms of PSD, such as physical medicine and rehabilitation (PM&R)
physicians or neuropsychologists at an IPR facility or a patient’s primary care physician
who knows their baseline function if discharged home. Conversely, patients with more
severe dysphagia, potentially requiring alternative nutrition via feeding tube, may be
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discharged to a SNF where there may not be healthcare providers trained in recognizing
symptoms of PSD, which may explain why these patients were not diagnosed with
depression on average until the end of the 90-day post-discharge follow-up period.

Another reason for our findings could be the time interval of this study, which was within
the 90 days after discharge from the acute hospital. Since “early” onset of PSD is defined
as symptoms of PSD within the first three months after stroke, and “late” onset is
considered any time subsequently (Lökk & Delbari, 2010), it is possible that patients in
this study who were not diagnosed with depression experienced late onset PSD outside
of the study time frame, in which case, their diagnoses were not captured.

The final reason for our study results could be the well-known problem of undercoding
and underdiagnosis of dysphagia and depression in administrative data (Cohen et al.,
2020; Conroy et al., 2020; Dziewas, et al., 2017; Gonzalez-Fernandez et al., 2008; Labeit
et al., 2018; Rofes et al., 2011; Takizawa et al., 2016; Starkstein & Robinson, 1989), which
may underestimate the true population values. Undercoding and underdiagnosis of
dysphagia are due to a number of factors, including lack of available dysphagia specialists
(speech-language pathologists [SLPs]), limited access to diagnostic equipment or
resources in certain medical settings, lack of consensus for which patients require
dysphagia screening, and use of inappropriate diagnostic tools with varying sensitivities
for detecting dysphagia (Dziewas, et al., 2017; Labeit et al., 2018; Rofes et al., 2011;
Takizawa et al., 2016). Similarly, undercoding and underdiagnosis of depression are due
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to factors, such as lack of healthcare provider training/experience, misclassification of
symptoms of depression in the setting of post-stroke cognitive and/or language
impairments and use of screening tools with inadequate sensitivity for detecting
depression (Conroy et al., 2020; Starkstein & Robinson, 1989; Williams, 2005).

Section 6: Aim 2 Limitations

We had the same limitations for Aim 2 as we had for Aim 1, with another example of key
information missing from administrative data being the lack specific medical codes for
important dysphagia-related considerations, such as diet texture, liquid consistency,
edentulous status, etc., which would be advantageous in a more robust classification of
dysphagia severity clusters. Additionally, using a subset of patients who had documented
NIHSS scores for Aim 2 had disadvantages in that (1) it substantially reduced our sample
size for Aim 2, and (2) it introduced bias, as not all facilities record the NIHSS in practice,
particularly not the smaller community or rural hospitals; therefore, patient data
containing NIHSS scores may disproportionately represent patients from large,
comprehensive stroke centers. Furthermore, cluster analysis is typically conducted on
large sample sizes, but our NIHSS sample size was much smaller than our original sample
size, potentially yielding less robust results. A future ADDSS validation study should be
conducted with a larger sample size.
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Aim 3 Discussion
Section 1: Brief Summary of Results

Objectives
Our objective was to compare the mean healthcare costs in post-stroke dysphagic
patients with and without a depression diagnosis in the 90-day follow-up period after
discharge from the acute hospital. Additionally, we applied the ADDSS to our data set to
analyze post-discharge costs in patients diagnosed with depression, stratified by
dysphagia severity.

Hypotheses and Results
We studied 359 Medicare beneficiaries hospitalized for AIS with a secondary diagnosis of
post-stroke dysphagia and examined their healthcare costs over a 90-day post-discharge
period in 2017. Fifteen percent of post-stroke dysphagic patients had a diagnosis of
depression. Consistent with our Aim 3 hypothesis, we found that dysphagic patients with
a PSD diagnosis had greater total healthcare costs in the 90 days after discharge than
dysphagic patients without a PSD diagnosis. Stratifying for dysphagia severity using the
ADDSS revealed the same results, that patients with depression and dysphagia
(irrespective of dysphagia severity) incurred higher total healthcare costs in the 90 days
after discharge compared to dysphagic patients without depression, with an unadjusted
additional cost of $12,667. Furthermore, we found that stroke severity and dysphagia
severity significantly contributed to the variations in cost, as seen in an increase in
unadjusted marginal cost difference from $12,667 to $15,556 (after controlling for
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dysphagia severity and stroke severity). Additionally, we found that the presence of
depression resulted in a 36% increase in cost after controlling for dysphagia severity and
stroke severity. These results are discussed in detail below.

Section 2: Cost Analysis

Unadjusted Cost
When examining unadjusted total cost by dysphagia severity groups and depression
diagnosis, we found that patients with mild and severe dysphagia with a depression
diagnosis incurred higher mean total costs ($15,914 and $11,680, respectively) than
those without a depression diagnosis in the same dysphagia severity groups, while those
with moderate dysphagia and a depression diagnosis incurred $316 lower mean total
costs compared to patients with moderate dysphagia without a depression diagnosis. We
also found that patients with moderate dysphagia had higher unadjusted mean inpatient
costs after discharge than those with mild or severe dysphagia, meaning that patients
with moderate dysphagia had more post-discharge readmissions to the acute hospital
and/or inpatient rehabilitation admissions.

Although counterintuitive at first glance, these findings are compatible with the medical
characteristics of patients in the moderate dysphagia severity group. These patients had
moderate/severe stroke severity (the highest stroke severity of the three dysphagia
groups) and were very ill as evidenced by the many comorbidities/complications in this
group, including cognitive impairment, malnutrition, dehydration, and feeding tube use.
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In addition, patients in the moderate dysphagia group demonstrated the highest
proportions of respiratory comorbidities, including intubation and
tracheotomy/tracheostomy. Thus, the higher post-discharge inpatient costs for acute
hospital readmissions were likely driven by their stroke severity (with greater stroke
severity a predictor for worse outcomes; Adams et al., 1999) and serious respiratory
issues. Furthermore, because this group had moderate/severe stroke severity, likely
resulting in greater impairment and disability, they presumably required more intensive
rehabilitation. Accordingly, this group had the largest proportion of discharge to IPR
facilities compared to the mild and severe dysphagia groups, which also contributed to
their higher post-discharge inpatient costs. Conversely, we did not find a notable
difference in mean total costs between patients with and without depression in the
moderate dysphagia group. The reason for this is likely due to cost of care being primarily
dictated by moderate/severe stroke severity and respiratory complications, which may
have obscured any depression-related costs.

Adjusted Cost
When measuring the effect of PSD and dysphagia severity in combination on total 90-day
post-discharge cost, we found that having mild dysphagia with a PSD diagnosis was
significantly associated with higher total 90-day costs and that stroke severity had a
significant effect on cost. Controlling for stroke severity, the marginal cost difference was
$15,914 higher for patients with mild dysphagia and a diagnosis of depression compared
to those with mild dysphagia without a diagnosis of depression, which supported our
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hypothesis that patients with post-stroke dysphagia and PSD with incur greater
healthcare costs than post-stroke dysphagic patients without PSD. These findings are also
in line with our findings from Aim 2 in which patients with mild dysphagia were
diagnosed with PSD sooner than those with moderate or severe dysphagia. Thus, it is
logical that patients with mild dysphagia, who were diagnosed with PSD early in the 90day post-discharge follow-up window and likely received treatment for depression earlier
in the post-discharge follow-up period, would incur higher post-discharge costs than
those with mild dysphagia without the addition disease burden and those with more
severe dysphagia severity, who were not diagnosed with PSD until much later in the 90day post-discharge window. It is important to note that the dysphagia severity groups
had an unequal number of observations for each cluster (mild: n=266, moderate: n=42,
and severe: n=51), which could explain why associations between depression diagnosis
and moderate and severe dysphagia severity, respectively, did not reach statistical
significance, despite having similar directionality as the significant result.

To moderate the effect of the small number of observations in the moderate and severe
dysphagia severity clusters and better understand the cost differences between the mild
dysphagia and moderate and severe dysphagia groups, we “collapsed” the moderate and
severe categories into one group, creating a dichotomized variable, “mild” (patients
classified as having mild dysphagia severity) versus “not mild” (patients classified as
having moderate or severe dysphagia severity), which resulted in 266 observations for
the “mild” group and 93 observations for the “not mild” group. For our final result, when
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assessing the cost differences between patients stratified by two severity groups (mild
versus not mild), we found that depression, moderate or severe dysphagia severity, and
stroke severity all had significant effects on cost. When we controlled for dysphagia
severity and stroke severity, the marginal cost difference for dysphagic patients with a
diagnosis of depression was $10,745 higher than for those without depression. These
finding may be more intuitive than our previous findings in that it may be more feasible
for patients with both greater dysphagia severity and greater stroke severity, along with
their respective comorbidities and complications, to incur higher mean total healthcare
costs than patients with mild dysphagia.

Related Research
Although there are no other studies that have examined 90-day post-discharge costs in
dysphagic patients with PSD, there are similar studies by which to make general
comparisons. For example, in a recent systematic review by Marin et al. (2020), the
authors examined healthcare costs associated with post-stroke dysphagia and related
complications and found evidence that patients diagnosed with dysphagia after stroke
incurred higher costs than patients not diagnosed with dysphagia after stroke. There
were very few studies that assessed post-discharge cost; however, the authors found two
that examined healthcare costs after discharge from the acute hospital. One study by
Bonilha and colleagues (2014) examined the one-year cost associated with post-stroke
dysphagia, while the other study by Gomes and colleagues (2016) examined the
predictive ability of the Malnutrition Universal Screening Tool (MUST) on stroke
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outcomes, including risk of malnutrition and hospitalization costs. Gomes et al. (2016)
prospectively recruited patients over the age of 18 with a diagnosis of ischemic or
hemorrhagic stroke from two hyperacute stroke units in London and assessed all
hospitalization costs during a six-month period after stroke (Gomes et al., 2016). Gomes
et al. (2020) found an increase in costs from patients with low risk of malnutrition (via
MUST) to patients with high risk of malnutrition, from £4,920 (approximately $8,780
[USD, 2019]) to £8,720 (approximately $15,560 [USD, 2019]), respectively (Marin et al.,
2020, p. 11). Furthermore, the researchers reported 77% higher median costs for
patients with high risk of malnutrition compared to those with low risk of malnutrition
(Gomes et al., 2020). Gomes et al. (2020) did not directly link malnutrition risk to poststroke dysphagia as they did not formally assess dysphagia; however, results of
“inadequate swallow” from a bedside nursing swallow screen were reported. The
researchers found that patients with high risk of malnutrition were more likely to have
“inadequate swallow” (Gomes et al., 2020), indicating possible dysphagia. Thus, even
though higher malnutrition costs were not directly attributed to dysphagia, it is feasible
that because malnutrition in patients after stroke is a common (and serious) complication
of post-stroke dysphagia (Foley et al., 2009), higher healthcare costs could have
potentially been a consequence of dysphagia-related malnutrition. Although we cannot
directly compare our results to Gomes et al.’s (2020) findings, there appears to be a
similar inclination in directionality of the association between post stroke dysphagiarelated diagnoses and higher healthcare costs.
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With regard to depression, stroke survivors with PSD generally have greater healthcare
utilization (Jia et al., 2006); therefore, higher healthcare costs would be expected in this
patient population. Again, to our knowledge, there are no other studies that examined
90-day post-discharge costs in dysphagic patients with PSD; however, we can make
general comparisons to similar studies. Husaini, et al. (2013) conducted a study
retrospectively examining the effect of depression on hospitalization costs in stroke
patients using data from the 2008 Tennessee Hospital Discharge Data System and found
that depressive symptoms were associated with increased healthcare costs. The
researchers reported that stroke patients with depression had approximately 63% higher
mean hospitalization costs compared to the stroke only cohort ($77,864 versus $47,790,
respectively; Husaini, et al., 2013). In another study, Chinthammit et al. (2017)
retrospectively examined the impact of co-occurring conditions on total and component
healthcare expenditures (e.g., inpatient, outpatient, emergency room (ER), prescription
drugs, home health, and other) in stroke survivors versus a non-stroke matched control
group using 2002-2012 Medical Expenditure Panel Survey (MEPS) data. The researchers
found that total expenditures were significantly higher in stroke patients with certain
concurrent conditions, such as depression, compared to matched controls ($23,122
versus $19,705, respectively; Chinthammit et al., 2017). They also found that stroke
patients with depression had significantly greater inpatient expenditures compared to
matched controls ($8,878 versus $6,736, respectively; Chinthammit et al., 2017).
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Although differences in methodologies, patient populations (i.e., stroke type), study
timeframes, and primary outcomes among the studies discussed do not allow for direct
comparisons with our study results, there is a clear trend in higher healthcare costs
associated with the two separate stroke sequelae, dysphagia and depression,
respectively. Thus, it is reasonable to suggest that post-stroke dysphagic patients with
PSD would also incur higher healthcare costs than post-stroke dysphagic patients without
PSD, which is what we found in this study. The increase in healthcare costs is likely due to
increased healthcare utilization as a result of the higher healthcare utilization by patients
diagnosed with depression after stroke, which have previously not been examined. This
study is a starting point towards understanding the healthcare costs associated with both
post-stroke dysphagia and PSD. Its value is not only in establishing these costs but also in
highlighting the need for earlier detection and intervention for patients with post-stroke
dysphagia and PSD with the goals of providing appropriate care for patients and
potentially easing the economic burden of these co-occurring conditions.

Section 3: Aim 3 Limitations

We had the same limitations for Aim 3 as we had for Aims 1 and 2, with some additions.
First, the administrative files from which we extracted our claims data did not provide
itemized cost; therefore, we did not have access to medication cost and could not assess
the cost of pharmacological treatment for PSD. Second, the small sample sizes in our
moderate and severe dysphagia severity subgroups could have been prohibitive in
observing an effect in those groups, thus, biasing our findings.

CHAPTER 6: CONCLUSION
This research has contributed to the existing dysphagia body of knowledge by examining
a rarely studied population, post-stroke dysphagic patients with depression, and
revealing new insights into the relationship between post-stroke dysphagia and PSD.
Furthermore, this study has addressed a gap in the literature by providing a novel
method for dysphagia severity classification in stroke patients for use with
administrative-level data, which previously did not exist.

Results of this study demonstrated evidence of an association between PSD and poststroke dysphagia. That is, patients with post-stroke dysphagia had significantly greater
odds and hazard of being diagnosed with PSD within 90 days after discharge, and patients
diagnosed with both dysphagia and PSD incurred higher post-discharge healthcare costs.
In the application of our novel dysphagia severity index (the ADDSS), we found that
patients with less dysphagia severity were diagnosed with PSD sooner after discharge
than patients with greater dysphagia severity, which highlighted the need for early and
recurrent depression screening for post-stroke patients, particularly, with greater
dysphagia severity. We also found that (counterintuitively) greater dysphagia severity did
not increase the odds of PSD diagnosis after discharge, which we proposed could be due
to several reasons, one of which could be that having dysphagia matters the most in
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relation to PSD, regardless of severity. Another reason could be due to the well-known
problems of underdiagnosis and undercoding of dysphagia and depression, which could
have been barriers in detecting the true proportions of patients with diagnoses of poststroke dysphagia and PSD, especially in patients with more severe dysphagia, in which
depressive symptoms can be more challenging to detect and also due to healthcare
providers’ focus on life-sustaining functions over psychological manifestations in the
acute post-stroke setting. Furthermore, we discovered an interesting and unexpected
finding that (in discordance with some literature) dysphagia severity categories were not
the same as stroke severity categories, which has implications for administrative-level
post-stroke dysphagia related research and the methodologies used to classify dysphagia
severity. These findings also highlight the importance of not using stroke severity as a
proxy for dysphagia severity in stroke research.

The foundational knowledge gained from this study is a starting point to understanding
the influence of PSD on post-stroke dysphagia in pursuit of improved identification of and
earlier intervention for dysphagic patients with depression after stroke. Furthermore, the
glaring problems of underdetection and underdiagnosis of dysphagia and PSD discussed
in this study underscore the importance of active and continued monitoring for
depressive symptoms in this patient population and the need for implementation of
adjunctive screening for depressive symptoms along with post-stroke dysphagia
screening and/or assessment. Additionally, the potential utility for use of the ADDSS not
only in administrative-level research but also in conjunction with additional data sources,
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such as randomized clinical trials or prospective cohort studies, guides the next steps in
this line of research, which is to validate the ADDSS. Finally, despite the prevalence of this
patient population, the cost of care in patients with post-stroke dysphagia and
depression has not been examined prior to this study; therefore, future studies to
quantify healthcare costs of acute and chronic post-stroke dysphagic patients with
depression are warranted.

138

REFERENCES
1.

Abbas, O. A. (2008). Comparisons between data clustering algorithms. The
International Arab Journal of Information Technology, 5(3), 320-325.

2.

Aben, I., Verhey, F., Strik, J., Lousberg, R., Lodder, J., & Honig, A. (2003). A
comparative study into the one-year cumulative incidence of depression after stroke
and myocardial infarction. J Neurol Neurosurg Psychiatry, 74(5), 581-585.
https://doi.org/10.1136/jnnp.74.5.581

3.

Adams, H. P., Jr., Davis, P. H., Leira, E. C., Chang, K. C., Bendixen, B. H., Clarke, W. R.,
Woolson, R. F., & Hansen, M. D. (1999). Baseline NIH Stroke Scale score strongly
predicts outcome after stroke: A report of the Trial of Org 10172 in Acute Stroke
Treatment (TOAST). Neurology, 53(1), 126-131.
https://doi.org/10.1212/wnl.53.1.126

4.

Alaghehbandan, R., & MacDonald, D. (2013). Use of administrative health databases
and case definitions in surveillance of depressive disorders: A review. OA
Epidemiology, 1(1), 3. https://doi.org/10.13172/2053-079X-1-1-539

5.

Alaghehbandan, R., Macdonald, D., Barrett, B., Collins, K., & Chen, Y. (2012). Using
administrative databases in the surveillance of depressive disorders - Case
definitions. Popul Health Manag, 15(6), 372-80.
https://doi.org/10.1089/pop.2011.0084

6.

Allen, J., Greene, M., Sabido, I., Stretton, M., & Miles, A. (2020). Economic costs of
dysphagia among hospitalized patients. Laryngoscope, 130(4), 974-979.
https://doi.org/10.1002/lary.28194

139

7.

Allison, P.D., & SAS Institute. (2010). Survival Analysis Using SAS®: A Practical Guide,
Second edition. SAS Institute.

8.

Altman, K. W., Yu, G. P., & Schaefer, S. D. (2010). Consequence of dysphagia in the
hospitalized patient: Impact on prognosis and hospital resources. Arch Otolaryngol
Head Neck Surg, 136(8), 784-789. https://doi.org/10.1001/archoto.2010.129

9.

American Psychiatric Association. (2013). Diagnostic and statistical manual of mental
disorders, 5th edition: DSM-5 (5th ed.). American Psychiatric Publishing.

10. American Speech-Language-Hearing Association (ASHA). (n.d.) Adult Dysphagia.
https://www.asha.org/practice-portal/clinical-topics/adult-dysphagia/#collapse_7
11. Appelros, P., Stegmayr, B., & Terént, A. (2010). A review on sex differences in stroke
treatment and outcome. Acta Neurol Scand, 121(6), 359-369.
https://doi.org/10.1111/j.1600-0404.2009.01258.x
12. Attrill, S., White, S., Murray, J., Hammond, S., & Doeltgen, S. (2018). Impact of
oropharyngeal dysphagia on healthcare cost and length of stay in hospital: A
systematic review. BMC Health Serv Res, 18(1), 594. https://doi.org/10.1186/s12913018-3376-3
13. Ayasrah, S. M., Ahmad, M. M., & Basheti, I. A. (2018). Post-Stroke depression in
Jordan: Prevalence correlates and predictors. J Stroke Cerebrovasc Dis, 27(5), 11341142. https://doi.org/10.1016/j.jstrokecerebrovasdis.2017.11.027
14. Ayerbe, L., Ayis, S., Crichton, S., Wolfe, C.D., & Rudd, A. G. (2013). The natural history
of depression up to 15 years after stroke: The South London Stroke Register. Stroke,
44(4), 1105-1110. https://doi.org/10.1161/strokeaha.111.679340

140

15. Ayerbe, L., Ayis, S., Rudd, A. G., Heuschmann, P. U., & Wolfe, C. D. (2011). Natural
history, predictors, and associations of depression 5 years after stroke: The South
London Stroke Register. Stroke, 42(7), 1907-1911.
https://doi.org/10.1161/strokeaha.110.605808
16. Ayis, S. A., Ayerbe, L., Crichton, S. L., Rudd, A. G., & Wolfe, C. D. (2016). The natural
history of depression and trajectories of symptoms long term after stroke: The
prospective south London stroke register. J Affect Disord, 194, 65-71.
https://doi.org/10.1016/j.jad.2016.01.030
17. Babkair, L. A. (2017). Risk factors for poststroke depression: An integrative review. J
Neurosci Nurs, 49(2), 73-84. https://doi.org/10.1097/jnn.0000000000000271
18. Bahcecı, K., Umay, E., Gundogdu, I., Gurcay, E., Ozturk, E., & Alıcura, S. (2017). The
effect of swallowing rehabilitation on quality of life of the dysphagic patients with
cortical ischemic stroke. Iranian Journal of Neurology, 16(4), 178–184.
19. Bartlett, R. S., & Thibeault, S. L. (2018). Insights into oropharyngeal dysphagia from
administrative data and clinical registries: A literature review. Am J Speech Lang
Pathol, 27(2), 868-883. https://doi.org/10.1044/2018_ajslp-17-0158
20. Beck, A. T. & Steer, R. A., (1993). Beck depression inventory manual. Psychological
Corporation.
21. Belafsky, P. C., Mouadeb, D. A., Rees, C. J., Pryor, J. C., Postma, G. N., Allen, J., &
Leonard, R. J. (2008). Validity and reliability of the Eating Assessment Tool (EAT-10).
Annals of Otology, Rhinology & Laryngology, 117(12), 919–924.
https://doi.org/10.1177/000348940811701210

141

22. Bellera, C. A., MacGrogan, G., Debled, M., Tunon de Lara, C., Brouste,
V., & Mathoulin-Pélissier, S. (2010). Variables with time-varying effects and the Cox
model: Some statistical concepts illustrated with a prognostic factor study in breast
cancer. BMC Med Res Methodol, 10(20). https://doi.org/10.1186/1471-2288-10-20
23. Bhalla, D. (n.d.). Cluster Analysis Using SAS.
https://www.listendata.com/2014/10/cluster-analysis-using-sas.html
24. Bhogal, S. K., Teasell, R., Foley, N., & Speechley, M. (2004). Lesion location and
poststroke depression: Systematic review of the methodological limitations in the
literature. Stroke, 35(3), 794-802.
https://doi.org/10.1161/01.STR.0000117237.98749.26
25. Blough, D. K., & Ramsey, S. D. (2000). Using generalized linear models to assess
medical care costs. Health Services & Outcomes Research Methodology, 1(2), 185202.
26. Bonilha, H. S., Simpson, A. N., Ellis, C., Mauldin, P., Martin-Harris, B., & Simpson, K.
(2014). The one-year attributable cost of post-stroke dysphagia. Dysphagia, 29(5),
545-552. https://doi.org/10.1007/s00455-014-9543-8
27. Brott, T., Adams, H.P. Jr., Olinger, C.P., Marler, J.R., Barsan, W.G., Biller, J., Spilker, J.,
Holleran, R., Eberle, R., & Hertzberg, V. (1989). Measurements of acute cerebral
infarction: A clinical examination scale. Stroke, 20(7), 864-870.
https://doi.org/10.1161/01.STR.20.7.864

142

28. Bucur, M., & Papagno, C. (2018). A systematic review of noninvasive brain
stimulation for post-stroke depression. J Affect Disord, 238, 69-78.
https://doi.org/10.1016/j.jad.2018.05.026
29. Bussell, S. A., & González-Fernández, M. (2011). Racial disparities in the development
of dysphagia after stroke: Further evidence from the Medicare database. Arch Phys
Med Rehabil, 92(5), 737-742. https://doi.org/10.1016/j.apmr.2010.12.005
30. Caliński, T., & Harabasz, J. (1974). A dendrite method for cluster analysis.
Communications in Statistics—Theory and Methods, 3, 1–27.
31. Castagna, A., Ferrara, L., Asnaghi, E., Rega, V., & Fiorini, G. (2019). Functional
limitations and cognitive impairment predict the outcome of dysphagia in older
patients after an acute neurologic event. NeuroRehabilitation, 44(3), 413-418.
https://doi.org/10.3233/nre-182635
32. Centers for Disease Control and Prevention. (2017, September 6). Progress has
stalled in US stroke death rates after decades of decline. Retrieved March 10, 2021,
from https://www.cdc.gov/media/releases/2017/p0906-vs-stroke.html
33. Centers for Disease Control and Prevention. (2020, September 8). Stroke Facts.
Retrieved March 10, 2021, from https://www.cdc.gov/stroke/facts.htm
34. Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987). A new method of
classifying prognostic comorbidity in longitudinal studies: Development and
validation. Journal of Chronic Diseases, 40(5), 373-383.
https://doi.org/10.1016/0021-9681(87)90171-8

143

35. Chen, C. M., Chang, C. H., Hsu, H. C., Lin, C. H., & Chen, K. H. (2015). Factors
predicting the total medical costs associated with first-ever ischeamic stroke patients
transferred to the rehabilitation ward. J Rehabil Med, 47(2), 120-125.
https://doi.org/10.2340/16501977-1894
36. Chinthammit, C., Coull, B. M., Nimworapan, M., & Bhattacharjee, S. (2017). Cooccurring chronic conditions and economic burden among stroke survivors in the
United States: A propensity score-matched analysis. J Stroke Cerebrovasc Dis, 26(2),
393-402. https://doi.org/10.1016/j.jstrokecerebrovasdis.2016.09.040
37. Chollet, F., Tardy, J., Albucher, J. F., Thalamas, C., Berard, E., Lamy, C., Bejot, Y.,
Deltour, S., Jaillard, A., Niclot, P., Guillon, B., Moulin, T., Marque, P., Pariente, J.,
Arnaud, C., & Loubinoux, I. (2011). Fluoxetine for motor recovery after acute
ischaemic stroke (FLAME): A randomised placebo-controlled trial. Lancet Neurol,
10(2), 123-130. https://doi.org/10.1016/s1474-4422(10)70314-8
38. Cichero, J. A., & Murdoch, B. E. (2006). Dysphagia: Foundation, theory and practice.
John Wiley & Sons, Ltd.
39. Cichero, J. A., Lam, P., Steele, C. M., Hanson, B., Chen, J., Dantas, R. O., Duivestein, J.,
Kayashita, J., Lecko, C., Murray, J., Pillay, M., Riquelme, L., & Stanschus, S. (2017).
Development of international terminology and definitions for texture-modified foods
and thickened fluids used in dysphagia management: The IDDSI framework.
Dysphagia, 32(2), 293-314. https://doi.org/10.1007/s00455-016-9758-y

144

40. CMS.gov. (2020). Limited Data Set (LDS) Files. Retrieved October 19, 2020, from
https://www.cms.gov/Research-Statistics-Data-and-Systems/Files-for-Order/DataDisclosures-Data-Agreements/DUA_-_NewLDS
41. Cohen, D. L., Roffe, C., Beavan, J., Blackett, B., Fairfield, C. A., Hamdy, S., Havard, D.,
McFarlane, M., McLauglin, C., Randall, M., Robson, K., Scutt, P., Smith, C., Smithard,
D., Sprigg, N., Warusevitane, A., Watkins, C., Woodhouse, L., & Bath, P.M. (2016).
Post-stroke dysphagia: A review and design considerations for future trials.
International Journal of Stroke, 11(4), 399–411.
https://doi.org/10.1177/1747493016639057
42. Cohen, S. M., Lekan, D., Risoli, T., Jr., Lee, H. J., Misono, S., Whitson, H. E., & Raman,
S. (2020) Association between dysphagia and inpatient outcomes across frailty level
among patients ≥ 50 years of age. Dysphagia, 35(5), 787-797.
https://doi.org/10.1007/s00455-019-10084-z
43. Cohen, S., Murphy, M. L. M., & Prather, A. A. (2019). Ten surprising facts about
stressful life events and disease risk. Annu Rev Psychol, 70, 577-597.
https://doi.org/10.1146/annurev-psych-010418-102857
44. Cole, M. G., Elie, L. M., McCusker, J., Bellavance, F., & Mansour, A. (2001). Feasibility
and effectiveness of treatments for post-stroke depression in elderly inpatients:
Systematic review. J Geriatr Psychiatry Neurol, 14(1), 37-41.
https://doi.org/10.1177/089198870101400109
45. Conroy, S. K., Brownlowe, K. B., & McAllister, T. W. (2020). Depression comorbid with
stroke, traumatic brain injury, Parkinson's disease, and multiple sclerosis: Diagnosis

145

and treatment. Focus (American Psychiatric Publishing), 18(2), 150–161.
https://doi.org/10.1176/appi.focus.20200004
46. Cox, D.R. (1972). Regression models and life-tables. Journal of the Royal Statistical
Society. Series B (Methodological), 34(2), 187-220.
47. Crary, M. A., Mann, G. D., & Groher, M. E. (2005). Initial psychometric assessment of
a functional oral intake scale for dysphagia in stroke patients. Arch Phys Med Rehabil,
86(8), 1516-1520. https://doi.org/10.1016/j.apmr.2004.11.049
48. Damush, T. M., Jia, H., Ried, L. D., Qin, H., Cameon, R., Plue, L., & Williams, L. S.
(2008). Case-finding algorithm for post-stroke depression in the veterans health
administration. Int J Geriatr Psychiatry, 23(5), 517-522.
https://doi.org/10.1002/gps.1930
49. Daniels, S. K., Brailey, K., Priestly, D. H., Herrington, L. R., Weisberg, L. A., & Foundas,
A. L. (1998). Aspiration in patients with acute stroke. Arch Phys Med Rehabil, 79(1),
14-19. https://doi.org/10.1016/s0003-9993(98)90200-3
50. Dar, S. K., Venigalla, H., Khan, A.M., Ahmed, R., Mekala, H. M., Zain, H., & Shagufta, S.
(2017). Post stroke depression frequently overlooked, undiagnosed, untreated.
Neuropsychiatry, 7(6), 906-919.
https://doi.org/10.4172/NEUROPSYCHIATRY.1000296
51. Das, J., & Rajanikant, G. K. (2018). Post stroke depression: The sequelae of cerebral
stroke. Neuroscience and Biobehavioral Reviews, 90, 104–114.
https://doi.org/10.1016/j.neubiorev.2018.04.005

146

52. De Ryck, A., Brouns, R., Geurden, M., Elseviers, M., De Deyn, P. P., & Engelborghs, S.
(2014). Risk factors for poststroke depression: Identification of inconsistencies based
on a systematic review. J Geriatr Psychiatry Neurol, 27(3), 147-158.
https://doi.org/10.1177/0891988714527514
53. De Stefano, A., Dispenza, F., Kulamarva, G., Lamarca, G., Faita, A., Merico, A.,
Sardanelli, G., Gabellone, S., & Antonaci, A. (2021, Mar). Predictive factors of severity
and persistence of oropharyngeal dysphagia in sub-acute stroke. Eur Arch
Otorhinolaryngol, 278(3), 741-748. https://doi.org/10.1007/s00405-020-06429-2
54. Dehaghani, S. E., Yadegari, F., Asgari, A., Chitsaz, A., & Karami, M. (2016). Brain
regions involved in swallowing: Evidence from stroke patients in a cross-sectional
study. Journal of Research in Medical Sciences, 21, 45. https://doi.org/10.4103/17351995.183997
55. Douven, E., Kohler, S., Rodriguez, M. M. F., Staals, J., Verhey, F. R. J., & Aalten, P.
(2017). Imaging markers of post-stroke depression and apathy: A systematic review
and meta-analysis. Neuropsychology Review, 27(3), 202-219.
https://doi.org/10.1007/s11065-017-9356-2
56. Dziewas, R., Beck, A. M., Clave, P., Hamdy, S., Heppner, H. J., Langmore, S. E.,
Leischker, A., Martino, R., Pluschinski, P., Roesler, A., Shaker, R., Warnecke, T.,
Sieber, C. C., Volkert, D., & Wirth, R. (2017). Recognizing the importance of
dysphagia: Stumbling blocks and stepping stones in the twenty-first century.
Dysphagia, 32(1), 78-82. https://doi.org/10.1007/s00455-016-9746-2

147

57. Edelstein, B. A., Drozdick, L. W., & Ciliberti, C. M. (2010). Chapter 1 - Assessment of
depression and bereavement in older adults. In P. A. Lichtenberg (Ed.), handbook of
assessment in clinical gerontology (Second edition) (pp. 3-43). Academic Press.
https://doi.org/https://doi.org/10.1016/B978-0-12-374961-1.10001-6
58. Ekberg, O., Hamdy, S., Woisard, V., Wuttge-Hannig, A., & Ortega, P. (2002). Social
and psychological burden of dysphagia: Its impact on diagnosis and
treatment. Dysphagia, 17(2), 139–146. https://doi.org/10.1007/s00455-001-0113-5
59. Ertekin, C., & Aydogdu, I. (2003). Neurophysiology of swallowing. Clinical
Neurophysiology, 114(12), 2226–2244. https://doi.org/10.1016/s13882457(03)00237-2
60. Everitt, B. S., Landau, S., Leese, M., & Stahl, D. (2010). Cluster Analysis. Wiley.
61. Fisher, L. D., & Lin, D. Y. (1999). Time-dependent covariates in the Cox proportional
hazards regression model. Annual Review of Public Health, 20(1), 145-157.
https://doi.org/10.1146/annurev.publhealth.20.1.145
62. Foley, N. C., Martin, R. E., Salter, K. L., & Teasell, R. W. (2009). A review of the
relationship between dysphagia and malnutrition following stroke. J Rehabil Med,
41(9), 707-713. https://doi.org/10.2340/16501977-0415
63. Frades, I., & Matthiesen, R. (2010). Overview on techniques in cluster
analysis. Methods In Molecular Biology (Clifton, N.J.), 593, 81–107.
https://doi.org/10.1007/978-1-60327-194-3_5
64. Gillen, R., Eberhardt, T. L., Tennen, H., Affleck, G., & Groszmann, Y. (1999). Screening
for depression in stroke: Relationship to rehabilitation efficiency. Journal of Stroke

148

and Cerebrovascular Diseases, 8(5), 300-306. https://doi.org/10.1016/S10523057(99)80004-4
65. Goldmann, E., Roberts, E. T., Parikh, N. S., Lord, A. S., & Boden-Albala, B. (2016).
Race/Ethnic differences in post-stroke depression (PSD): Findings from the Stroke
Warning Information and Faster Treatment (SWIFT) Study. Ethn Dis, 26(1), 1-8.
https://doi.org/10.18865/ed.26.1.1
66. Goldstein, L. B., Samsa, G. P., Matchar, D. B., & Horner, R. D. (2004). Charlson index
comorbidity adjustment for ischemic stroke outcome studies. Stroke, 35(8), 19411945. https://doi.org/10.1161/01.STR.0000135225.80898.1c
67. Gonzalez-Fernandez, M., Gardyn, M., Wyckoff, S., Ky, P.K., & Palmer, J. B. (2009).
Validation of ICD-9 Code 787.2 for identification of individuals with dysphagia from
administrative databases. Dysphagia, 24(4), 398-402.
https://doi.org/10.1007/s00455-009-9216-1
68. Gonzalez-Fernandez, M., Kuhlemeier, K., & Palmer, J. (2008). Racial disparities in the
development of dysphagia after stroke: Analysis of the California (MIRCal) and New
York (SPARCS) inpatient databases. Archives of Physical Medicine and Rehabilitation,
89, 1358-1365. https://doi.org/10.1016/j.apmr.2008.02.016
69. Hackett, M. L., & Pickles, K. (2014). Part I: Frequency of depression after stroke: An
updated systematic review and meta-analysis of observational studies. Int J Stroke,
9(8), 1017-1025. https://doi.org/10.1111/ijs.12357

149

70. Hennessy, C. H., Moriarty, D. G., Zack, M. M., Scherr, P. A., & Brackbill, R. (1994).
Measuring health-related quality of life for public health surveillance. Public Health
Rep, 109(5), 665-672.
71. Hilari, K., Byng, S., Lamping, D. L., & Smith, S. C. (2003). Stroke and Aphasia Quality of
Life Scale-39 (SAQOL-39): Evaluation of acceptability, reliability, and validity. Stroke,
34(8), 1944–1950. https://doi.org/10.1161/01.STR.0000081987.46660.ED
72. Hobart, J. C., Williams, L. S., Moran, K., & Thompson, A. J. (2002). Quality of life
measurement after stroke: Uses and abuses of the SF-36. Stroke, 33(5), 1348-1356.
https://doi.org/10.1161/01.str.0000015030.59594.b3
73. Holland, G., Jayasekeran, V., Pendleton, N., Horan, M., Jones, M., & Hamdy, S.
(2011). Prevalence and symptom profiling of oropharyngeal dysphagia in a
community dwelling of an elderly population: A self-reporting questionnaire survey.
Dis Esophagus, 24(7), 476-480. https://doi.org/10.1111/j.1442-2050.2011.01182.x
74. Hosmer, D. W., Lemeshow, S., & Sturdivant, R. X. (2013). Applied logistic regression Third edition. Wiley.
75. Husaini, B., Levine, R., Sharp, L., Cain, V., Novotny, M., Hull, P., Orum, G., Samad, Z.,
Sampson, U., & Moonis, M. (2013). Depression increases stroke hospitalization cost:
An analysis of 17,010 stroke patients in 2008 by race and gender. Stroke Res Treat,
2013, 846732. https://doi.org/10.1155/2013/846732
76. Ibrahimagic, O. C., Smajlovic, D., Kunic, S., Dostovic, Z., Custovic, A., Sehanovic, A., &
Kojic, B. (2019). Post-Stroke depression. Materia Socio-Medica, 31(1), 31–34.
https://doi.org/10.5455/msm.2019.31.31-34

150

77. Jean, A. (2001). Brain stem control of swallowing: Neuronal network and cellular
mechanisms. Physiological Reviews, 81(2), 929–969.
https://doi.org/10.1152/physrev.2001.81.2.929
78. Jeyaseelan, R. D., Vargo, M. M., & Chae, J. (2015). National Institutes of Health Stroke
Scale (NIHSS) as an early predictor of poststroke dysphagia. PM R, 7(6), 593-598.
https://doi.org/10.1016/j.pmrj.2014.12.007
79. Jia, H., Chumbler, N. R., Wang, X., Chuang, H. C., Damush, T. M., Cameon, R., &
Williams, L. S. (2010). Racial and ethnic disparities in post-stroke depression
detection. Int J Geriatr Psychiatry, 25(3), 298-304. https://doi.org/10.1002/gps.2339
80. Kang, J. H., Park, R. Y., Lee, S. J., Kim, J. Y., Yoon, S. R., & Jung, K. I. (2012). The effect
of bedside exercise program on stroke patients with dysphagia. Ann Rehabil Med,
36(4), 512-520. https://doi.org/10.5535/arm.2012.36.4.512
81. Kaplan, R. M., Chambers, D. A., & Glasgow, R. E. (2014). Big data and large sample
size: A cautionary note on the potential for bias. Clin Transl Sci, 7(4), 342-346.
https://doi.org/10.1111/cts.12178
82. Khedr, E. M., Abbass, M. A., Soliman, R. K., Zaki, A. F., & Gamea, A. (2021). Poststroke dysphagia: Frequency, risk factors, and topographic representation: Hospitalbased study. The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 57(1),
23. https://doi.org/10.1186/s41983-021-00281-9
83. King, R. S. (2015). Cluster analysis and data mining: An introduction. Mercury
Learning & Information.

151

84. Koton, S., Bornstein, N. M., Tsabari, R., & Tanne, D. (2010). Derivation and validation
of the prolonged length of stay score in acute stroke patients. Neurology, 74(19),
1511-1516. https://doi.org/10.1212/WNL.0b013e3181dd4dc5
85. Krebbers, I., Simon, S. R., Pilz, W., Kremer, B., Winkens, B., & Baijens, L. W. J. (2020).
Patients with head-and-neck cancer: Dysphagia and affective symptoms. Folia
Phoniatr Logop, 1-8. https://doi.org/10.1159/000508367
86. Kuehner, C. (2017). Why is depression more common among women than among
men? Lancet Psychiatry, 4(2), 146-158. https://doi.org/10.1016/s22150366(16)30263-2
87. Kumar, S., Selim, M. H., & Caplan, L. R. (2010). Medical complications after stroke.
The Lancet Neurology, 9(1), 105–118. https://doi.org/10.1016/S14744422(09)70266-2
88. Kutlubaev, M. A., & Hackett, M. L. (2014). Part II: Predictors of depression after
stroke and impact of depression on stroke outcome: An updated systematic review
of observational studies. Int J Stroke, 9(8), 1026-1036.
https://doi.org/10.1111/ijs.12356
89. Labeit, B., Mueller, H., Muhle, P., Claus, I., Warnecke, T., Dziewas, R., & SuntrupKrueger, S. (2018). Predicting dysphagia with National Institute of Health Stroke
Scale: Distinction between infra- and supratentorial region is essential.
Cerebrovascular Diseases, 46, 150-158. https://doi.org/10.1159/000493371
90. Lang, I. M. (2009). Brain stem control of the phases of swallowing. Dysphagia,
24, 333-348. https://doi.org/10.1007/s00455-009-9211-6

152

91. Lazzarino, A. I., Hamer, M., Stamatakis, E., & Steptoe, A. (2013a). The combined
association of psychological distress and socioeconomic status with all-cause
mortality: A national cohort study. JAMA Intern Med, 173(1), 22-27.
https://doi.org/10.1001/2013.jamainternmed.951
92. Lazzarino, A. I., Hamer, M., Stamatakis, E., & Steptoe, A. (2013b). Low socioeconomic
status and psychological distress as synergistic predictors of mortality from stroke
and coronary heart disease. Psychosom Med, 75(3), 311-316.
https://doi.org/10.1097/PSY.0b013e3182898e6d
93. Leentjens, A. F., Aben, I., Lodder, J., & Verhey, F. R. (2006). General and diseasespecific risk factors for depression after ischemic stroke: A two-step Cox regression
analysis. Int Psychogeriatr, 18(4), 739-748.
https://doi.org/10.1017/s1041610206003486
94. Lin, D., Wei, L., & Ying, Z. (1993). Checking the Cox model with cumulative sums of
martingale-based residuals. Biometrika, 80, 557-572.
95. Liu, L., Xiao, Y., Zhang, W., Yao, L., Gao, X., Chandan, S., & Lui, S. (2017). Functional
changes of neural circuits in stroke patients with dysphagia: A meta-analysis. Journal
of Evidence-Based Medicine, 10(3), 189–195. https://doi.org/10.1111/jebm.12242
96. Logemann, J. (1998). Evaluation and Treatment of Swallowing Disorders – Second
edition. Pro-Ed, Inc.
97. Lökk, J., & Delbari, A. (2010). Management of depression in elderly stroke patients.
Neuropsychiatric disease and treatment, 6, 539-549.
https://doi.org/10.2147/NDT.S7637

153

98. Lu, X. (2018). An introduction to clustering techniques.
https://www.sas.com/content/dam/SAS/support/en/sas-global-forumproceedings/2018/2615-2018.pdf
99. MacQueen, J. B. (1967). Some methods for classification and analysis of multivariate
observations.
100. Malandraki, G., & Robbins, J. (2013). Dysphagia. Handbook of Clinical Neurology, 110,
255-271. https://doi.org/10.1016/B978-0-444-52901-5.00021-6
101. Manning, W. G., Basu, A., & Mullahy, J. (2005). Generalized modeling approaches to
risk adjustment of skewed outcomes data. J Health Econ, 24(3), 465-488.
https://doi.org/10.1016/j.jhealeco.2004.09.011
102. Marin, S., Serra-Prat, M., Ortega, O., & Clavé, P. (2018). Cost of oropharyngeal
dysphagia after stroke: Protocol for a systematic review. BMJ Open, 8(12), e022775.
https://doi.org/10.1136/bmjopen-2018-022775
103. Marin, S., Serra-Prat, M., Ortega, O., & Clavé, P. (2020). Healthcare-related cost of
oropharyngeal dysphagia and its complications pneumonia and malnutrition after
stroke: A systematic review. BMJ Open, 10(8), e031629.
https://doi.org/10.1136/bmjopen-2019-031629
104. Martino, R., Foley, N., Bhogal, S., Diamant, N., Speechley, M., & Teasell, R. (2005).
Dysphagia after stroke: Incidence, diagnosis, and pulmonary complications. Stroke,
36(12), 2756–2763. https://doi.org/10.1161/01.STR.0000190056.76543.eb

154

105. Martino, R., Martin, R. E., & Black, S. (2012). Dysphagia after stroke and its
management. CMAJ: Canadian Medical Association Journal, 184(10), 1127-1128.
https://doi.org/10.1503/cmaj.101659
106. Matsuo, K., & Palmer, J. B. (2008). Anatomy and physiology of feeding and
swallowing: Normal and abnormal. Physical Medicine and Rehabilitation Clinics of
North America, 19(4), 691–vii. https://doi.org/10.1016/j.pmr.2008.06.001
107. McCarthy, M. J., Sucharew, H. J., Alwell, K., Moomaw, C. J., Woo, D., Flaherty, M. L.,
Khatri, P., Ferioli, S., Adeoye, O., Kleindorfer, D. O., & Kissela, B. M. (2016). Age,
subjective stress, and depression after ischemic stroke. Journal of Behavioral
Medicine, 39(1), 55–64. https://doi.org/10.1007/s10865-015-9663-0
108. McHorney, C. A., Bricker, D. E., Kramer, A. E., Rosenbek, J. C., Robbins, J., Chignell, K.
A., Logemann, J. A., & Clarke, C. (2000a). The SWAL-QOL outcomes tool for
oropharyngeal dysphagia in adults: I. Conceptual foundation and item development.
Dysphagia, 15(3), 115–121. https://doi.org/10.1007/s004550010012
109. McHorney, C. A., Bricker, D. E., Robbins, J., Kramer, A. E., Rosenbek, J. C., & Chignell,
K. A. (2000b). The SWAL-QOL outcomes tool for oropharyngeal dysphagia in adults:
II. Item reduction and preliminary scaling. Dysphagia, 15(3), 122–133.
https://doi.org/10.1007/s004550010013
110. McHorney, C. A., Robbins, J., Lomax, K., Rosenbek, J. C., Chignell, K., Kramer, A. E., &
Bricker, D. E. (2002). The SWAL-QOL and SWAL-CARE outcomes tool for
oropharyngeal dysphagia in adults: III. Documentation of reliability and validity.
Dysphagia, 17(2), 97–114. https://doi.org/10.1007/s00455-001-0109-1

155

111. Mead, G. E., Hsieh, C. F., Lee, R., Kutlubaev, M. A., Claxton, A., Hankey, G. J., &
Hackett, M. L. (2012). Selective serotonin reuptake inhibitors (SSRIs) for stroke
recovery. Cochrane Database Syst Rev, 14(11), CD009286.
https://doi.org/10.1002/14651858.CD009286.pub2
112. Medicare Beneficiary Demographics. (2017, June). A data book: Health care spending
and the Medicare program. Retrieved March 10, 2021, from
http://www.medpac.gov/docs/default-source/databook/jun17_databooksec2_sec.pdf
113. Mickey, R. M., & Greenland, S. (1989). The impact of confounder selection criteria on
effect estimation. Am J Epidemiol, 129(1), 125-137.
https://doi.org/10.1093/oxfordjournals.aje.a115101
114. Mistry, S., & Hamdy, S. (2008). Neural control of feeding and swallowing. Physical
Medicine and Rehabilitation Clinics of North America, 19(4), 709–728.
https://doi.org/10.1016/j.pmr.2008.05.002
115. Montgomery, D. C., Peck, E. A., & Vining, G. G. (2012). Introduction to linear
regression analysis - Fifth edition. Wiley.
116. Moon, S., & Shin, J. (2006). Health care utilization among Medicare-Medicaid dual
eligibles: A count data analysis. BMC Public Health, 6, 88.
https://doi.org/10.1186/1471-2458-6-88
117. Moriarty, D. G., Zack, M. M., & Kobau, R. (2003). The Centers for Disease Control and
Prevention's Healthy Days Measures – Population tracking of perceived physical and

156

mental health over time. Health And Quality Of Life Outcomes, 1(1), 37.
https://doi.org/10.1186/1477-7525-1-37
118. Mosier. K., & Bereznaya, I. (2001). Parallel cortical networks for volitional control of
swallowing in humans. Experimental Brain Research, 140, 280–289.
https://doi.org/10.1007/s002210100813
119. Namasivayam-MacDonald, A. M., & Shune, S. E. (2018). The Burden of Dysphagia on
Family Caregivers of the Elderly: A Systematic Review. Geriatrics (Basel, Switzerland),
3(2), 30. https://doi.org/10.3390/geriatrics3020030
120. Nemani, K., & Gurin, L. (2021). Neuropsychiatric complications after stroke. Semin
Neurol. https://doi.org/10.1055/s-0040-1722723
121. Ostir, G. V., Berges, I. M., Ottenbacher, A., & Ottenbacher, K. J. (2011). Patterns of
change in depression after stroke. Journal of the American Geriatrics Society, 59(2),
314–320. https://doi.org/10.1111/j.1532-5415.2010.03266.x
122. Otto, D. M., Ribeiro, M. C., Barea, L. M., Mancopes, R., & Almeida, S. T. (2016).
Association between neurological injury and the severity of oropharyngeal dysphagia
after stroke. CoDAS, 28(6), 724–729. https://doi.org/10.1590/23171782/20162015139
123. Paolucci, S., Antonucci, G., Grasso, M. G., Morelli, D., Troisi, E., Coiro, P., De Angelis,
D., Rizzi, F., & Bragoni, M. (2001). Post-stroke depression, antidepressant treatment
and rehabilitation results. A case-control study. Cerebrovascular Diseases, 12(3),
264–271. https://doi.org/10.1159/000047714

157

124. Paolucci, S., Iosa, M., Coiro, P., Venturiero, V., Savo, A., De Angelis, D., & Morone, G.
(2019). Post-stroke depression increases disability more than 15% in ischemic stroke
survivors: A case-control study [original research]. Frontiers in Neurology, 10(926).
https://doi.org/10.3389/fneur.2019.00926
125. Paolucci, S., Iosa, M., Coiro, P., Venturiero, V., Savo, A., De Angelis, D., & Morone, G.
(2019). Post-stroke depression increases disability more than 15% in ischemic stroke
survivors: A case-control study. Frontiers in Neurology, 10(926).
https://doi.org/10.3389/fneur.2019.00926
126. Parikh, R. M., Robinson, R. G., Lipsey, J. R., Starkstein, S. E., Fedoroff, J. P., & Price, T.
R. (1990). The impact of poststroke depression on recovery in activities of daily living
over a 2-year follow-up. Arch Neurol, 47, 785–789.
https://doi.org/10.1001/archneur.1990.00530070083014
127. Patel, P. D., Salwi, S., Liles, C., Mistry, A. M., Mistry, E. A., Fusco, M. R., Chitale, R. V.,
& Shannon, C. N. (2021). Creation and validation of a stroke scale to increase utility
of national inpatient sample administrative data for clinical stroke research. J Stroke
Cerebrovasc Dis, 30(4), 105658.
https://doi.org/10.1016/j.jstrokecerebrovasdis.2021.105658
128. Paul, P., Pennell, M. L., & Lemeshow, S. (2013). Standardizing the power of the
Hosmer-Lemeshow goodness of fit test in large data sets. Stat Med, 32(1), 67-80.
https://doi.org/10.1002/sim.5525
129. Practice Management Information Corporation (PMIC). (2019). PMIC Digital Book
Series: HCPCS 2020. Practice Management Information Corporation.

158

130. Quan, H., Li, B., Couris, C. M., Fushimi, K., Graham, P., Hider, P., Januel, J. M., &
Sundararajan, V. (2011). Updating and validating the Charlson comorbidity index and
score for risk adjustment in hospital discharge abstracts using data from 6 countries.
American Journal of Epidemiology, 173, 676–682.
https://doi.org/10.1093/aje/kwq433
131. Quan, H., Sundararajan, V., Halfon, P., Fong,A., Burnand, B., Luthi, J. C., Saunders, L.
D., Beck, C. A., Feasby, T. E., & Ghali, W. A. (2005). Coding algorithms for defining
comorbidities in ICD-9-CM and ICD-10 administrative data. Medical Care, 43, 1130–
1139. https://doi.org/10.1097/01.mlr.0000182534.19832.83
132. Robbins, J., Levine, R. L., & Maser, A. (1993). Swallowing after unilateral stroke of the
cerebral cortex. Arch Phys Med Rehabil, 74, 1295–1300.
https://doi.org/10.1016/0003-9993(93)90082-l
133. Robinson, R. G., & Jorge, R. E. (2016). Post-Stroke depression: A review. Am J
Psychiatry, 173(3), 221-31. https://doi.org/10.1176/appi.ajp.2015.15030363
134. Rofes, L., Arreola, V., Almirall, J., Cabré, M., Campins, L., García-Peris, P., Speyer, R., &
Clavé, P. (2011). Diagnosis and management of oropharyngeal dysphagia and its
nutritional and respiratory complications in the elderly. Gastroenterology Research
and Practice, 2011, 818979. https://doi.org/10.1155/2011/818979
135. Rofes, L., Vilardell, N., & Clavé, P. (2013). Post-stroke dysphagia: Progress at last.
Neurogastroenterol Motil, 25(4), 278-282. https://doi.org/10.1111/nmo.12112

159

136. Saposnik, G., Cote, R., Phillips, S., Gubitz, G., Bayer, N., Minuk, J., & Black, S. (2008).
Stroke outcome in those over 80: a multicenter cohort study across Canada. Stroke,
39(8), 2310-2317. https://doi.org/10.1161/strokeaha.107.511402
137. Sarle, W. S. (1983). Cubic Clustering Criterion (Technical Report A-108). SAS Institute,
Inc.
138. SAS Institute, Inc. (1999). SAS/STAT® User’s Guide, 8th ed. SAS Institute, Inc.
139. SAS Institute, Inc. (2015). SAS/STAT® 14.1 User’s Guide. SAS Institute, Inc.
140. Sasegbon, A., & Hamdy, S. (2017). The anatomy and physiology of normal and
abnormal swallowing in oropharyngeal dysphagia. Neurogastroenterology and
Motility, 29(11), 1–15. https://doi.org/10.1111/nmo.13100
141. Saxena, S. K., Ng, T. P., Yong, D., Fong, N. P., & Koh, G. (2008). Subthreshold
depression and cognitive impairment but not demented in stroke patients during
their rehabilitation. Acta Neurol Scand, 117(2), 133-140.
https://doi.org/10.1111/j.1600-0404.2007.00922.x
142. Schober, P., & Vetter, T. R. (2018). Survival analysis and interpretation of time-toevent data: The tortoise and the hare. Anesthesia & Analgesia, 127(3), 792-798.
https://doi.org/10.1213/ANE.0000000000003653
143. Schreiber-Gregory, D. N. (2017). Multicollinearity: What is it, why should we care,
and how can it be controlled? [White paper]. Proceedings of the SAS Global Forum
2017 Conference. https://support.sas.com/resources/papers/proceedings17/14042017.pdf

160

144. Shapiro, S. S. & Wilk, M. B. (1965). An analysis of variance test for normality
(complete samples). Biometrika, 52(3–4), 591-611.
https://doi.org/10.1093/biomet/52.3-4.591
145. Shi, Y., Yang, D., Zeng, Y., & Wu, W. (2017a). Risk factors for post-stroke depression:
A meta-analysis. Front Aging Neurosci, 9, 218.
https://doi.org/10.3389/fnagi.2017.00218
146. Shi, Y., Zeng, Y., Wu, L., Liu, Z., Zhang, S., Yang, J., & Wu, W. (2017b). A study of the
brain functional network of post-stroke depression in three different lesion locations.
Scientific Reports, 7(1), 14795. https://doi.org/10.1038/s41598-017-14675-4
147. Sienkiewicz-Jarosz, H., Milewska, D., Bochyńska, A., Chełmniak, A., Dworek, N.,
Kasprzyk, K., Gałecka, K., Szczepańska-Szarej, A., Chwojnicki, K., Zyluk, B., Słowik, A.,
& Ryglewicz, D. (2010). Predictors of depressive symptoms in patients with stroke –
A three-month follow-up. Neurol Neurochir Pol, 44(1), 13-20.
https://doi.org/10.1016/s0028-3843(14)60402-3
148. Simpson, A. N., Wilmskoetter, J., Hong, I., Li, C.Y., Jauch, E. C., Bonilha, H. S.,
Anderson, K., Harvey, J., & Simpson, K. N. (2018). Stroke Administrative Severity
Index: Using administrative data for 30-day poststroke outcomes prediction. J Comp
Eff Res, 7(4), 293-304. https://doi.org/10.2217/cer-2017-0058
149. Smarr, K. L., & Keefer, A. L. (2011). Measures of depression and depressive
symptoms: Beck Depression Inventory-II (BDI-II), Center for Epidemiologic Studies
Depression Scale (CES-D), Geriatric Depression Scale (GDS), Hospital Anxiety and

161

Depression Scale (HADS), and Patient Health Questionnaire-9 (PHQ-9). Arthritis Care
Res (Hoboken), 63 Suppl 11, S454-466. https://doi.org/10.1002/acr.20556
150. Son, Y. G., Shin, J., & Ryu, H. G. (2017). Pneumonitis and pneumonia after aspiration.
Journal of Dental Anesthesia and Pain Medicine, 17(1), 1–12.
https://doi.org/10.17245/jdapm.2017.17.1.1
151. Starkstein, S. E, & Robinson, R. G. (1989). Affective disorders and cerebral vascular
disease. Br J Psychiatry, 154, 170–182.
152. Stein, L. K., Kornspun, A., Erdman, J., & Dhamoon, M. S. (2020). Readmissions for
depression and suicide attempt following stroke and myocardial infarction.
Cerebrovasc Dis Extra, 10(2), 94-104. https://doi.org/10.1159/000509454
153. Steindel, S. J. (2010). International classification of diseases, 10th edition, clinical
modification and procedure coding system: Descriptive overview of the next
generation HIPAA code sets. J Am Med Inform Assoc, 17(3), 274-82.
https://doi.org/10.1136/jamia.2009.001230
154. Stewart, J. T. (2004). Why don't physicians consider depression in the elderly? Agerelated bias, atypical symptoms, and ineffective screening approaches may be at
play. Postgrad Med, 115(6), 57-59. https://doi.org/10.3810/pgm.2004.06.1539
155. Stoltzfus, J. C. (2011). Logistic regression: A brief primer. Acad Emerg Med, 18(10),
1099-1104. https://doi.org/10.1111/j.1553-2712.2011.01185.x
156. Suntrup-Krueger, S., Kemmling, A., Warnecke, T., Hamacher, C., Oelenberg, S.,
Niederstadt, T., Heindel, W., Wiendl, H., & Dziewas, R. (2017). The impact of lesion
location on dysphagia incidence, pattern and complications in acute stroke. Part 2:

162

Oropharyngeal residue, swallow and cough response, and pneumonia. Eur J Neurol,
24(6), 867-874. https://doi.org/10.1111/ene.13307
157. Takizawa, C., Gemmell, E., Kenworthy, J., & Speyer, R. (2016). A systematic review of
the prevalence of oropharyngeal dysphagia in stroke, Parkinson's disease,
Alzheimer's disease, head injury, and pneumonia. Dysphagia, 31(3), 434-441.
https://doi.org/10.1007/s00455-016-9695-9
158. Timmerman, A. A., Speyer, R., Heijnen, B. J., & Klijn-Zwijnenberg, I. R. (2014).
Psychometric characteristics of health-related quality-of-life questionnaires in
oropharyngeal dysphagia. Dysphagia, 29(2), 183-198.
https://doi.org/10.1007/s00455-013-9511-8
159. Towfighi, A., Ovbiagele, B., El Husseini, N., Hackett, M. L., Jorge, R. E., Kissela, B. M.,
Mitchell, P. H., Skolarus, L. E., Whooley, M. A., & Williams, L. S. (2017). Poststroke
depression: A scientific statement for healthcare professionals from the American
Heart Association/American Stroke Association. Stroke, 48(2), e30e43. https://doi.org/10.1161/STR.0000000000000113
160. UCLA: Statistical Consulting Group. (n.d.-a). Introduction to Survival Analysis in SAS.
Retrieved December 30, 2020, from https://stats.idre.ucla.edu/sas/seminars/sassurvival/
161. UCLA: Statistical Consulting Group. (n.d.-b). Poisson Regression: SAS Annotated
Output. Retrieved February 27, 2021, from
https://stats.idre.ucla.edu/sas/output/poisson-regression/

163

162. VanDerwerker, C. J., Gregory, C. M., & Simpson, K. N. (2020). Using inferred mobility
status to estimate the time to major depressive disorder diagnosis post-spinal cord
injury. Arch Phys Med Rehabil, 101(4), 658-666.
https://doi.org/10.1016/j.apmr.2019.11.014
163. Verdonschot, R. J., Baijens, L. W. J., Serroyen, J. L., Leue, C., & Kremer, B. (2013).
Symptoms of anxiety and depression assessed with the Hospital Anxiety and
Depression Scale in patients with oropharyngeal dysphagia. Journal of Psychosomatic
Research, 75(5), 451-455. https://doi.org/10.1016/j.jpsychores.2013.08.021
164. Verdonschot, R. J., Baijens, L. W. J., Vanbelle, S., van de Kolk, I., Kremer, B., & Leue, C.
(2017). Affective symptoms in patients with oropharyngeal dysphagia: A systematic
review. J Psychosom Res, 97, 102-110.
https://doi.org/10.1016/j.jpsychores.2017.04.006
165. Verdonschot, R. J., Baijens, L., Vanbelle, S., Florie, M., Kremer, B., & Leue, C. (2016).
The relationship between fiberoptic endoscopic evaluation of swallowing outcome
and symptoms of anxiety and depression in dysphagic patients. Laryngoscope,
126(5), E199-207. https://doi.org/10.1002/lary.25698
166. Vittinghoff, E., Shiboski, S. C., Glidden, D. V., & McCulloch, C. E. (2005). Regression
methods in biostatistics: Linear, logistic, survival, and repeated measures models.
Springer.
167. Ware, J. E., Jr., Gandek, B., Guyer, R., & Deng, N. (2016). Standardizing diseasespecific quality of life measures across multiple chronic conditions: development and

164

initial evaluation of the QOL Disease Impact Scale (QDIS®). Health and quality of life
outcomes, 14, 84-84. https://doi.org/10.1186/s12955-016-0483-x
168. White, H. (1980). A heteroskedasticity-consistent covariance matrix estimator and a
direct test for heteroskedasticity. Econometrica, 48(4), 817–838.
https://doi.org/10.2307/1912934
169. Wiest, M. M., Lee, K. J., & Carlin, J. B. (2015). Statistics for clinicians: An introduction
to logistic regression. J Paediatr Child Health, 51(7), 670-673.
https://doi.org/10.1111/jpc.12895
170. Williams, L. S. (2005). Depression and stroke: cause or consequence? Semin Neurol,
25(4), 396-409. https://doi.org/10.1055/s-2005-923534
171. Williams, L. S., Weinberger, M., Harris, L. E., Clark, D. O., & Biller, J. (1999).
Development of a stroke-specific quality of life scale. Stroke, 30(7), 1362-1369.
https://doi.org/10.1161/01.str.30.7.1362
172. Wilmskoetter, J., Bonilha, L., Martin-Harris, B., Elm, J. J., Horn, J., & Bonilha, H. S.
(2019a). Factors influencing oral intake improvement and feeding tube dependency
in patients with poststroke dysphagia. Journal of Stroke and Cerebrovascular
Diseases, 28(6), 1421-1430.
https://doi.org/10.1016/j.jstrokecerebrovasdis.2019.03.031
173. Wilmskoetter, J., Bonilha, L., Martin-Harris, B., Elm, J. J., Horn, J., & Bonilha, H.
S. (2019b). Mapping acute lesion locations to physiological swallow impairments
after stroke. Neuroimage Clin, 22,
101685. https://doi.org/10.1016/j.nicl.2019.101685

165

174. Wilmskoetter, J., Daniels, S. K., & Miller, A. J. (2020). Cortical and subcortical control
of swallowing-Can we use information from lesion locations to improve diagnosis
and treatment for patients with stroke? Am J Speech Lang Pathol, 29(2s), 1030-1043.
https://doi.org/10.1044/2019_ajslp-19-00068
175. Winters, R., Winters, A., & Amedee, R. G. (2010). Statistics: A brief overview. The
Ochsner Journal, 10(3), 213–216.
176. Zhang, S., Xu, M., Liu, Z. J., Feng, J., & Ma, Y. (2020). Neuropsychiatric issues after
stroke: Clinical significance and therapeutic implications. World J Psychiatry, 10(6),
125-138. https://doi.org/10.5498/wjp.v10.i6.125
177. Žikić, T. R., Divjak, I., Jovićević, M., Semnic, M., Slankamenac, P., Žarkov, M., & Žikić,
M. (2014). The effect of post stroke depression on functional outcome and quality of
life. Acta Clinica Croatica, 53(3), 294–301.

166

APPENDICES
Appendix 1: ICD-10-CM Codes
Variable

ICD-10 Code

Description

Aspiration
pneumonia

J13, J14, J15.0, J15.1,
J15.20, J15.211,
J15.212, J15.29, J15.3,
J15.4, J15.5, J15.6,
J15.8, J18.9, J69.0

Due to: Streptococcus pneumoniae; Hemophilus
influenzae; Klebsiella pneumoniae;
Pseudomonas; Staphylococcus, unspecified;
Methicillin susceptible Staphylococcus aureus;
Methicillin resistant Staphylococcus aureus;
Other staphylococcus; Streptococcus, group B;
Other streptococci; Escherichia coli; Other Gramnegative bacteria; Other specified bacteria;
Unspecified organism; Pneumonitis due to
inhalation of food and vomit

Aspiration of food

T17.220, T17.320,
T17.520, T17.820,
T17.920, T17.420

Food in pharynx causing asphyxiation; Food in
larynx causing asphyxiation; Food in bronchus
causing asphyxiation; Food in other parts of
respiratory tract causing asphyxiation; Food in
respiratory tract, part unspecified, causing
asphyxiation; Food in trachea causing
asphyxiation

Cognitive
impairment

I69.01, I69.11, I69.21,
I69.31, I69.81, I69.91,
G31.84, G31.9, R41.4,
R41.81, R41.82,
R41.9, S06, F01, F02,
F03, F68.8

Cognitive deficits following: Nontraumatic
subarachnoid hemorrhage; Nontraumatic
intracerebral hemorrhage; Other nontraumatic
intracranial hemorrhage; Cerebral infarction;
Other cerebrovascular disease; Unspecified
cerebrovascular disease; Mild cognitive
impairment; Degenerative disease of nervous
system, unspecified; Neurologic neglect
syndrome; Age-related cognitive decline; Altered
mental status, unspecified; Unspecified
symptoms and signs involving cognitive functions
and awareness; Intracranial injury; Vascular
dementia; Dementia in other diseases classified
elsewhere; Unspecified dementia; Other
specified disorders of adult personality and
behavior

Dehydration

E86.0

Dehydration

Depression

F32.x, F33.x

Major depressive disorder, single episode; Major
depressive disorder, recurrent
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Dysphagia

Edentulous

R13.x

Aphagia or Dysphagia

I69.091, I69.191,
I69.291, I69.391,
I69.891, I69.991

Dysphagia following nontraumatic subarachnoid
hemorrhage; Dysphagia following
nontraumatic intracerebral hemorrhage;
Dysphagia following other nontraumatic
intracranial hemorrhage; Dysphagia
following cerebral infarction or stroke NOS;
Dysphagia following cerebrovascular disease,
specified NEC; Dysphagia following
cerebrovascular disease, unspecified

K08.1a, K08.10a,
K08.101, K08.102,
K08.103, K08.104,
K08.109, K08.11a,
K08.111, K08.112,
K08.113, K08.114,
K08.119, K08.12a,
K08.121, K08.122,
K08.123, K08.124,
K08.129, K08.13a,
K08.131, K08.132,
K08.133, K08.134,
K08.139, K08.19a,
K08.191, K08.192,
K08.193, K08.194,
K08.199

Complete loss of teeth; Complete loss of teeth,
unspecified cause; Complete loss of teeth,
unspecified cause, class I; Complete loss of teeth,
unspecified cause, class II; Complete loss of
teeth, unspecified cause, class III; Complete loss
of teeth, unspecified cause, class IV; Complete
loss of teeth UC, unspecified class; Complete loss
of teeth due to trauma; Complete loss of teeth
due to trauma, class I; Complete loss of teeth due
to trauma, class II; Complete loss of teeth due to
trauma, class III; Complete loss of teeth due to
trauma, class IV; Complete loss of teeth due to
trauma, unspecified class; Complete loss of teeth
due to periodontal disease; Complete loss of
teeth due to periodontal disease, class I;
Complete loss of teeth due to periodontal
disease, class II; Complete loss of teeth due to
periodontal disease, class III; Complete loss of
teeth due to periodontal disease, class IV;
Complete loss of teeth due to periodontal
disease, unspecified class; Complete loss of teeth
due to caries; Complete loss of teeth due to
caries, class I; Complete loss of teeth due to
caries, class II; Complete loss of teeth due to
caries, class III; Complete loss of teeth due to
caries, class IV; Complete loss of teeth due to
caries, unspecified class; Complete loss of teeth
due to other specified cause; Complete loss of
teeth due to other specified cause, class I;
Complete loss of teeth due to other specified
cause, class II; Complete loss of teeth due to
other specified cause, class III; Complete loss of
teeth due to other specified cause, class IV;
Complete loss of teeth due to other specified
cause, unspecified class
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Esophageal
disorder

K20.80, K20.81,
K20.90, K20.91,
K21.00, K21.01, K22.0,
K22.5

Other esophagitis, specified NEC without
bleeding; Other esophagitis with
bleeding; Esophagitis, unspecified without
bleeding; Esophagitis, unspecified with bleeding;
Gastro-esophageal reflux disease with
esophagitis without bleeding; Gastro-esophageal
reflux disease with esophagitis with
bleeding; Achalasia of cardia; Diverticulum of
esophagus, acquired

Feeding problems

R63.3, R63.4, R63.6,
R63.8, Z93.1

Problem with feeding; Abnormal weight loss
(cause unknown); Underweight; Other symptoms
and signs concerning food and fluid intake;
Presence of gastrostomy

Malnutrition

E44.1, E44.0, E43.0,
E46

Mild protein-calorie malnutrition; Moderate
protein-calorie malnutrition; Unspecified severe
protein-calorie malnutrition; Unspecified proteincalorie malnutrition

Paralysis of vocal
cords and larynx

J38.0, J38.00, J38.01,
J38.02

Paralysis of vocal cords and larynx; Paralysis of
vocal cords and larynx, unspecified; Paralysis of
vocal cords and larynx, unilateral; Paralysis of
vocal cords and larynx, bilateral

Respiratory
problems

J80, J96, R06.0,
R06.00, R06.03

Acute respiratory distress syndrome; Respiratory
failure NEC; Dyspnea; Dyspnea, unspecified,
Acute respiratory distress

Tracheostomy
status

Z93.0

Tracheostomy status

Stroke (ischemic)

I63.x

Cerebral infarction

Footnote: a=non-billable code, NEC=not elsewhere classified, NOS=not otherwise
specified
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Appendix 2: ICD-10-PCS Codes
Variable

ICD-10 Code

Description

Feeding device,
insertion

0DH90UZ, 0DH93UZ,
0DH94UZ, 0DH97UZ,
0DH98UZ, 0DH50UZ,
0DH53UZ, 0DH54UZ,
0DH57UZ, 0DH58UZ,
0DHB0UZ, 0DHB3UZ,
0DHB4UZ, 0DHB7UZ,
0DHB8UZ, 0DH80UZ,
0DH83UZ, 0DH84UZ,
0DH87UZ, 0DH88UZ,
0DHA0UZ, 0DHA3UZ,
0DHA4UZ, 0DHA7UZ,
0DHA8UZ, 0DH60UZ,
0DH63UZ, 0DH64UZ,
0DH67UZ, 0DH68UZ

Feeding device,
removal

0DP50UZ, 0DP53UZ,
0DP54UZ, 0DPD0UZ,
0DPD3UZ, 0DPD4UZ,
0DP00UZ, 0DP03UZ,
0DP04UZ, 0DP60UZ,
0DP63UZ, 0DP64UZ

Insertion of device in: Duodenum, open
approach; Duodenum, percutaneous approach;
Duodenum, percutaneous endoscopic approach;
Duodenum, via natural or artificial opening;
Duodenum, via natural or artificial opening
endoscopic; Esophagus, open approach;
Esophagus, percutaneous approach; Esophagus,
percutaneous endoscopic approach; Esophagus,
via natural or artificial opening; Esophagus, via
natural or artificial opening endoscopic; Ileum,
open approach; Ileum, percutaneous approach;
Ileum, percutaneous endoscopic approach; Ileum,
via natural or artificial opening; Ileum, via natural
or artificial opening endoscopic; Small intestine,
open approach; Small intestine, percutaneous
approach; Small intestine, percutaneous
endoscopic approach; Small intestine, via natural
or artificial opening; Small intestine, via natural or
artificial opening endoscopic; Jejunum, open
approach; Jejunum, percutaneous approach;
Jejunum, percutaneous endoscopic approach
(PEJ); Jejunum, via natural or artificial opening;
Jejunum, via natural or artificial opening
endoscopic; Stomach, open approach; Stomach,
percutaneous approach; Stomach, percutaneous
endoscopic approach (PEG); Stomach, via natural
or artificial opening; Stomach, via natural or
artificial opening endoscopic
Removal of device from: Esophagus, open
approach; Esophagus, percutaneous approach;
Esophagus, percutaneous endoscopic approach;
Lower intestinal tract, open approach; Lower
intestinal tract, percutaneous approach; Lower
intestinal tract, percutaneous endoscopic
approach; Upper intestinal tract, open approach;
Upper intestinal tract, percutaneous approach;
Upper intestinal tract, percutaneous endoscopic
approach; Stomach,
open approach; Stomach, percutaneous
approach; Stomach, percutaneous endoscopic
approach
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Intubation

0BH17EZ

Insertion of endotracheal airway into trachea via
natural or artificial opening

Swallowing
assessment

F00ZHZZ, F00ZJWZ,
F00ZJTZ, F00ZJYZ

Bedside swallowing and oral function assessment;
Instrumental swallowing and oral function
assessment using swallowing equipment;
Instrumental swallowing and oral function
assessment using aerodynamic function
equipment; Instrumental swallowing and oral
function assessment using other equipment

Swallowing
treatment

F06ZDZZ, F06ZDMZ,
F06ZDTZ, F06ZDVZ,
F06ZDYZ

Swallowing dysfunction treatment; Swallowing
dysfunction treatment using
augmentative/alternative communication
equipment; Swallowing dysfunction treatment
using aerodynamic function
equipment; Swallowing dysfunction treatment
using speech prosthesis; Swallowing dysfunction
treatment using other equipment

Tracheotomy

0B110F4, 0B113F4,
0B114F4

Bypass trachea to cutaneous with tracheostomy
device, open approach; Bypass trachea to
cutaneous with tracheostomy device,
percutaneous approach; Bypass trachea to
cutaneous with tracheostomy device,
percutaneous endoscopic approach;

Tracheostomy
device removal

0BP10FZ, 0BP13FZ,
0BP1XFZ, 0BP14FZ,
0BP17FZ, 0BP18FZ

Removal of tracheostomy device from trachea,
open approach; Removal of tracheostomy device
from trachea, percutaneous approach; Removal
of tracheostomy device from trachea, external
approach; Removal of tracheostomy device from
trachea, percutaneous endoscopic approach;
Removal of tracheostomy device from trachea,
via natural or artificial opening; Removal of
tracheostomy device from trachea, via natural or
artificial opening

Ventilator use

5A1935Z, 5A1945Z,
5A19557

Respiratory ventilation, <24 consecutive hours;
Respiratory ventilation, 24-96 consecutive hours;
Respiratory ventilation, >96 consecutive hours
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Appendix 3: Level I CPT and Level II HCPCS Codes
Variable

CPT Code

Description

Swallowing
assessment

92610, 74230 a,
92611a, 92612,
92616

Evaluation of oral and pharyngeal swallowing
function; Swallowing function, with
cineradiography/videoradiography (modified
barium swallow study); Motion fluoroscopic
evaluation of swallowing function by cine or video
recording (modified barium swallow study);
Flexible fiberoptic endoscopic evaluation of
swallowing by cine or video recording (FEES);
Flexible fiberoptic endoscopic evaluation of
swallowing and laryngeal sensory testing by cine or
video recording (FEESST)

Swallowing
treatment

92526, 92508

Treatment of swallowing dysfunction and/or oral
function for feeding; Group dysphagia therapy

Variable

HCPCS Code

Description

Enteral feeding

B4081, B4082,
B4083, B4087,
B4088

Nasogastric tubing with stylet; Nasogastric tubing
without stylet; Stomach tube levin;
Gastrostomy/Jejunostomy tube, standard;
Gastrostomy/Jejunostomy tube, low-profile

B4102, B4149,
B4150, B4152B4155, B4157

Formulas

Food thickener

B4100b

Food thickener, administered orally

Speaking valve

L8501

Tracheostomy speaking valve

Suction

A4628, A4605,
A4624

Oropharyngeal suction catheter; Tracheal suction
catheter, closed system; Tracheal suction catheter,
any type other than closed system

Ventilator, home
use

E0465

Home ventilator, any type, used with invasive
interface, (e.g., tracheostomy tube)

Footnote: a74230 (radiology) + 92611 (speech-language pathology) should be billed
together, b=non-billable code
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Appendix 4: Dysphagia-related variables for cluster analysis
Variable

Code

Aspiration pneumonia

J13, J14, J15.0, J15.1, J15.20, J15.211, J15.212, J15.29, J15.3, J15.4,
J15.5, J15.6, J15.8, J18.9, J69.0

Aspiration of food

T17.220, T17.320, T17.520, T17.820, T17.920, T17.420

Cognitive impairment

I69.01, I69.11, I69.21, I69.31, I69.81, I69.91, G31.84, G31.9, R41.4,
R41.81, R41.82, R41.9, S06, F01, F02, F03, F68.8

Dehydration

E86.0

Edentulous

K08.1, K08.10, K08.101, K08.102, K08.103, K08.104, K08.109,
K08.11, K08.111, K08.112, K08.113, K08.114, K08.119, K08.12,
K08.121, K08.122, K08.123, K08.124, K08.129, K08.13, K08.131,
K08.132, K08.133, K08.134, K08.139, K08.19, K08.191, K08.192,
K08.193, K08.194, K08.199

Enteral feeding

B4081b, B4082b, B4083b, B4087b, B4088b, B4102b, B4149b, B4150b,
B4152b-B4155b, B4157b

Esophageal disorder

K20.80, K20.81, K20.90, K20.91, K21.00, K21.01, K22.0, K22.5

Feeding device, insertion
(placement)

0DH90UZ, 0DH93UZ, 0DH94UZ, 0DH97UZ, 0DH98UZ, 0DH50UZ,
0DH53UZ, 0DH54UZ, 0DH57UZ, 0DH58UZ, 0DHB0UZ, 0DHB3UZ,
0DHB4UZ, 0DHB7UZ, 0DHB8UZ, 0DH80UZ, 0DH83UZ, 0DH84UZ,
0DH87UZ, 0DH88UZ, 0DHA0UZ, 0DHA3UZ, 0DHA4UZ, 0DHA7UZ,
0DHA8UZ, 0DH60UZ, 0DH63UZ, 0DH64UZ, 0DH67UZ, 0DH68UZ

Feeding device, removal

0DP50UZ, 0DP53UZ, 0DP54UZ, 0DPD0UZ, 0DPD3UZ, 0DPD4UZ,
0DP00UZ, 0DP03UZ, 0DP04UZ, 0DP60UZ, 0DP63UZ, 0DP64UZ

Feeding problems

R63.3, R63.4, R63.6, R63.8, Z93.1

Food thickener

B4100b

Malnutrition

E44.1, E44.0, E43.0, E46

Intubation

0BH17EZ
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Paralysis of vocal cords
and larynx

J38.0, J38.00, J38.01, J38.02

Respiratory problems

J80, J96, R06.0, R06.00, R06.03

Speaking valve

L8501b

Suction

A4628b, A4605b, A4624b

Swallowing assessment

F00ZHZZ, F00ZJWZ, F00ZJTZ, F00ZJYZ, 92610a, 74230a, 92611a,
92612a, 92616a

Swallowing treatment

F06ZDZZ, F06ZDMZ, F06ZDTZ, F06ZDVZ, F06ZDYZ, 92526a,
92508a

Trachectomy/
Tracheostomy

0B110F4, 0B113F4, 0B114F4, Z93.0

Tracheostomy device
removal

0BP10FZ, 0BP13FZ, 0BP1XFZ, 0BP14FZ, 0BP17FZ, 0BP18FZ

Ventilator use

5A1935Z, 5A1945Z, 5A19557, E0465b

Footnote: aCPT codes, bHCPCS codes
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Appendix 5: Healthcare costs by dysphagia severity
Clustera

Variable
N=359 (100%)

Costb Incurred
IP
OP
HH
SNf
Carrier

Mild
Dysphagia

Moderate
Dysphagia

Severe
Dysphagia

Emphasis on
cognitive
impairment
n=266 (74%)

Emphasis on
respiratory
compromise
n=42 (12%)

Emphasis on
alternative
nutrition
n=51 (14%)

Mean (SD)
Range

Mean (SD)
Range

Mean (SD)
Range

26,159 (15,282)
0-73,484
1,758 (3,545)
3- 26,838

43,933 (31,554)
6,578-134,407
1,358 (1,851)
29-8,778

26,580 (16,707)
4,960-83,053
1,063 (1,253)
22-4,747

<.0028

3,944 (2,133)
0-14,559
18,431 (10,883)
0-56,641
2,658 (2,601)
0-19,703

4,225 (2,134)
0-6,714
18,662 (11,330)
2,295-45,994
4,136 (3,411)
212-15,152

5,746 (2,088)
2,454-8,994
21,721 (11,331)
0-42,891
2,955 (2,254)
0-11,005

0.0881

p-value

0.9189

0.2131
0.0051

Footnote: N=population size, n=sample size, SD=standard deviation, IP=inpatient costs
after discharge, OP=outpatient costs, HH=home health costs, SNf=skilled nursing facility
costs, Carrier=carrier costs
a
Mild dysphagia severity with moderate stroke; Moderate dysphagia severity with
moderate/severe stroke; Severe dysphagia severity with moderate stroke.
b
Cost in United States dollars (USD).
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Appendix 6: Healthcare costs by discharge location

a

Cost
incurred
N=359
(100%)

Total 90
IP
OP
HH
SNf
Carrier

Home
n=64 (18%)
Mean (SD)
Range
10,114 (11,217)
24-46,601
13,831 (6,649)
6,290-25,666
1,226 (1,798)
10-7,675

3,962 (2,575)
372-14,559
13,393 (10,475)
1,434-30,390
1,765 (1,963)
0-13,251

Discharge Location
IPR
SNF
n=132 (37%)
n=149 (41%)
Mean (SD)
Mean (SD)
Range
Range
46,528 (21,480) 28,367 (20,604)
276-148,772
55-119,188
32,047 (14,720) 19,076 (15,912)
0-109,993
0-83,053
1,801 (3,991)
1,608 (2,880)
3-26,838
28-19,424

4,408 (1,831)
0-8,994
19,339 (9,834)
233-56,641
3,516 (2,512)
0-19,703

3,829 (2,020)
0-6,787
19,391 (11,556)
0-6,542
2,357 (2,424)
0-11,061

Trans
n=14 (4%)
Mean (SD)
Range
81,207 (41,766)
11,129-149,559

p-value

<.0001

61,136 (35,344)
6,819-134,407

<.0001

1,583 (1,320)
85-3571

0.4951

1,841 (974)
858-2,806

0.0671

17,929 (12,809)
3,852-45,994

0.5003

7,133 (4,137)
1,981-15,152

<.0001

Footnote: N=population size, n=sample size, SD=standard deviation, IPR=inpatient
rehabilitation, SNF=skilled nursing facility, Trans=transferred to another facility, Total
90=total healthcare related costs during 90-day period after discharge, IP=inpatient costs
after discharge, OP=outpatient costs, HH=home health costs, SNf= skilled nursing facility
costs, Carrier=carrier costs.
a
Cost in United States dollars (USD)

